<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//TaxonX//DTD Taxonomic Treatment Publishing DTD v0 20100105//EN" "https://pharmacia.pensoft.net/nlm/tax-treatment-NS0.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:tp="http://www.plazi.org/taxpub" article-type="review-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">89</journal-id>
      <journal-id journal-id-type="index">urn:lsid:arphahub.com:pub:CCBBD2E1-BDAF-5702-AE4B-0E4910A4C7D6</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">Pharmacia</journal-title>
        <abbrev-journal-title xml:lang="en">PHAR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0428-0296</issn>
      <issn pub-type="epub">2603-557X</issn>
      <publisher>
        <publisher-name>Bulgarian Pharmaceutical Scientific Society</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3897/pharmacia.72.e159352</article-id>
      <article-id pub-id-type="publisher-id">159352</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review Article</subject>
        </subj-group>
        <subj-group subj-group-type="scientific_subject">
          <subject>Pharmaceutics</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>﻿Pharmacological applications of azomethine derivatives in the therapy of different diseases</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Pencheva</surname>
            <given-names>Ivanka</given-names>
          </name>
          <uri content-type="orcid">https://orcid.org/0000-0002-8974-1694</uri>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Peikova</surname>
            <given-names>Lily</given-names>
          </name>
          <uri content-type="orcid">https://orcid.org/0000-0002-8030-3479</uri>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Tsvetkova</surname>
            <given-names>Dobrina</given-names>
          </name>
          <email xlink:type="simple">dtsvetkova@pharmfac.mu-sofia.bg</email>
          <uri content-type="orcid">https://orcid.org/0000-0002-4284-8101</uri>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
        <label>1</label>
        <addr-line content-type="verbatim">Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University, Sofia, Bulgaria</addr-line>
        <institution>Medical University</institution>
        <addr-line content-type="city">Sofia</addr-line>
        <country>Bulgaria</country>
      </aff>
      <author-notes>
        <fn fn-type="corresp">
          <p>Corresponding author: Dobrina Tsvetkova (<email xlink:type="simple">dtsvetkova@pharmfac.mu-sofia.bg</email>)</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2025</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>08</month>
        <year>2025</year>
      </pub-date>
      <volume>72</volume>
      <fpage>1</fpage>
      <lpage>17</lpage>
      <uri content-type="arpha" xlink:href="http://openbiodiv.net/C78C3D66-3EA2-530A-A18B-B2AC405C9199">C78C3D66-3EA2-530A-A18B-B2AC405C9199</uri>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>05</month>
          <year>2025</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>05</month>
          <year>2025</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Ivanka Pencheva, Lily Peikova, Dobrina Tsvetkova</copyright-statement>
        <license license-type="creative-commons-attribution" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <label>﻿Abstract</label>
        <p>Compounds with an azomethine structure belong to different chemical classes—they are hydrazones, phenylhydrazones, semicarbazones, thiosemicarbazones, and oximes. Interest in these compounds has been particularly high recently due to the fact that they exhibit a number of biological activities. The presence of an azomethine group has been found to be responsible for the anticancer, antibacterial, antiviral, anti-COVID-19, antifungal, antimalarial, anthelmintic, anti-inflammatory, antioxidant, anti-Alzheimer, antidiabetic, antiarthritic, antidepressant, and antiepileptic pharmacological activities. The fragment of the azomethine group is contained in the chemical structure of a large number of drugs with applications in the treatment of various pathologies. Drugs—azomethine derivatives with the following pharmacological effects—are used in therapy: antitumor: mitoguazone, triapine, zorubicin; antiinfective: nitrofurazone, nitrofurantoin, nifurzide, nifuroxazide, nifuratel; antiviral: metisazone; antiarrhythmic: azimilide; acetylcholinesterase reactivators: pralidoxime, obidoxime, rimedoxime, methoxime; muscle relaxants: dantrolene, azumolene; antiplatelet: carbazochrome; antimigraine: iprazochrome; antidepressants: fluvoxamine; antimicrobial oxime-based cephalosporins—2<sup>nd</sup> generation: cefuroxime, cefuzonam, cefteram; 3<sup>rd</sup> generation: cefdinir, cefdaloxime, cefixime, ceftizoxime, cefetamet, cefpodoxime, cefotaxime, cefditoren, cefodizime, ceftiofur, cefteram, cefmenoxime, ceftriaxone, ceftiolene, ceftazidime; 4<sup>th</sup> generation: cefepime, cefpirome, cefozoprame; 5<sup>th</sup> generation: ceftobiprole, ceftaroline, cefiderocol.</p>
        <p>This article reviews in detail compounds containing Schiff bases and their derivatives, including drugs with an azomethine structure, as well as their biological properties and applications.</p>
      </abstract>
      <kwd-group>
        <label>Keywords</label>
        <kwd>azomethine drugs</kwd>
        <kwd>pharmacological effects</kwd>
        <kwd>diseases</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <sec sec-type="Citation" id="SECID0EZD">
        <title>Citation</title>
        <p>Pencheva I, Peikova L, Tsvetkova D (2025) Pharmacological applications of azomethine derivatives in the therapy of different diseases. Pharmacia 72: 1–17. <ext-link xlink:href="10.3897/pharmacia.72.e159352" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3897/pharmacia.72.e159352</ext-link></p>
      </sec>
    </notes>
  </front>
  <body>
    <sec sec-type="﻿Introduction" id="SECID0EEE">
      <title>﻿Introduction</title>
      <sec sec-type="﻿I. Schiff bases" id="SECID0EIE">
        <title>﻿I. Schiff bases</title>
        <p>Schiff bases are compounds with an azomethine structure, which are formed as a result of the nucleophilic addition reaction of aldehydes and ketones to primary amines and which contain an azomethine group (–CH=N–) in their structure (R<sub>1</sub>, R<sub>2</sub>, and R<sub>3</sub> are alkyl or aryl substituents) (Fig. <xref ref-type="fig" rid="F1">1</xref>; <xref ref-type="bibr" rid="B150">Subasi 2022</xref>).</p>
        <fig id="F1" position="float" orientation="portrait">
          <object-id content-type="doi">10.3897/pharmacia.72.e159352.figure1</object-id>
          <object-id content-type="arpha">FF8ACABC-1BAD-537E-AAEE-2C9768D76F9B</object-id>
          <label>Figure 1.</label>
          <caption>
            <p>Structure of Schiff bases.</p>
          </caption>
          <graphic xlink:href="pharmacia-72-e159352-g001.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_1401512.jpg">
            <uri content-type="original_file">https://binary.pensoft.net/fig/1401512</uri>
          </graphic>
        </fig>
        <p>For the first time, azomethine derivatives were obtained by the German scientist Hugo Schiff in 1864 by condensation of a carbonyl group (aldehyde, ketone) with a primary aliphatic or aromatic amine. In the first step of the Schiff base synthesis, a carbinolamine intermediate is formed from the condensation of the carbonyl group with the primary amine, and in the second step, a Schiff base is obtained from the dehydration of the intermediate (<xref ref-type="bibr" rid="B150">Subasi 2022</xref>).</p>
        <p>The types of amines that are condensed with carbonyl compounds are derivatives of hydroxylamine, hydrazine, phenylhydrazine, semicarbazide, thiosemicarbazide, and hydroxylamine. The names of the respective condensation products, depending on the type of amine, can be classified as hydrazones, phenylhydrazones, semicarbazones, thiosemicarbazones, and oximes (<xref ref-type="bibr" rid="B124">Raczuk et al. 2022</xref>).</p>
        <p>The electron pairs on the nitrogen atom in the azomethine group determine basic properties. In Schiff compounds derived from aldehydes containing an ortho-hydroxy group, there are two tautomeric structures: phenol-imine and ketone-amine, which are identified by nuclear magnetic resonance (NMR), UV-VIS spectrophotometry, and X-ray crystallography. In studies with Schiff bases derived from 2-hydroxy-1-naphthaldehyde and some aromatic and aliphatic amines (ammonia, methylamine, and phenylamine), it has been observed that the keto form is dominant in polar solvents, while the enol form is predominant in nonpolar solvents (<xref ref-type="bibr" rid="B150">Subasi 2022</xref>).</p>
        <p>The azomethine bond (–CH=N–) is a weak chromophore that absorbs in the ultraviolet region. Conjugation with phenyl groups causes a bathochromic shift of the absorption maximum of the –CH=N– chromophore to the visible region. In the presence of deactivating substituents in the aromatic ring, such as a halogen atom, the wavelength of the absorption maximum decreases due to the hypsochromic effect of the substituents. The infrared bands of the –CH=N– bond are observed in the interval 1610 cm<sup>−1</sup> – 1635 cm<sup>−1</sup> (<xref ref-type="bibr" rid="B150">Subasi 2022</xref>).</p>
        <p>Over the past few decades, there has been great interest in Schiff derivatives (<xref ref-type="bibr" rid="B6">Al Zoubi et al. 2018</xref>; <xref ref-type="bibr" rid="B9">Aljamali et al. 2021</xref>). The presence of an azomethine group (<xref ref-type="bibr" rid="B9">Aljamali et al. 2021</xref>) has been found to be responsible for the following main important pharmacological activities of Schiff bases (<xref ref-type="bibr" rid="B31">Chaubey and Pandeya 2012</xref>): antitumor (<xref ref-type="bibr" rid="B67">Howsaui et al. 2021</xref>) and antibacterial (<xref ref-type="bibr" rid="B32">Chen et al. 2019</xref>; <xref ref-type="bibr" rid="B53">Gacitúa et al. 2022</xref>).</p>
        <sec sec-type="﻿1. Antitumor activity of Schiff derivatives" id="SECID0ECH">
          <title>﻿<italic>1. Antitumor activity of Schiff derivatives</italic></title>
          <p>It has been described that the anticancer effect is exerted by Schiff bases of:</p>
          <list list-type="order">
            <list-item>
              <p>Isatin (<xref ref-type="bibr" rid="B85">Liang et al. 2014</xref>) and pyrazole (<xref ref-type="bibr" rid="B64">Hassan et al. 2023</xref>);
</p>
            </list-item>
            <list-item>
              <p>Benzimidazole and its complexes (<xref ref-type="bibr" rid="B89">Magd-El-Din et al. 2018</xref>);
</p>
            </list-item>
            <list-item>
              <p>Bases containing nitro groups (<xref ref-type="bibr" rid="B9">Aljamali et al. 2021</xref>);
</p>
            </list-item>
            <list-item>
              <p>Co(II), Ni(II), and Cu(II) complexes of Schiff bases of 4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol (<xref ref-type="bibr" rid="B156">Tyagi et al. 2015</xref>).
</p>
            </list-item>
          </list>
          <p>Bases of 5-chloroisatin (<xref ref-type="bibr" rid="B120">Pervez et al. 2016</xref>), sulfamoylisatin (<xref ref-type="bibr" rid="B99">Meenakshi et al. 2015</xref>), and 5-morpholinosulfonylisatin (<xref ref-type="bibr" rid="B17">Ammar et al. 2018</xref>) have been studied for antitumor properties. It has been found that bis-bases of 5-chloroisatin and their Cu(II) complexes are effective against the H157 lung carcinoma cell line (<xref ref-type="bibr" rid="B120">Pervez et al. 2016</xref>). Phenylenediamine, 5-morpholinosulfonylisatin, and bis(morpholinosulfonyl)-2-indolinone Schiff analogues with antiproliferative activity towards the HCT116 cell line have been obtained (<xref ref-type="bibr" rid="B69">Iacopetta et al. 2011</xref>; <xref ref-type="bibr" rid="B17">Ammar et al. 2018</xref>).</p>
          <p>Schiff derivatives and their metal complexes (<xref ref-type="bibr" rid="B153">Tadele and Tsega 2019</xref>) exhibit antitumor activity, such as Pt(II) complexes based on Schiff bases with effects in breast cancer (<xref ref-type="bibr" rid="B103">Moghadam et al. 2023</xref>).</p>
        </sec>
        <sec sec-type="﻿2. Antimicrobial activity of Schiff bases" id="SECID0EMBAC">
          <title>﻿<italic>2. Antimicrobial activity of Schiff bases</italic></title>
          <p>It has been shown that Schiff compounds containing nitro groups possess antimicrobial effects (<xref ref-type="bibr" rid="B9">Aljamali et al. 2021</xref>). Schiff derivatives of 5-chlorosalicylaldehyde exert antibacterial activity against strains of <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Escherichia">Escherichia</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="coli">coli</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Staphylococcus">Staphylococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="aureus">aureus</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Micrococcus">Micrococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="luteus">luteus</tp:taxon-name-part></tp:taxon-name></italic>. Schiff compounds of salicylaldehyde have antibacterial properties towards <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Mycobacterium">Mycobacterium</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="tuberculosis">tuberculosis</tp:taxon-name-part></tp:taxon-name></italic>. Schiff agents synthesized from 2-hydroxy-1-naphthaldehyde and α-amino acids (L-tyrosine, L-arginine, and L-lysine) and their manganese complexes are potential antibacterial agents against Gram-positive and Gram-negative bacteria (<xref ref-type="bibr" rid="B106">Mukhtar et al. 2021</xref>). Bis-Schiff bases, derivatives of 5-substituted isatins with diamines such as 4,4’-diaminophenyl and 3,3-dimethoxybenzidine, give bis-N-[(1,3-dihydro)-2H-indol-2-one]4,4-diamino-1,1-biphenyl derivatives, which are effective against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Staphylococcus">Staphylococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="aureus">aureus</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Staphylococcus">Staphylococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="epidermidis">epidermidis</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Escherichia">Escherichia</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="coli">coli</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Klebsiella">Klebsiella</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="pneumoniae">pneumoniae</tp:taxon-name-part></tp:taxon-name></italic>, and fungi (<italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Aspergillus">Aspergillus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="flavus">flavus</tp:taxon-name-part></tp:taxon-name></italic> and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Candida">Candida</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="albicans">albicans</tp:taxon-name-part></tp:taxon-name></italic>) (<xref ref-type="bibr" rid="B77">Kandile et al. 2017</xref>). Bis-Schiff bases, derivatives of 3-(4-aminophenylimino)-5-fluoro-2H-indolin-2-one (Nirma et al. 2010) and of 5-nitroisatin (<xref ref-type="bibr" rid="B122">Prakash and Raja 2013</xref>), exhibit activity against the bacterial strains <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Staphylococcus">Staphylococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="aureus">aureus</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Staphylococcus">Staphylococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="epidermidis">epidermidis</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Bacillus">Bacillus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="cereus">cereus</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Escherichia">Escherichia</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="coli">coli</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Klebsiella">Klebsiella</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="pneumoniae">pneumoniae</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Micrococcus">Micrococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="luteus">luteus</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Pseudomonas">Pseudomonas</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="aeruginosa">aeruginosa</tp:taxon-name-part></tp:taxon-name></italic>, and against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Aspergillus">Aspergillus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="fumigatus">fumigatus</tp:taxon-name-part></tp:taxon-name></italic> and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Aspergillus">Aspergillus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="niger">niger</tp:taxon-name-part></tp:taxon-name></italic> (Nirma et al. 2010; <xref ref-type="bibr" rid="B122">Prakash and Raja 2013</xref>).</p>
          <p>Metal complexes of Schiff bases have been studied for antibacterial properties (<xref ref-type="bibr" rid="B161">Waddai et al. 2018</xref>; <xref ref-type="bibr" rid="B75">Jorge et al. 2024</xref>). Schiff analogues of isatin and 2,3-diaminobutane and their metal complexes are potentially effective against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Staphylococcus">Staphylococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="aureus">aureus</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Escherichia">Escherichia</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="coli">coli</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Candida">Candida</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="albicans">albicans</tp:taxon-name-part></tp:taxon-name></italic> (Katherashala and Bollam 2014). Compared to chloramphenicol, the palladium complex of a bis-Schiff base synthesized by condensation of isatin with 1,3-diaminopropane has been confirmed to possess stronger activity against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Staphylococcus">Staphylococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="aureus">aureus</tp:taxon-name-part></tp:taxon-name></italic> and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Escherichia">Escherichia</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="coli">coli</tp:taxon-name-part></tp:taxon-name></italic> (<xref ref-type="bibr" rid="B144">Shukla et al. 2015</xref>). Bis-Schiff bases of isatin with ciprofloxacin are active against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Staphylococcus">Staphylococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="aureus">aureus</tp:taxon-name-part></tp:taxon-name></italic> and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Pseudomonas">Pseudomonas</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="aeruginosa">aeruginosa</tp:taxon-name-part></tp:taxon-name></italic> (<xref ref-type="bibr" rid="B122">Prakash and Raja 2013</xref>). Bis-Schiff derivatives of 5-methoxyisatin with thiophene-2-carboxaldehyde have been found to be more active than amoxicillin against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Staphylococcus">Staphylococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="aureus">aureus</tp:taxon-name-part></tp:taxon-name></italic> (<xref ref-type="bibr" rid="B11">Al-Mudhafar and Kamoon 2020</xref>).</p>
          <p>The mechanisms of action of Schiff bases on microorganisms depend on the metabolic processes and the structure of the cell wall. One hypothesis is that the cell wall of microorganisms is disrupted as a result of hydrogen bonds forming between the imine groups of Schiff derivatives and the active centers of microbial cells. Another mechanism involves denaturation of one or more cellular proteins, which disrupts normal cellular functions. The effect may also be based on the ability of the imine groups of Schiff analogues to form complexes with metals Mg², Zn², and Ca², which are necessary for bacterial metabolic processes and growth. The stronger activity of bis-Schiff bases of isatin is due to the presence of two imine groups (–C=N–), which bind more effectively to the cell wall of bacteria (<xref ref-type="bibr" rid="B125">Raju et al. 2022</xref>). Isatin Schiff base derivatives exert activity against fungal strains <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Candida">Candida</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="albicans">albicans</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Cryptococcus">Cryptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="neoformans">neoformans</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Epidermophyton">Epidermophyton</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="floccosum">floccosum</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Microsporum">Microsporum</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="audouinii">audouinii</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Microsporum">Microsporum</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="gypseum">gypseum</tp:taxon-name-part></tp:taxon-name></italic> (<xref ref-type="bibr" rid="B24">Aziz et al. 2020</xref>).</p>
          <p>Antibacterial properties exhibit bis-Schiff bases of:</p>
          <list list-type="order">
            <list-item>
              <p>4-chloro-2-aminophenol and salicylaldehyde derivatives (<xref ref-type="bibr" rid="B35">Cinarli et al. 2012</xref>);
</p>
            </list-item>
            <list-item>
              <p>4-methyl-2-aminophenol and aldehydes (<xref ref-type="bibr" rid="B59">Gürbüz et al. 2012</xref>);
</p>
            </list-item>
            <list-item>
              <p>3,3’-diaminodipropylamine and benzaldehyde (<xref ref-type="bibr" rid="B94">Matar et al. 2015</xref>);
</p>
            </list-item>
            <list-item>
              <p>5-aminopyrazole (<xref ref-type="bibr" rid="B63">Hassan et al. 2019</xref>);
</p>
            </list-item>
            <list-item>
              <p>Co(II), Ni(II), and Cu(II) complexes (<xref ref-type="bibr" rid="B48">El-Gammal et al. 2021</xref>; <xref ref-type="bibr" rid="B151">Sumalatha et al. 2021</xref>);
</p>
            </list-item>
            <list-item>
              <p>Co(II), Cu(II), Cd(II), and Mn(II) complexes of Schiff bases of amino acids (<xref ref-type="bibr" rid="B119">Pervaiz et al. 2019</xref>);
</p>
            </list-item>
            <list-item>
              <p>Isatin and 2,3-diaminobutane and their metal complexes (Katherashala and Bollam 2014).
</p>
            </list-item>
          </list>
          <p>It has been investigated that different derivatives possess antibacterial potential, such as Schiff bases of:</p>
          <list list-type="order">
            <list-item>
              <p>5-nitroisatin; isatin and ciprofloxacin (<xref ref-type="bibr" rid="B122">Prakash and Raja 2013</xref>); 5-substituted isatins with diamines (<xref ref-type="bibr" rid="B77">Kandile et al. 2017</xref>);
</p>
            </list-item>
            <list-item>
              <p>3-(4-amino)phenylimino)-5-fluoroindolin-2-one (Nirma et al. 2010);
</p>
            </list-item>
            <list-item>
              <p>Isatin with 1,3-diaminopropane and their palladium complexes (<xref ref-type="bibr" rid="B144">Shukla et al. 2015</xref>).
</p>
            </list-item>
          </list>
          <p>Antituberculosis activity has been demonstrated for Schiff bases of 1-alkylisatin, hydrazide of isonicotinic acid (<xref ref-type="bibr" rid="B2">Aboul-Fadl et al. 2003</xref>), and of isatin (1H-indole-2,3-dione) (<xref ref-type="bibr" rid="B126">Rangaraju et al. 2013</xref>). It has been observed that the antituberculosis effect is exerted by bis-Schiff bases of isatin with p-dimethylaminobenzaldehyde and their coordination complexes with Co(II), Ni(II), Cu(II), and Mn(II) (Sangamesh et al. 2011).</p>
          <p>Other pharmacological activities of Schiff bases include antiviral (<xref ref-type="bibr" rid="B32">Chen et al. 2019</xref>; <xref ref-type="bibr" rid="B80">Kaushik et al. 2023</xref>), anti-COVID-19 (<xref ref-type="bibr" rid="B13">Alshammari et al. 2021</xref>), antifungal (<xref ref-type="bibr" rid="B88">Magalhães et al. 2020</xref>), antimalarial (<xref ref-type="bibr" rid="B5">Aggarwal et al. 2018</xref>), anthelmintic (<xref ref-type="bibr" rid="B92">Mathew et al. 2010</xref>), anti-inflammatory (<xref ref-type="bibr" rid="B132">Sandhu et al. 2023</xref>), antioxidant (<xref ref-type="bibr" rid="B9">Aljamali et al. 2021</xref>), anti-Alzheimer, antiarthritic (<xref ref-type="bibr" rid="B10">Alkahtani et al. 2023</xref>), antidepressant (<xref ref-type="bibr" rid="B102">Mesripour et al. 2023</xref>), antiepileptic (<xref ref-type="bibr" rid="B31">Chaubey and Pandeya 2012</xref>), and antidiabetic (Abbasi et al. 2021; <xref ref-type="bibr" rid="B37">Daoud et al. 2022</xref>).</p>
          <p>Bis-Schiff bases of isatin-thiazole exhibit anti-HIV properties (<xref ref-type="bibr" rid="B101">Meleddu et al. 2017</xref>). It has been evaluated that Schiff bases of N-substituted 2-quinolonyl-acetohydrazides possess antiviral potential (<xref ref-type="bibr" rid="B13">Alshammari et al. 2021</xref>).</p>
          <p>Cinnamyl-Schiff bases are known as antifungal agents (<xref ref-type="bibr" rid="B88">Magalhães et al. 2020</xref>).</p>
          <p>It has been demonstrated that Schiff bases of pyrazole possess antimalarial activity (<xref ref-type="bibr" rid="B5">Aggarwal et al. 2018</xref>).</p>
          <p>Schiff bases of 1,3,4-thiadiazole derivatives exert an anthelmintic effect (<xref ref-type="bibr" rid="B92">Mathew et al. 2010</xref>).</p>
          <p>It has been reported that Schiff bases of pyrazole (<xref ref-type="bibr" rid="B10">Alkahtani et al. 2023</xref>), thymol, and carvacrol (<xref ref-type="bibr" rid="B83">Kumar and Rawat 2013</xref>) exhibit antioxidant properties.</p>
          <p>Schiff bases of pyrazole (<xref ref-type="bibr" rid="B10">Alkahtani et al. 2023</xref>) and coumarin (<xref ref-type="bibr" rid="B61">Hasan et al. 2023</xref>) can play a beneficial role against Alzheimer’s disease.</p>
          <p>It has been described that Schiff bases of isatin with 2-aminopyridine possess antiepileptic potential (<xref ref-type="bibr" rid="B31">Chaubey and Pandeya 2012</xref>). Antiepileptic activity has been observed for bis-Schiff bases of lamotrigine with isatin and 5-chloroisatin (<xref ref-type="bibr" rid="B82">Kulkarni et al. 2017</xref>).</p>
          <p>Bis-Schiff derivatives (<xref ref-type="bibr" rid="B37">Daoud et al. 2022</xref>) exert an antidiabetic effect, which is due to their ability to inhibit the enzymes α-amylase and α-glucosidase (Abbasi et al. 2021).</p>
        </sec>
        <sec sec-type="﻿3. Multitarget profile of activity of Schiff bases" id="SECID0EFEAE">
          <title>﻿<italic>3. Multitarget profile of activity of Schiff bases</italic></title>
          <p>A number of Schiff compounds have been found to exhibit a multitarget profile of activity. Esters of Schiff analogues are potential anticancer, antioxidant, and anti-inflammatory agents (<xref ref-type="bibr" rid="B109">Noureen et al. 2013</xref>). Mono- and bis-Schiff bases of morpholine derivatives have been studied for antitumor and antimalarial activity (<xref ref-type="bibr" rid="B72">Jarrahpour et al. 2015</xref>). Antimicrobial and antioxidant properties of Schiff agents containing aromatic nitro groups (<xref ref-type="bibr" rid="B158">Vhanale et al. 2022</xref>) and Co(II), Ni(II), and Cu(II) complexes of Schiff bases have been observed (<xref ref-type="bibr" rid="B151">Sumalatha et al. 2021</xref>).</p>
          <p>Schiff derivatives of 4-[(1E)-N-(2-aminoethyl)ethanimidoyl]benzene-1,3-diol have been confirmed to possess antimicrobial, antioxidant, and antitumor effects (<xref ref-type="bibr" rid="B47">Ejidike and Ajibade 2016</xref>). It has been reported that metal Fe(II), Co(II), Cu(II), Ni(II), and Zn(II) complexes of the Schiff base of triazole, 2-{(E)-[(3-{[(Z)-(2-hydroxyphenyl)methylidene)]amino}-1H-1,2,4-triazol-5-yl)imino]methyl}phenol, obtained from the condensation reaction of 2-hydroxybenzaldehyde with 3,5-diamino-1,2,4-triazole, exhibit antimicrobial, antioxidant, and anti-acetylcholinesterase effects (<xref ref-type="bibr" rid="B152">Sumrra et al. 2018</xref>). Schiff bases of 2-amino-5-aryl-1,3,4-thiadiazole exert potential antibacterial, antituberculosis, analgesic, and anti-inflammatory activity (<xref ref-type="bibr" rid="B115">Pandey et al. 2012</xref>).</p>
          <p>It has been described that Schiff compounds derived from 4-aminoantipyrine analogues have analgesic, antipyretic, and antirheumatic properties (<xref ref-type="bibr" rid="B106">Mukhtar et al. 2021</xref>). Pyrazole Schiff derivatives have been found to be potential antioxidant, anti-Alzheimer, antidiabetic, and antiarthritic agents (<xref ref-type="bibr" rid="B10">Alkahtani et al. 2023</xref>).</p>
          <p>Schiff bases synthesized from 2-naphthaldehyde-substituted aromatic amines have been studied for antioxidant and anti-Alzheimer effects (<xref ref-type="bibr" rid="B111">Oladipo et al. 2023</xref>). The antiarthritic (<xref ref-type="bibr" rid="B37">Daoud et al. 2022</xref>) and anti-inflammatory activities are related to the ability of these agents to suppress the activity of proteinase enzymes, which is an indicator of inflammatory processes (<xref ref-type="bibr" rid="B115">Pandey et al. 2012</xref>).</p>
          <p>It has been investigated that Schiff analogues of isatin (2,3-dioxindole) (<xref ref-type="bibr" rid="B24">Aziz et al. 2020</xref>) with aryl aldehydes, heteroaryl aldehydes, and dialdehydes are characterized by multitarget activity (<xref ref-type="bibr" rid="B64">Hassan et al. 2023</xref>), such as antibacterial, antiviral, and fungicidal effects (<xref ref-type="bibr" rid="B71">Jarrahpour et al. 2007</xref>). Antimicrobial, analgesic, and anti-inflammatory properties have been established for Schiff derivatives of 5-substituted isatin (<xref ref-type="bibr" rid="B116">Panneerselvam et al. 2010</xref>). Bis-Schiff bases of isatin exhibit antibacterial, antiviral, and antioxidant effects (<xref ref-type="bibr" rid="B12">Al-Mudhafar et al. 2022</xref>).</p>
          <p>Antimicrobial, antifungal, and anti-inflammatory activity has been demonstrated for bis-Schiff derivatives of 5-fluorosubstituted isatin (<xref ref-type="bibr" rid="B122">Prakash and Raja 2013</xref>). It has been confirmed that bis-Schiff bases of 5-sulfamoyl isatin possess anti-inflammatory properties and are active against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Staphylococcus">Staphylococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="epidermidis">epidermidis</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Pseudomonas">Pseudomonas</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="aeruginosa">aeruginosa</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Fusarium">Fusarium</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="oxysporum">oxysporum</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Aspergillus">Aspergillus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="flavus">flavus</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Penicillium">Penicillium</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="notatum">notatum</tp:taxon-name-part></tp:taxon-name></italic> (<xref ref-type="bibr" rid="B86">Lingala et al. 2013</xref>).</p>
        </sec>
      </sec>
      <sec sec-type="﻿II. Hydrazones" id="SECID0E1IAE">
        <title>﻿II. Hydrazones</title>
        <p>Compounds containing an azomethine moiety include hydrazones (<xref ref-type="bibr" rid="B82">Kulkarni et al. 2017</xref>), semicarbazones (<xref ref-type="bibr" rid="B82">Kulkarni et al. 2017</xref>), thiosemicarbazones (<xref ref-type="bibr" rid="B60">Güzel et al. 2008</xref>), and oximes (Dhuguru et al<xref ref-type="bibr" rid="B45">. 2022</xref>).</p>
        <p>Hydrazones represent an important class of biologically active drug molecules containing an azomethine –CH=N–NH– group and are formed by the reaction of hydrazine or hydrazide with aldehydes and ketones. The azomethine structure determines a wide range of pharmacological properties of N-acylhydrazones (<xref ref-type="bibr" rid="B155">Thota et al. 2018</xref>; Dhuguru et al<xref ref-type="bibr" rid="B45">. 2022</xref>), which exhibit antitumor (<xref ref-type="bibr" rid="B84">Li et al. 2018</xref>; <xref ref-type="bibr" rid="B19">Aneja et al. 2019</xref>; <xref ref-type="bibr" rid="B42">Demurtas et al. 2019</xref>; <xref ref-type="bibr" rid="B56">Govindaiah et al. 2019</xref>; <xref ref-type="bibr" rid="B27">Banumathi et al. 2022</xref>; <xref ref-type="bibr" rid="B139">Shah et al. 2022</xref>; Vilková<xref ref-type="bibr" rid="B45"> 2022</xref>; Kassab et al. 2023), antimicrobial (Guilherme 2019; <xref ref-type="bibr" rid="B127">Rezki et al. 2019</xref>; <xref ref-type="bibr" rid="B166">Yao et al. 2021</xref>), antituberculosis (<xref ref-type="bibr" rid="B29">Bonnett et al. 2018</xref>; <xref ref-type="bibr" rid="B91">Mandewale et al. 2019</xref>; <xref ref-type="bibr" rid="B129">Rohane et al. 2020</xref>), antiviral—including against Epstein-Barr virus (<xref ref-type="bibr" rid="B128">Reznichenko et al. 2019</xref>) and HIV (<xref ref-type="bibr" rid="B167">Yoneda et al. 2014</xref>)—fungicidal (<xref ref-type="bibr" rid="B90">Mali et al. 2021</xref>), antimalarial (<xref ref-type="bibr" rid="B46">dos Santos Filho et al. 2016</xref>), anti-Leishmanial (<xref ref-type="bibr" rid="B70">Jacomini et al. 2016</xref>; <xref ref-type="bibr" rid="B160">Visbal et al. 2023</xref>), anthelmintic, antiprotozoal, antischistosome (<xref ref-type="bibr" rid="B147">Socea et al. 2022</xref>), and trypanocidal (<xref ref-type="bibr" rid="B137">Serafim et al. 2014</xref>) effects.</p>
        <p>Antitumor activity has been demonstrated for hydrazones of acridine (Vilková<xref ref-type="bibr" rid="B45"> 2022</xref>), coumarin (<xref ref-type="bibr" rid="B56">Govindaiah et al. 2019</xref>), indole (<xref ref-type="bibr" rid="B42">Demurtas et al. 2019</xref>), isoniazid (<xref ref-type="bibr" rid="B139">Shah et al. 2022</xref>), α-carboline (<xref ref-type="bibr" rid="B84">Li et al. 2018</xref>), and azo-hydrazones (<xref ref-type="bibr" rid="B27">Banumathi et al. 2022</xref>). Isatin-triazole hydrazones have been developed as potential inhibitors of microtubule kinase and are promising agents for the treatment of cell proliferation and metastasis (<xref ref-type="bibr" rid="B19">Aneja et al. 2019</xref>). It has been reported that azo-hydrazone analogues exert activity against solid tumors by stimulating death signaling pathways (<xref ref-type="bibr" rid="B27">Banumathi et al. 2022</xref>). Some indole hydrazones can be used as multifunctional agents due to their antiproliferative and antioxidant effects (<xref ref-type="bibr" rid="B42">Demurtas et al. 2019</xref>).</p>
        <p>Coumarin-hydrazone derivatives have been designed as compounds targeting tubulin and reducing cancer cell growth (<xref ref-type="bibr" rid="B56">Govindaiah et al. 2019</xref>). α-Carboline/acylhydrazone hybrids have been discovered as antitumor agents capable of overcoming cancer drug resistance (<xref ref-type="bibr" rid="B84">Li et al. 2018</xref>). Hydrazone derivatives of isonicotinic hydrazide exhibit cytotoxic and antibacterial potential (<xref ref-type="bibr" rid="B139">Shah et al. 2022</xref>). Acridine-based N-acylhydrazone analogues have been investigated as promising anticancer agents (<xref ref-type="bibr" rid="B159">Vilková et al. 2022</xref>).</p>
        <p>By inducing apoptosis, the derivative 5-bromo-1-methyl-N’-[(E)-(1-methyl-1H-indol-3-yl)methylidene]-1H-indol-3-carbohydrazide possesses anticancer activity in breast and colon tumors. The compound 1-(4-methoxybenzyl)-N’-(7-methyl-2-oxoindolin-3-ylidene)-1H-1,2,3-triazole-4-carbohydrazide has shown antiproliferative effects (<xref ref-type="bibr" rid="B19">Aneja et al. 2019</xref>). The derivatives N’-(1-(4,7-dihydroxy-2-oxo-2H-chromen-3-yl)ethylidene)benzohydrazide and N’-(1-(4-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene)benzohydrazide exert antiproliferative activity comparable to doxorubicin.</p>
        <p>Acylhydrazones exhibit antimicrobial effects against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Bacillus">Bacillus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="subtilis">subtilis</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Clostridium">Clostridium</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="difficile">difficile</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Enterococcus">Enterococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="faecalis">faecalis</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Escherichia">Escherichia</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="coli">coli</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Haemophilus">Haemophilus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="influenzae">influenzae</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Mycobacterium">Mycobacterium</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="tuberculosis">tuberculosis</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Pseudomonas">Pseudomonas</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="aeruginosa">aeruginosa</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Salmonella">Salmonella</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="typhimurium">typhimurium</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Staphylococcus">Staphylococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="aureus">aureus</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">Streptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic>, and possess antiparasitic activity toward <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Entamoeba">Entamoeba</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="histolytica">histolytica</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Leishmania">Leishmania</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="amazonensis">amazonensis</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Trypanosoma">Trypanosoma</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="cruzi">cruzi</tp:taxon-name-part></tp:taxon-name></italic> (<xref ref-type="bibr" rid="B147">Socea et al. 2022</xref>).</p>
        <p>Antibacterial effects are exhibited by hydrazones of isoniazid (<xref ref-type="bibr" rid="B139">Shah et al. 2022</xref>), pyridine (<xref ref-type="bibr" rid="B127">Rezki et al. 2019</xref>), and aminoguanine (<xref ref-type="bibr" rid="B166">Yao et al. 2021</xref>). Acylhydrazones derived from carbohydrates also demonstrate antimicrobial activity (Guilherme 2019). Pyridinium hydrazone-phenoxy conjugates have been evaluated for targeting resistant microbial strains due to their antibacterial potential (<xref ref-type="bibr" rid="B127">Rezki et al. 2019</xref>). Aminoguanidine derivatives containing an acylhydrazone moiety exert antimicrobial effects (<xref ref-type="bibr" rid="B166">Yao et al. 2021</xref>).</p>
        <p>Hydrazones of quinoline (<xref ref-type="bibr" rid="B91">Mandewale et al. 2019</xref>) and eugenol (<xref ref-type="bibr" rid="B129">Rohane et al. 2020</xref>) are active against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Mycobacterium">Mycobacterium</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="tuberculosis">tuberculosis</tp:taxon-name-part></tp:taxon-name></italic> (<xref ref-type="bibr" rid="B29">Bonnett et al. 2018</xref>). Zinc complexes of hydrazone derivatives of 3,4-dihydroquinolin-2-one have been studied for antitubercular properties (<xref ref-type="bibr" rid="B91">Mandewale et al. 2019</xref>). Hydrazones of eugenol have been developed as in vitro antimycobacterial agents (<xref ref-type="bibr" rid="B129">Rohane et al. 2020</xref>).</p>
        <p>Bis(acylhydrazones) are modulators of Epstein–Barr virus immune evasion (<xref ref-type="bibr" rid="B128">Reznichenko et al. 2019</xref>). Oxoquinoline-acylhydrazone derivatives have been reported as inhibitors of HSV-1 DNA polymerase and may be used against HIV-1 (<xref ref-type="bibr" rid="B167">Yoneda et al. 2014</xref>).</p>
        <p>Anti-leishmanial properties have been established for naphthylacylhydrazones (<xref ref-type="bibr" rid="B160">Visbal et al. 2023</xref>) and pyrazolohydrazones (<xref ref-type="bibr" rid="B70">Jacomini et al. 2016</xref>). Some antimalarial compounds have been obtained from conjugation of N-acylhydrazone and 1,2,4-oxadiazoles (<xref ref-type="bibr" rid="B46">dos Santos Filho et al. 2016</xref>). Zinc(II)-sterol hydrazone complexes exhibit antiparasitic action against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Leishmania">Leishmania</tp:taxon-name-part></tp:taxon-name></italic> (<xref ref-type="bibr" rid="B160">Visbal et al. 2023</xref>).</p>
        <p>Pyrazolo[3,4-d]pyridazinone-N-acylhydrazone-(bi)thiophene hybrids have been reported to possess activity against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Leishmania">Leishmania</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="amazonensis">amazonensis</tp:taxon-name-part></tp:taxon-name></italic> (<xref ref-type="bibr" rid="B70">Jacomini et al. 2016</xref>). Hybrid derivatives of N-acylhydrazone and furoxan groups exert selective anti-<italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Trypanosoma">Trypanosoma</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="cruzi">cruzi</tp:taxon-name-part></tp:taxon-name></italic> effects (<xref ref-type="bibr" rid="B137">Serafim et al. 2014</xref>).</p>
        <p>Hydrazone derivatives are potential antidiabetic (<xref ref-type="bibr" rid="B154">Tariq et al. 2019</xref>), anti-inflammatory (Cordeiro et al. 2016, 2020), analgesic (<xref ref-type="bibr" rid="B93">Marchev et al. 2019</xref>), antioxidant (<xref ref-type="bibr" rid="B42">Demurtas et al. 2019</xref>; <xref ref-type="bibr" rid="B49">El-Mekabaty et al. 2021</xref>), anti-acetylcholinesterase (<xref ref-type="bibr" rid="B30">Bozbey et al. 2020</xref>), and antiglaucoma (<xref ref-type="bibr" rid="B30">Bozbey et al. 2020</xref>) agents. Hydrazone derivatives have also been studied for anticonvulsant (<xref ref-type="bibr" rid="B93">Marchev et al. 2019</xref>; <xref ref-type="bibr" rid="B107">Nesterkina et al. 2020</xref>), antihypertensive, antiplatelet, cardiotonic (de Oliveira et al. 2020), and immunomodulatory effects (<xref ref-type="bibr" rid="B100">Meira et al. 2018</xref>).</p>
        <p>Xanthenone-based hydrazones are α-glucosidase inhibitors and exhibit antidiabetic function (<xref ref-type="bibr" rid="B154">Tariq et al. 2019</xref>). The antidiabetic effect of flurbiprofen hydrazone Schiff bases has been studied (<xref ref-type="bibr" rid="B7">Alam et al. 2022</xref>).</p>
        <p>Hydrazones possess anti-inflammatory activity. Tetrahydronaphthyl-N-acylhydrazones exhibit in vivo anti-TNF-α effects and can reduce inflammatory processes (Cordeiro et al. 2016). Anti-inflammatory potential has also been demonstrated for 2-aminopyridinyl-N-acylhydrazones (Cordeiro et al. 2020).</p>
        <p>Analgesic activity has been confirmed for some hydrazones, including aryhydrazone-based hybrids (<xref ref-type="bibr" rid="B93">Marchev et al. 2019</xref>). Indole hydrazones with antioxidant effects have been designed (<xref ref-type="bibr" rid="B42">Demurtas et al. 2019</xref>). Benzenesulfonamide hydrazones have been found to inhibit carbonic anhydrase (<xref ref-type="bibr" rid="B141">Sharma et al. 2019</xref>). Verbenone hydrazones show anticonvulsant properties (<xref ref-type="bibr" rid="B107">Nesterkina et al. 2020</xref>).</p>
        <p>Guanylhydrazones are widely studied molecules of great scientific interest due to their broad biological potential, including antitumor (<xref ref-type="bibr" rid="B51">Franca et al. 2016</xref>), antibacterial (<xref ref-type="bibr" rid="B54">Gadad et al. 2000</xref>), antimalarial, antihypertensive, antidiabetic, and trypanocidal activities (<xref ref-type="bibr" rid="B23">Azevedo de Brito et al. 2017</xref>).</p>
        <p>Guanylhydrazones exhibit biological activity against lung, breast, and glioma tumors. The 3-nitrophenyl and 4-nitrophenyl moieties of guanylhydrazones are important pharmacophoric groups that enhance affinity for specific tumor receptors. The guanylhydrazone derivatives 2-[(3,5-di-tert-butyl-4-hydroxyphenyl)methylene]hydrazinecarboximidamide, 2-([1,10-biphenyl]-4-ylmethylene)hydrazinecarboximidamide, and 2-[(3,4-dichlorophenyl)methylene]hydrazinecarboximidamide possess pharmacological activity against neoplastic cell lines such as colon (HCT-8), melanoma (MDA-MB435), glioblastoma (SF-295), and promyelocytic leukemia (HL-60) (<xref ref-type="bibr" rid="B51">Franca et al. 2016</xref>).</p>
        <p>A number of hydrazones have been found to exhibit a multitargeted mechanism of action against various diseases, thus making them useful drug candidates. The broad biological potential of hydrazones encourages their continued exploration for new pharmacological applications.</p>
      </sec>
      <sec sec-type="﻿III. Thiosemicarbazones" id="SECID0EPZAE">
        <title>﻿III. Thiosemicarbazones</title>
        <p>Thiosemicarbazones are condensation products of thiosemicarbazide with an aldehyde or ketone (<xref ref-type="bibr" rid="B95">Matesanz et al. 2021</xref>), and they exert antitumor (<xref ref-type="bibr" rid="B140">Shakya and Yadav 2020</xref>), antiviral (<xref ref-type="bibr" rid="B104">Moharana et al. 2020</xref>), fungicidal (<xref ref-type="bibr" rid="B14">Altıntop et al. 2016</xref>), antimalarial (<xref ref-type="bibr" rid="B96">Matsa et al. 2019</xref>; <xref ref-type="bibr" rid="B18">Anant et al. 2022</xref>), trypanocidal (<xref ref-type="bibr" rid="B145">Silva et al. 2019</xref>), anti-Alzheimer (<xref ref-type="bibr" rid="B113">Palanimuthu et al. 2017</xref>; <xref ref-type="bibr" rid="B97">Mavroidi et al. 2022</xref>), antioxidant (<xref ref-type="bibr" rid="B165">Yang et al. 2020</xref>), and antidiabetic (<xref ref-type="bibr" rid="B142">Shehzad et al. 2019</xref>) effects.</p>
        <p>Thiosemicarbazones have demonstrated activity against Alzheimer’s disease in vitro (<xref ref-type="bibr" rid="B97">Mavroidi et al. 2022</xref>). The antioxidant properties of camphene-based thiosemicarbazones have been evaluated (<xref ref-type="bibr" rid="B165">Yang et al. 2020</xref>). The antidiabetic potential of adamantyl-thiosemicarbazones has been explored, and it has been shown that this effect results from the inhibition of aldose reductase (<xref ref-type="bibr" rid="B142">Shehzad et al. 2019</xref>).</p>
        <p>Some thiosemicarbazones exhibit multitarget activity. Naphthalene-substituted thiosemicarbazone derivatives have been shown to be potent antifungal and anticancer agents (<xref ref-type="bibr" rid="B14">Altıntop et al. 2016</xref>). Thiosemicarbazones and semicarbazones containing the 1,2,3-1H-triazole–isatin scaffold possess cytotoxic and trypanocidal activity (<xref ref-type="bibr" rid="B145">Silva et al. 2019</xref>).</p>
        <p>Pyridoxal 4-N-(1-benzylpiperidin-4-yl)thiosemicarbazone exhibits antiproliferative effects, inhibits amyloid-β aggregation, suppresses oxidative stress, and exerts moderate anti-acetylcholinesterase activity (<xref ref-type="bibr" rid="B113">Palanimuthu et al. 2017</xref>). A multitargeting effect is also demonstrated by a Zn(II) thiosemicarbazone complex, which is active against SARS-CoV-2 and exhibits anti-inflammatory properties (<xref ref-type="bibr" rid="B21">Arslan et al. 2023</xref>). Quinazolinone thiosemicarbazones and their metal complexes possess antitumor, antimicrobial, antiepileptic, and analgesic activities (<xref ref-type="bibr" rid="B15">Aly et al. 2010</xref>). The compound 4-(1-adamantyl)-3-thiosemicarbazone is effective against Gram-positive and Gram-negative bacteria, as well as <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Candida">Candida</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="albicans">albicans</tp:taxon-name-part></tp:taxon-name></italic> (<xref ref-type="bibr" rid="B121">Pham et al. 2020</xref>).</p>
        <p>Thiosemicarbazone derivatives exert anticancer activity against various cell lines, including cholangiocarcinoma (HuCCA-1), liver carcinoma (HepG2), and lung carcinoma (A549) (<xref ref-type="bibr" rid="B140">Shakya and Yadav 2020</xref>). Isatin-based thiosemicarbazones have been reported to exhibit antiproliferative activity against acute lymphoblastic leukemia (MOLT-3) cells (<xref ref-type="bibr" rid="B133">Saranya et al. 2019</xref>). Antitumor effects have also been demonstrated for thiosemicarbazone complexes with Au(I) (<xref ref-type="bibr" rid="B55">González-Barcia et al. 2019</xref>), bis(thiosemicarbazones) of Zn(II) (<xref ref-type="bibr" rid="B114">Palma et al. 2019</xref>), and Co(II), Ni(II), Zn(II), and Pd(II) complexes derived from 2-acetyl-5-chlorothiophene thiosemicarbazone (<xref ref-type="bibr" rid="B136">Şen et al. 2019</xref>).</p>
        <p>The following thiosemicarbazones (<xref ref-type="bibr" rid="B44">de Siqueira et al. 2019</xref>; <xref ref-type="bibr" rid="B66">Heffeter et al. 2019</xref>) have shown promising antitumor properties:</p>
        <list list-type="order">
          <list-item>
            <p>1-indanone (<xref ref-type="bibr" rid="B148">Sólimo et al. 2018</xref>) and Ga(III) (<xref ref-type="bibr" rid="B123">Qi et al. 2018</xref>);
</p>
          </list-item>
          <list-item>
            <p>Pyridine and quinoline (<xref ref-type="bibr" rid="B105">Mrozek-Wilczkiewicz et al. 2019</xref>);
</p>
          </list-item>
          <list-item>
            <p>5-nitrothiophene (<xref ref-type="bibr" rid="B131">Roque-Marques et al. 2019</xref>);
</p>
          </list-item>
          <list-item>
            <p>Bromophenol (<xref ref-type="bibr" rid="B58">Guo et al. 2019</xref>);
</p>
          </list-item>
          <list-item>
            <p>Cu(II) complexes of chitosan (<xref ref-type="bibr" rid="B3">Adhikari et al. 2023</xref>);
</p>
          </list-item>
          <list-item>
            <p>Cu(II), Zn(II) (<xref ref-type="bibr" rid="B20">Anjum et al. 2019</xref>);
</p>
          </list-item>
          <list-item>
            <p>thiophene and cinnamaldehyde (<xref ref-type="bibr" rid="B110">Nyawade et al. 2021</xref>);
</p>
          </list-item>
          <list-item>
            <p>Fe(III) and Cu(II) (<xref ref-type="bibr" rid="B76">Kallus et al. 2019</xref>);
</p>
          </list-item>
          <list-item>
            <p>Indole (<xref ref-type="bibr" rid="B65">He et al. 2019</xref>).
</p>
          </list-item>
        </list>
        <p>It has been reported that <italic>N4</italic>-aryl-substituted thiosemicarbazones derived from 1-indanones (<xref ref-type="bibr" rid="B148">Sólimo et al. 2018</xref>) and gallium(III)–thiosemicarbazone complexes (<xref ref-type="bibr" rid="B123">Qi et al. 2018</xref>) are potential antitumor agents for breast cancer treatment.</p>
        <p>Derivatives of 5-nitro-thiophene–thiosemicarbazone have demonstrated anticancer activity, with a mechanism of action involving the induction of apoptosis and stimulation of DNA intercalation (<xref ref-type="bibr" rid="B131">Roque-Marques et al. 2019</xref>). Bromophenol–thiosemicarbazone hybrids have been evaluated as potent, selective inhibitors of poly(ADP-ribose) polymerase-1, suggesting promising anticancer potential (<xref ref-type="bibr" rid="B58">Guo et al. 2019</xref>). The <italic>in vitro</italic> antitumor activity of copper and zinc bis(thiosemicarbazone) complexes has also been demonstrated (<xref ref-type="bibr" rid="B20">Anjum et al. 2019</xref>). Thiosemicarbazones derived from 2-acetyl-5-methylthiophene and cinnamaldehyde, along with their palladium(II) complexes, have been investigated for antiproliferative effects (<xref ref-type="bibr" rid="B110">Nyawade et al. 2021</xref>). In addition, biotin-conjugated anticancer thiosemicarbazones and their iron(III) and copper(II) complexes have been evaluated for their antitumor properties (<xref ref-type="bibr" rid="B76">Kallus et al. 2019</xref>). Thiosemicarbazone derivatives of indole have been observed to exert antiproliferative activity (<xref ref-type="bibr" rid="B65">He et al. 2019</xref>).</p>
        <p>Thiosemicarbazones were among the first discovered antiviral agents and, like their parent thiosemicarbazides, display activity against various viruses, including herpes simplex virus types 1 and 2, dengue virus, hepatitis C virus, and influenza virus (<xref ref-type="bibr" rid="B104">Moharana et al. 2020</xref>). Thiosemicarbazones containing benzene, thiophene, or pyridine rings have shown activity against vaccinia virus infection, with the strongest effects observed for thiosemicarbazones of:</p>
        <list list-type="order">
          <list-item>
            <p>Benzaldehyde and p-acetamido-, p-methoxy-, p-propoxy-, and p-ectylsulfanyl analogues;
</p>
          </list-item>
          <list-item>
            <p><italic>P</italic>-aminobenzaldehyde (<xref ref-type="bibr" rid="B104">Moharana et al. 2020</xref>);
                    </p>
          </list-item>
          <list-item>
            <p>Isatin (<xref ref-type="bibr" rid="B138">Sevinçli et al. 2020</xref>); benzimidazole (<xref ref-type="bibr" rid="B52">Francesconi et al. 2020</xref>);
</p>
          </list-item>
          <list-item>
            <p>Salicylaldehyde (<xref ref-type="bibr" rid="B130">Rogolino et al. 2015</xref>);
</p>
          </list-item>
          <list-item>
            <p>α-amino acids (<xref ref-type="bibr" rid="B112">Padmanabhan et al. 2017</xref>).
</p>
          </list-item>
        </list>
        <p><italic>P</italic>-aminobenzaldehyde-3-thiosemicarbazones were first discovered in 1950 by Hamre, Bernstein, and Donovick and were shown to exhibit antiviral activity (<xref ref-type="bibr" rid="B104">Moharana et al. 2020</xref>). Antiviral effects have also been reported for 5-fluoro-1H-indole-2,3-dione 3-thiosemicarbazones (<xref ref-type="bibr" rid="B138">Sevinçli et al. 2020</xref>). (Thio)semicarbazone-based benzimidazole derivatives have demonstrated antiviral activity against human respiratory viruses (<xref ref-type="bibr" rid="B52">Francesconi et al. 2020</xref>).</p>
        <p>Salicylaldehyde thiosemicarbazones have been found to inhibit influenza virus endonuclease activity (<xref ref-type="bibr" rid="B130">Rogolino et al. 2015</xref>). In addition, thiosemicarbazones derived from α-amino acids have been evaluated for their antiviral activity against dengue virus (<xref ref-type="bibr" rid="B112">Padmanabhan et al. 2017</xref>).</p>
        <p>Currently, there is great relevance in the study of the potential activity of:</p>
        <list list-type="order">
          <list-item>
            <p>Schiff bases and their metal complexes with multitarget activity, such as anticancer, antibacterial, and fungicidal triazole-Schiff bases and their oxovanadium(IV) complexes (<xref ref-type="bibr" rid="B34">Chohan et al. 2010</xref>);
</p>
          </list-item>
          <list-item>
            <p>N-acylhydrazones (<xref ref-type="bibr" rid="B78">Kassab 2023</xref>) and metal complexes of Schiff bases with antitumor effects (<xref ref-type="bibr" rid="B153">Tadele and Tsega 2019</xref>; <xref ref-type="bibr" rid="B78">Kassab 2023</xref>), such as Pt(II) complexes of Schiff bases in breast cancer (<xref ref-type="bibr" rid="B103">Moghadam et al. 2023</xref>);
</p>
          </list-item>
          <list-item>
            <p>Schiff bases with antimicrobial (Jorge et al. 2023), antidiabetic, antioxidant (<xref ref-type="bibr" rid="B16">Amine-Khodja and Boulebd 2023</xref>; <xref ref-type="bibr" rid="B111">Oladipo et al. 2023</xref>), and anticholinesterase (<xref ref-type="bibr" rid="B61">Hasan et al. 2023</xref>) properties;
</p>
          </list-item>
          <list-item>
            <p>Schiff bases of chitosan (<xref ref-type="bibr" rid="B168">Zarei et al. 2024</xref>);
</p>
          </list-item>
          <list-item>
            <p>Schiff bases with multitarget action.
</p>
          </list-item>
        </list>
        <p>It has been shown that multitarget action of Schiff bases derived from 2-naphthaldehyde as compounds with antidiabetic and antioxidant potential (<xref ref-type="bibr" rid="B111">Oladipo et al. 2023</xref>). It has been observed that 1,4-bisphenylhydrazone derivatives exert antioxidant effects and are acetylcholinesterase inhibitors (<xref ref-type="bibr" rid="B16">Amine-Khodja and Boulebd 2023</xref>).</p>
      </sec>
      <sec sec-type="﻿IV. Application of drugs with azomethine structure" id="SECID0EVEAG">
        <title>﻿IV. Application of drugs with azomethine structure</title>
        <p>The fragment of the azomethine group is contained in the chemical structure of drugs, with possible applications in the treatment of various pathologies. Drugs—azomethine derivatives with the following pharmacological effects are used in therapy (<xref ref-type="bibr" rid="B147">Socea et al. 2022</xref>):</p>
        <list list-type="order">
          <list-item>
            <p>Antitumor: mitoguazone (<xref ref-type="bibr" rid="B81">Knight et al. 1983</xref>), Triapine (<xref ref-type="bibr" rid="B118">Pelivan et al. 2015</xref>), zorubicin (<xref ref-type="bibr" rid="B73">Jelić et al. 1997</xref>);
</p>
          </list-item>
          <list-item>
            <p>Antiinfective: nitrofurazone, nitrofurantoin, nifurzide, nifuroxazide. nifuratel (<xref ref-type="bibr" rid="B155">Thota et al. 2018</xref>; <xref ref-type="bibr" rid="B147">Socea et al. 2022</xref>), furazolidone (<xref ref-type="bibr" rid="B68">Huttner et al. 2015</xref>);
</p>
          </list-item>
          <list-item>
            <p>Anti-Mycobacterium: thioacetazone (<xref ref-type="bibr" rid="B146">Singh et al. 2022</xref>);
</p>
          </list-item>
          <list-item>
            <p>Antiviral: metisazone (<xref ref-type="bibr" rid="B39">De Clercq 2010</xref>);
</p>
          </list-item>
          <list-item>
            <p>Antiarrhythmic: azimilide (VerNooy and Mangru 2005);
</p>
          </list-item>
          <list-item>
            <p>Acetylcholinesterase reactivators: pralidoxime, obidoxime, rimedoxime, and methoxime (<xref ref-type="bibr" rid="B26">Banerjee et al. 2014</xref>; Dhuguru et al<xref ref-type="bibr" rid="B45">. 2022</xref>);
</p>
          </list-item>
          <list-item>
            <p>Muscle relaxants: dantrolene (<xref ref-type="bibr" rid="B164">Yang et al. 2023</xref>), azumolene (<xref ref-type="bibr" rid="B36">Corrêa et al. 2013</xref>);
</p>
          </list-item>
          <list-item>
            <p>Antiplatelet: carbazochrome (<xref ref-type="bibr" rid="B28">Basile et al. 2001</xref>);
</p>
          </list-item>
          <list-item>
            <p>Antimigraine: iprazochrome (<xref ref-type="bibr" rid="B28">Basile et al. 2001</xref>);
</p>
          </list-item>
          <list-item>
            <p>Antidepressants: fluvoxamine (<xref ref-type="bibr" rid="B62">Hashimoto et al. 2022</xref>);
</p>
          </list-item>
          <list-item>
            <p>Antimicrobial oxime-based cephalosporins.
</p>
          </list-item>
        </list>
        <sec sec-type="﻿1. Anticancer drugs with azomethine structure" id="SECID0ERHAG">
          <title>﻿<italic>1. Anticancer drugs with azomethine structure</italic></title>
          <p>Antitumor drugs with azomethine structure are presented in Fig. <xref ref-type="fig" rid="F2">2</xref>.</p>
          <fig id="F2" position="float" orientation="portrait">
            <object-id content-type="doi">10.3897/pharmacia.72.e159352.figure2</object-id>
            <object-id content-type="arpha">7FAC36AF-736F-5299-B580-5EC3B556E47C</object-id>
            <label>Figure 2.</label>
            <caption>
              <p>Chemical structures of antitumor drugs with an azomethine structure.</p>
            </caption>
            <graphic xlink:href="pharmacia-72-e159352-g002.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_1401513.jpg">
              <uri content-type="original_file">https://binary.pensoft.net/fig/1401513</uri>
            </graphic>
          </fig>
          <p>Mitoguazone (MGBG, methylglyoxal-bis-guanylhydrazone) is a synthetic polycarbonyl derivative with antineoplastic activity against Hodgkin and non-Hodgkin lymphoma, AIDS-related lymphoma, head and neck cancer, prostate, and esophageal cancer (<xref ref-type="bibr" rid="B81">Knight et al. 1983</xref>). The drug induces apoptosis as a suppressor of S-adenosyl-methionine decarboxylase, which disrupts polyamine biosynthesis. The compound stimulates p53-independent programmed cell death (<xref ref-type="bibr" rid="B38">Davidson et al. 1998</xref>), inhibiting spermidine synthesis in lymphocytes. Mitoguazone reduces the frequency of HIV-infected cells by suppressing the integration of HIV DNA into cellular DNA in monocytes and macrophages (<xref ref-type="bibr" rid="B74">Jin et al. 2015</xref>). The drug is assayed by HPLC with an internal standard, amiloride (<xref ref-type="bibr" rid="B33">Cheng et al. 2003</xref>).</p>
          <p>The α-N-heterocyclic thiosemicarbazone Triapine exhibits antitumor effects by inhibiting the catalytic activity of ribonucleotide reductase, the enzyme responsible for the conversion of ribonucleotides to their corresponding deoxyribonucleotides and, as a consequence, stopping DNA synthesis (<xref ref-type="bibr" rid="B118">Pelivan et al. 2015</xref>). Zorubicin is a benzoylhydrazone derivative of the anthracycline antineoplastic antibiotic daunorubicin. The drug interacts with topoisomerase II and inhibits DNA polymerases (<xref ref-type="bibr" rid="B73">Jelić et al. 1997</xref>).</p>
        </sec>
        <sec sec-type="﻿2. Anti-infective drugs – hydrazone derivatives" id="SECID0EFJAG">
          <title>﻿<italic>2. Anti-infective drugs – hydrazone derivatives</italic></title>
          <p>Approved for use N-acylhydrazone drugs are nitrofurazone, nitrofurantoin, nifurzide, nifuroxazide, and nifuratel (Fig. <xref ref-type="fig" rid="F3">3</xref>) (<xref ref-type="bibr" rid="B155">Thota et al. 2018</xref>; <xref ref-type="bibr" rid="B147">Socea et al. 2022</xref>).</p>
          <fig id="F3" position="float" orientation="portrait">
            <object-id content-type="doi">10.3897/pharmacia.72.e159352.figure3</object-id>
            <object-id content-type="arpha">ACF8BF37-B5A2-514A-809A-720815AF9A19</object-id>
            <label>Figure 3.</label>
            <caption>
              <p>Chemical structures of anti-infective drugs with an azomethine structure.</p>
            </caption>
            <graphic xlink:href="pharmacia-72-e159352-g003.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_1401514.jpg">
              <uri content-type="original_file">https://binary.pensoft.net/fig/1401514</uri>
            </graphic>
          </fig>
          <p>Furazolidone is a nitrofuran antibacterial agent and has a broad spectrum of activity, being active towards Gram-positive bacteria <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Clostridium">Clostridium</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="perfringens">perfringens</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Corynebacterium">Corynebacterium</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="pyogenes">pyogenes</tp:taxon-name-part></tp:taxon-name></italic>, streptococci, and staphylococci; Gram-negative bacteria <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Escherichia">Escherichia</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="coli">coli</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Salmonella">Salmonella</tp:taxon-name-part></tp:taxon-name> Dublin</italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Salmonella">Salmonella</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="typhimurium">typhimurium</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Shigella">Shigella</tp:taxon-name-part></tp:taxon-name></italic>; and protozoa <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Giardia">Giardia</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="lamblia">lamblia</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Eimeria">Eimeria</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Histomonas">Histomonas</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="meleagridis">meleagridis</tp:taxon-name-part></tp:taxon-name></italic> (<xref ref-type="bibr" rid="B87">Machado et al. 2008</xref>). Nitrofurantoin possesses antibacterial activity against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Bacillus">Bacillus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="subtilis">subtilis</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Citrobacter">Citrobacter</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Escherichia">Escherichia</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="coli">coli</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Enterococcus">Enterococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="faecalis">faecalis</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Klebsiella">Klebsiella</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Staphylococcus">Staphylococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="aureus">aureus</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Staphylococcus">Staphylococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="saprophyticus">saprophyticus</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">Streptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="agalactiae">agalactiae</tp:taxon-name-part></tp:taxon-name></italic>. Its efficacy in the treatment of urinary tract infections, combined with low bacterial resistance to this agent, makes it one of the first-line agents for the treatment of uncomplicated urinary tract infections, recommended by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases (<xref ref-type="bibr" rid="B68">Huttner et al. 2015</xref>).</p>
          <p>Nifuroxazide is an oral nitrofuran anti-infective drug and is active against bacteria such as <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Escherichia">Escherichia</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="coli">coli</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Klebsiella">Klebsiella</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Salmonella">Salmonella</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Shigella">Shigella</tp:taxon-name-part></tp:taxon-name></italic>, and staphylococci (<xref ref-type="bibr" rid="B25">Bailly 2019</xref>; Sarvi et al. 2019). Nifuratel is a topical antiprotozoal and antifungal drug and is effective against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Chlamydia">Chlamydia</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="trachomatis">trachomatis</tp:taxon-name-part></tp:taxon-name></italic> and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Mycoplasma">Mycoplasma</tp:taxon-name-part></tp:taxon-name></italic>. Nifurzide is an anti-infective agent useful towards Chagas infection (<xref ref-type="bibr" rid="B50">Forsyth et al. 2016</xref>).</p>
          <p>Anti-infective drugs – hydrazones are illustrated in Fig. <xref ref-type="fig" rid="F3">3</xref>.</p>
        </sec>
        <sec sec-type="﻿3. Antituberculosis, antiviral, and antiarrhythmic drugs with azomethine structure" id="SECID0EZRAG">
          <title>﻿<italic>3. Antituberculosis, antiviral, and antiarrhythmic drugs with azomethine structure</italic></title>
          <p>Fig. <xref ref-type="fig" rid="F4">4</xref> presents the chemical structures of thioacetazone, methisazone, and azimilide.</p>
          <fig id="F4" position="float" orientation="portrait">
            <object-id content-type="doi">10.3897/pharmacia.72.e159352.figure4</object-id>
            <object-id content-type="arpha">4365D2BE-AE65-5638-A840-AA1B9F35D837</object-id>
            <label>Figure 4.</label>
            <caption>
              <p>Azomethine drugs with anti-<tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Mycobacterium">Mycobacterium</tp:taxon-name-part></tp:taxon-name>, antiviral, and antiarrhythmic activity.</p>
            </caption>
            <graphic xlink:href="pharmacia-72-e159352-g004.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_1401515.jpg">
              <uri content-type="original_file">https://binary.pensoft.net/fig/1401515</uri>
            </graphic>
          </fig>
          <p>Thioacetazone (Amithiozone) exerts activity against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Mycobacterium">Mycobacterium</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="tuberculosis">tuberculosis</tp:taxon-name-part></tp:taxon-name></italic> and is useful only in preventing resistance to isoniazid and rifampicin. It has been withdrawn from use due to toxicity (<xref ref-type="bibr" rid="B146">Singh et al. 2022</xref>). The thiosemicarbazone approved for human use is methisazone (Marboran). This compound is a thiosemicarbazone derived from the condensation of N-methylisatin with thiosemicarbazide and is effective in the prevention of smallpox. It is approved by the FDA as an antiviral drug that acts by inhibiting mRNA and protein synthesis. It has been identified as anti-SARS-CoV-2 (COVID-19) (<xref ref-type="bibr" rid="B39">De Clercq 2010</xref>). Azimilide is a class III antiarrhythmic drug for controlling abnormal heart rhythms, affecting repolarization, and prolonging the duration of the action potential and the refractory period (VerNooy and Mangru 2005).</p>
        </sec>
        <sec sec-type="﻿4. Oximes – acetylcholinesterase reactivators and antibacterial drugs" id="SECID0ENTAG">
          <title>﻿<italic>4. Oximes – acetylcholinesterase reactivators and antibacterial drugs</italic></title>
          <p>Acetylcholinesterase reactivators include pralidoxime, obidoxime, rimedoxime, and methoxime. Pralidoxime is an FDA-approved drug (Fig. <xref ref-type="fig" rid="F5">5</xref>) (<xref ref-type="bibr" rid="B26">Banerjee et al. 2014</xref>; Dhuguru et al<xref ref-type="bibr" rid="B45">. 2022</xref>).</p>
          <fig id="F5" position="float" orientation="portrait">
            <object-id content-type="doi">10.3897/pharmacia.72.e159352.figure5</object-id>
            <object-id content-type="arpha">BAF39616-4480-578C-9848-A9E4DDAE2811</object-id>
            <label>Figure 5.</label>
            <caption>
              <p>Acetylcholinesterase reactivators with an azomethine structure.</p>
            </caption>
            <graphic xlink:href="pharmacia-72-e159352-g005.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_1401516.jpg">
              <uri content-type="original_file">https://binary.pensoft.net/fig/1401516</uri>
            </graphic>
          </fig>
        </sec>
        <sec sec-type="﻿5. Drugs – muscle relaxants with an azomethine structure" id="SECID0ENUAG">
          <title>﻿<italic>5. Drugs – muscle relaxants with an azomethine structure</italic></title>
          <p>Dantrolene (Fig. <xref ref-type="fig" rid="F6">6</xref>) is a postsynaptic muscle relaxant that inhibits the release of Ca<sup>2+</sup> ions from sarcoplasmic reticulum stores by antagonizing ryanodine receptors. It is used for the treatment and prevention of malignant hyperthermia, a rare, life-threatening condition induced by general anesthesia (<xref ref-type="bibr" rid="B164">Yang et al. 2023</xref>). Azumolene (Fig. <xref ref-type="fig" rid="F6">6</xref>) is a derivative of dantrolene with lower toxicity and fewer side effects (<xref ref-type="bibr" rid="B36">Corrêa et al. 2013</xref>).</p>
          <fig id="F6" position="float" orientation="portrait">
            <object-id content-type="doi">10.3897/pharmacia.72.e159352.figure6</object-id>
            <object-id content-type="arpha">0936DDAE-82AC-5847-99F8-E3FABC1185AA</object-id>
            <label>Figure 6.</label>
            <caption>
              <p>Chemical structures of muscle relaxants with an azomethine structure.</p>
            </caption>
            <graphic xlink:href="pharmacia-72-e159352-g006.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_1401517.jpg">
              <uri content-type="original_file">https://binary.pensoft.net/fig/1401517</uri>
            </graphic>
          </fig>
        </sec>
        <sec sec-type="﻿6. Antiplatelet, antimigraine, and antidepressant drugs with an azomethine structure" id="SECID0ETVAG">
          <title>﻿<italic>6. Antiplatelet, antimigraine, and antidepressant drugs with an azomethine structure</italic></title>
          <p>The antiplatelet drug carbazochrome (3-hydroxy-1-methyl-5,6-indolindione 5-semicarbazone) (Fig. <xref ref-type="fig" rid="F7">7</xref>) is a semicarbazone of adrenochrome. Iprazochrome (3-hydroxy-1-isopropyl-5,6-indolindione 5-semicarbazone) (Fig. <xref ref-type="fig" rid="F7">7</xref>) is a carbazochrome derivative antimigraine drug and is also used in diabetic retinopathy (<xref ref-type="bibr" rid="B28">Basile et al. 2001</xref>). Fluvoxamine is an antidepressant that functions as a selective serotonin reuptake inhibitor (<xref ref-type="bibr" rid="B62">Hashimoto et al. 2022</xref>) (Fig. <xref ref-type="fig" rid="F7">7</xref>).</p>
          <fig id="F7" position="float" orientation="portrait">
            <object-id content-type="doi">10.3897/pharmacia.72.e159352.figure7</object-id>
            <object-id content-type="arpha">DBE97C37-0F54-5E07-BD9D-20592F694974</object-id>
            <label>Figure 7.</label>
            <caption>
              <p>Chemical structure of carbazochromе, iprazochrome, and fluvoxamine.</p>
            </caption>
            <graphic xlink:href="pharmacia-72-e159352-g007.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_1401518.jpg">
              <uri content-type="original_file">https://binary.pensoft.net/fig/1401518</uri>
            </graphic>
          </fig>
        </sec>
        <sec sec-type="﻿7. Antimicrobial oxime-based cephalosporins: 2nd (Fig. 9), 3rd (Fig. 8), 4th, and 5th (Fig. 9) generations" id="SECID0E2WAG">
          <title>﻿<italic>7. Antimicrobial oxime-based cephalosporins: 2 <sup>nd</sup> (Fig. <xref ref-type="fig" rid="F9">9</xref>), 3 <sup>rd</sup> (Fig. <xref ref-type="fig" rid="F8">8</xref>), 4 <sup>th</sup> , and 5 <sup>th</sup> (Fig. <xref ref-type="fig" rid="F9">9</xref>) generations</italic></title>
          <p>Oxime-based cephalosporins are emerging as an important class of drugs with improved efficacy and a broad spectrum of antimicrobial activity against Gram-positive and Gram-negative pathogens. Cefuroxime, ceftizoxime, ceftpodoxime, and ceftmenoxime are FDA-approved oxime-based antibiotics (Dhuguru et al<xref ref-type="bibr" rid="B45">. 2022</xref>).</p>
          <p>Third-generation cephalosporins are used in the treatment of Gram-negative meningitis, Lyme disease, <tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Pseudomonas">Pseudomonas</tp:taxon-name-part></tp:taxon-name> pneumonia, and streptococcal endocarditis (<xref ref-type="bibr" rid="B149">Stetsiouk et al. 2023</xref>). Ceftriaxone is among the most widely used (<xref ref-type="bibr" rid="B143">Shirin and Islam 2020</xref>).</p>
          <p>Third- and fourth-generation cephalosporins (<xref ref-type="bibr" rid="B149">Stetsiouk et al. 2023</xref>) are often combined with the beta-lactamase inhibitor sulbactam. Cefepime is a fourth-generation cephalosporin effective against both Gram-positive and Gram-negative bacteria (<xref ref-type="bibr" rid="B163">Yahav et al. 2007</xref>).</p>
          <p>Ceftobiprole (<xref ref-type="bibr" rid="B135">Scheeren 2015</xref>), ceftaroline (<xref ref-type="bibr" rid="B162">Welte et al. 2019</xref>), and cefiderocol (<xref ref-type="bibr" rid="B98">McCreary et al. 2021</xref>) are fifth-generation cephalosporins. Ceftobiprole and ceftaroline are effective against methicillin-resistant <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Staphylococcus">Staphylococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="aureus">aureus</tp:taxon-name-part></tp:taxon-name></italic> (MRSA). Ceftobiprole is used for the treatment of hospital-acquired pneumonia (<xref ref-type="bibr" rid="B135">Scheeren 2015</xref>). Cefiderocol was approved by the FDA in 2019 for urinary tract infections and in 2020 for hospital-acquired pneumonia and ventilator-associated bacterial pneumonia (<xref ref-type="bibr" rid="B98">McCreary et al. 2021</xref>).</p>
          <p>Chemical structures of oxime-based cephalosporins are summarized in Fig. <xref ref-type="fig" rid="F8">8</xref> (3<sup>rd</sup> generation) and Fig. <xref ref-type="fig" rid="F9">9</xref> (2<sup>nd</sup>, 4<sup>th</sup>, and 5<sup>th</sup> generations).</p>
          <fig id="F8" position="float" orientation="portrait">
            <object-id content-type="doi">10.3897/pharmacia.72.e159352.figure8</object-id>
            <object-id content-type="arpha">AC0986A9-084C-5EAF-B24B-1806B236A3D8</object-id>
            <label>Figure 8.</label>
            <caption>
              <p>Oxime-based cephalosporins – 3<sup>rd</sup> generation.</p>
            </caption>
            <graphic xlink:href="pharmacia-72-e159352-g008.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_1401519.jpg">
              <uri content-type="original_file">https://binary.pensoft.net/fig/1401519</uri>
            </graphic>
          </fig>
          <fig id="F9" position="float" orientation="portrait">
            <object-id content-type="doi">10.3897/pharmacia.72.e159352.figure9</object-id>
            <object-id content-type="arpha">FB2D5E9A-4DEC-5D3B-9D97-BC05E39C9FDD</object-id>
            <label>Figure 9.</label>
            <caption>
              <p>Oxime-based cephalosporins – 2<sup>nd</sup>, 4<sup>th</sup>, and 5<sup>th</sup> generations.</p>
            </caption>
            <graphic xlink:href="pharmacia-72-e159352-g009.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_1401520.jpg">
              <uri content-type="original_file">https://binary.pensoft.net/fig/1401520</uri>
            </graphic>
          </fig>
        </sec>
      </sec>
    </sec>
    <sec sec-type="﻿Conclusion" id="SECID0EL2AG">
      <title>﻿Conclusion</title>
      <p>Compounds containing an azomethine moiety include hydrazones, semicarbazones, thiosemicarbazones, and oximes. The azomethine group has been found to be responsible for various pharmacological effects such as anticancer, antibacterial, antiviral, anti-COVID-19, antifungal, antimalarial, anthelmintic, anti-inflammatory, antioxidant, anti-Alzheimer, antidiabetic, antiarthritic, antidepressant, and antiepileptic activities. Approved anti-infective drugs with an N-acylhydrazone structure include nitrofurazone, nitrofurantoin, nifurzide, nifuroxazide, and nifuratel. Antitumor azomethines include mitoguazone, triapine, and zorubicin. Thioacetazone exhibits activity against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Mycobacterium">Mycobacterium</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="tuberculosis">tuberculosis</tp:taxon-name-part></tp:taxon-name></italic>. Acetylcholinesterase reactivators pralidoxime, obidoxime, rimedoxime, and methoxime are azomethine derivatives—oximes. Only pralidoxime is an FDA-approved drug. The semicarbazone carbazochrome is an antiplatelet drug, and its derivative iprazochrome is applied for migraine and diabetic retinopathy. Antimicrobial oxime-based cephalosporins belong to the 2<sup>nd</sup>, 3<sup>rd</sup>, 4<sup>th</sup>, and 5<sup>th</sup> generations.</p>
    </sec>
  </body>
  <back>
    <sec sec-type="﻿Additional information" id="SECID0EF3AG">
      <title>﻿Additional information</title>
      <p>
        <bold>Conflict of interest</bold>
      </p>
      <p>The authors have declared that no competing interests exist.</p>
      <p>
        <bold>Ethical statements</bold>
      </p>
      <p>The authors declare that no clinical trials were used in the present study.</p>
      <p>The authors declare that no experiments on humans or human tissues were performed for the present study.</p>
      <p>The authors declare that no informed consent was obtained from humans, donors, or donors’ representatives participating in the study.</p>
      <p>The authors declare that no experiments on animals were performed for the present study.</p>
      <p>The authors declare that no commercially available immortalized human or animal cell lines were used in the present study.</p>
      <p>
        <bold>Funding</bold>
      </p>
      <p>This study is financed by the European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria, project BG-RRP-2.004-0004-C012 “Strategic research and innovation program for development of Medical University - Sofia, Bulgaria.”</p>
      <p>
        <bold>Author contributions</bold>
      </p>
      <p>All authors have contributed equally.</p>
      <p>
        <bold>Author ORCIDs</bold>
      </p>
      <p>Ivanka Pencheva <ext-link xlink:href="https://orcid.org/0000-0002-8974-1694" ext-link-type="uri" xlink:type="simple">https://orcid.org/0000-0002-8974-1694</ext-link></p>
      <p>Lily Peikova <ext-link xlink:href="https://orcid.org/0000-0002-8030-3479" ext-link-type="uri" xlink:type="simple">https://orcid.org/0000-0002-8030-3479</ext-link></p>
      <p>Dobrina Tsvetkova <ext-link xlink:href="https://orcid.org/0000-0002-4284-8101" ext-link-type="uri" xlink:type="simple">https://orcid.org/0000-0002-4284-8101</ext-link></p>
      <p>
        <bold>Data availability</bold>
      </p>
      <p>All of the data that support the findings of this study are available in the main text.</p>
    </sec>
    <ref-list>
      <title>﻿References</title>
      <ref id="B1">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Abbas</surname><given-names>I</given-names></name><name name-style="western"><surname>Nadeem</surname><given-names>H</given-names></name><name name-style="western"><surname>Saeed</surname><given-names>A</given-names></name><name name-style="western"><surname>Kharl</surname><given-names>HAA</given-names></name><name name-style="western"><surname>Tahir</surname><given-names>MN</given-names></name><name name-style="western"><surname>Naseer</surname><given-names>MM</given-names></name></person-group> (<year>2021</year>) Isatin-hydrazide conjugates as potent α-amylase and α-glucosidase inhibitors: synthesis, structure and <italic>in vitro</italic> evaluations. Bioorganic Chemistry 116: 105385. <ext-link xlink:href="10.1016/j.bioorg.2021.105385" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.bioorg.2021.105385</ext-link></mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Aboul-Fadl</surname><given-names>T</given-names></name><name name-style="western"><surname>Mohammed</surname><given-names>FAH</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>EAS</given-names></name></person-group> (<year>2003</year>) <article-title>Synthesis, antitubercular activity and pharmacokinetic studies of some Schiff bases derived from 1-alkylisatin and isonicotinic acid hydrazide (INH).</article-title><source>Archives of Pharmacal Research</source><volume>26</volume>(<issue>10</issue>): <fpage>778</fpage>–<lpage>784</lpage>. <ext-link xlink:href="10.1007/BF02980020" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1007/BF02980020</ext-link></mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Adhikari</surname><given-names>HS</given-names></name><name name-style="western"><surname>Garai</surname><given-names>A</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>PN</given-names></name></person-group> (<year>2023</year>) Synthesis, characterization, and anticancer activity of chitosan functionalized isatin based thiosemicarbazones, and their copper(II) complexes. Carbohydrate Research 526: 108796. <ext-link xlink:href="10.1016/j.carres.2023.108796" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.carres.2023.108796</ext-link></mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Adibi</surname><given-names>H</given-names></name><name name-style="western"><surname>Khodaei</surname><given-names>MM</given-names></name><name name-style="western"><surname>Pakravan</surname><given-names>P</given-names></name><name name-style="western"><surname>Abiri</surname><given-names>R</given-names></name></person-group> (<year>2010</year>) <article-title>Synthesis, characterization, <italic>and in vitro</italic> antimicrobial evaluation of hydrazone and bishydrazone derivatives of isatin.</article-title><source>Pharmaceutical Chemistry Journal</source><volume>44</volume>(<issue>4</issue>): <fpage>219</fpage>–<lpage>227</lpage>. <ext-link xlink:href="10.1007/s11094-010-0436-3" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1007/s11094-010-0436-3</ext-link></mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Aggarwal</surname><given-names>S</given-names></name><name name-style="western"><surname>Paliwal</surname><given-names>D</given-names></name><name name-style="western"><surname>Kaushik</surname><given-names>D</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>GK</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name></person-group> (<year>2018</year>) <article-title>Pyrazole Schiff base hybrids as anti-malarial agents: synthesis, <italic>in vitro</italic> screening and computational study.</article-title><source>Combinatorial Chemistry High Throughput Screening</source><volume>21</volume>(<issue>3</issue>): <fpage>194</fpage>–<lpage>203</lpage>. <ext-link xlink:href="10.2174/1386207321666180213092911" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2174/1386207321666180213092911</ext-link></mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Al Zoubi</surname><given-names>W</given-names></name><name name-style="western"><surname>Al‐Hamdani</surname><given-names>AAS</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>SD</given-names></name><name name-style="western"><surname>Ko</surname><given-names>YG</given-names></name></person-group> (<year>2018</year>) Synthesis, characterization, and biological activity of Schiff bases metal complexes. Journal of Physical Organic Chemistry 31(2): e3752. <ext-link xlink:href="10.1002/poc.3752" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1002/poc.3752</ext-link></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Alam</surname><given-names>A</given-names></name><name name-style="western"><surname>Ali</surname><given-names>M</given-names></name><name name-style="western"><surname>Ur Rehman</surname><given-names>N</given-names></name><name name-style="western"><surname>Ullah</surname><given-names>S</given-names></name><name name-style="western"><surname>Halim</surname><given-names>SA</given-names></name><name name-style="western"><surname>Latif</surname><given-names>A</given-names></name><name name-style="western"><surname>Zainab</surname></name><name name-style="western"><surname>Khan</surname><given-names>A</given-names></name><name name-style="western"><surname>Ullah</surname><given-names>O</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>S</given-names></name><name name-style="western"><surname>Al-Harrasi</surname><given-names>A</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M</given-names></name></person-group> (<year>2022</year>) <article-title>Bio-oriented synthesis of novel (S)-Flurbiprofen clubbed hydrazone Schiff’s bases for diabetic management: <italic>in vitro</italic> and in silico studies.</article-title><source>Pharmaceuticals (Basel)</source><volume>15</volume>(<issue>6</issue>): <fpage>672</fpage>. <ext-link xlink:href="10.3390/ph15060672" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/ph15060672</ext-link></mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Ali</surname><given-names>SMM</given-names></name><name name-style="western"><surname>Azad</surname><given-names>MAK</given-names></name><name name-style="western"><surname>Jesmin</surname><given-names>M</given-names></name><name name-style="western"><surname>Ahsan</surname><given-names>S</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>MM</given-names></name><name name-style="western"><surname>Khanam</surname><given-names>JA</given-names></name><name name-style="western"><surname>Islam</surname><given-names>MN</given-names></name><name name-style="western"><surname>Shahriar</surname><given-names>SMS</given-names></name></person-group> (<year>2012</year>) <article-title>In vivo anticancer activity of vanillin semicarbazone.</article-title><source>Asian Pacific Journal of Tropical Biomedicine</source><volume>2</volume>(<issue>6</issue>): <fpage>438</fpage>–<lpage>442</lpage>. <ext-link xlink:href="10.1016/S2221-1691(12)60072-0" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/S2221-1691(12)60072-0</ext-link></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Aljamali</surname><given-names>NM</given-names></name><name name-style="western"><surname>Alasady</surname><given-names>D</given-names></name><name name-style="western"><surname>Hassen</surname><given-names>HS</given-names></name></person-group> (<year>2021</year>) <article-title>Review on azomethine-compounds with their applications.</article-title><source>International Journal of Chemical Synthesis and Chemical Reactions</source><volume>7</volume>(<issue>2</issue>): <fpage>1</fpage>–<lpage>10</lpage>. https://doi.org/10.37628</mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Alkahtani</surname><given-names>HM</given-names></name><name name-style="western"><surname>Almehizia</surname><given-names>AA</given-names></name><name name-style="western"><surname>Al-Omar</surname><given-names>MA</given-names></name><name name-style="western"><surname>Obaidullah</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Zen</surname><given-names>AA</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>AS</given-names></name><name name-style="western"><surname>Aboulthana</surname><given-names>WM</given-names></name></person-group> (<year>2023</year>) <article-title>In vitro evaluation and bioinformatics analysis of Schiff bases earing pyrazole scaffold as bioactive agents: antioxidant, anti-diabetic, anti-Alzheimer, and anti-arthritic.</article-title><source>Molecules (Basel, Switzerland)</source><volume>28</volume>(<issue>20</issue>): <fpage>7125</fpage>. <ext-link xlink:href="10.3390/molecules28207125" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/molecules28207125</ext-link></mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Al-Mudhafar</surname><given-names>MMJ</given-names></name><name name-style="western"><surname>Kamoon</surname><given-names>RA</given-names></name></person-group> (<year>2020</year>) <article-title>Synthesis, characterization, and antimicrobial activity of new Schiff’s and Mannich bases of isatin and isatin derivatives.</article-title><source>Journal of Global Pharma Technology</source><volume>12</volume>(<issue>1</issue>): <fpage>529</fpage>–<lpage>536</lpage>.</mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Al-Mudhafar</surname><given-names>MMJ</given-names></name><name name-style="western"><surname>Omar</surname><given-names>TNА</given-names></name><name name-style="western"><surname>Abdulhadi</surname><given-names>SL</given-names></name></person-group> (<year>2022</year>) <article-title>Bis-Schiff bases of isatin derivatives synthesis, and their biological activities: a review.</article-title><source>Al Mustansiriyah Journal of Pharmaceutical Sciences</source><volume>22</volume>(<issue>1</issue>): <fpage>23</fpage>–<lpage>48</lpage>. <ext-link xlink:href="10.32947/ajps.v22i1.827" ext-link-type="doi" xlink:type="simple">https://doi.org/10.32947/ajps.v22i1.827</ext-link></mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Alshammari</surname><given-names>MB</given-names></name><name name-style="western"><surname>Ramadan</surname><given-names>M</given-names></name><name name-style="western"><surname>Aly</surname><given-names>AA</given-names></name><name name-style="western"><surname>El-Sheref</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Bakht</surname><given-names>MA</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>MAA</given-names></name><name name-style="western"><surname>Shawky</surname><given-names>AM</given-names></name></person-group> (<year>2021</year>) Synthesis of potentially new Schiff bases of N-substituted-2-quinolonylacetohydrazides as anti-COVID-19 agents. Journal of Molecular Structure 1230: 129649. <ext-link xlink:href="10.1016/j.molstruc.2020.129649" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.molstruc.2020.129649</ext-link></mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Altıntop</surname><given-names>MD</given-names></name><name name-style="western"><surname>Atlı</surname><given-names>Ö</given-names></name><name name-style="western"><surname>Ilgın</surname><given-names>S</given-names></name><name name-style="western"><surname>Demirel</surname><given-names>R</given-names></name><name name-style="western"><surname>Özdemir</surname><given-names>A</given-names></name><name name-style="western"><surname>Kaplancıklı</surname><given-names>ZA</given-names></name></person-group> (<year>2016</year>) <article-title>Synthesis and biological evaluation of new naphthalene substituted thiosemicarbazone derivatives as potent antifungal and anticancer agents.</article-title><source>European Journal of Medicinal Chemistry</source><volume>108</volume>: <fpage>406</fpage>–<lpage>414</lpage>. <ext-link xlink:href="10.1016/j.ejmech.2015.11.041" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2015.11.041</ext-link></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Aly</surname><given-names>MM</given-names></name><name name-style="western"><surname>Mohamed</surname><given-names>YA</given-names></name><name name-style="western"><surname>El-Bayouki</surname><given-names>KAM</given-names></name><name name-style="western"><surname>Basyouni</surname><given-names>WM</given-names></name><name name-style="western"><surname>Abbas</surname><given-names>SY</given-names></name></person-group> (<year>2010</year>) <article-title>Synthesis of some new 4(3H)-quinazolinone-2-carboxaldehyde thiosemicarbazones and their metal complexes and a study on their anticonvulsant, analgesic, cytotoxic and antimicrobial activities – part-1.</article-title><source>European Journal of Medicinal Chemistry</source><volume>45</volume>(<issue>8</issue>): <fpage>3365</fpage>–<lpage>3373</lpage>. <ext-link xlink:href="10.1016/j.ejmech.2010.04.020" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2010.04.020</ext-link></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Amine-Khodja</surname><given-names>I</given-names></name><name name-style="western"><surname>Boulebd</surname><given-names>H</given-names></name></person-group> (<year>2023</year>) <article-title>Synthesis, biological evaluation, theoretical investigations, docking study and ADME parameters of some 1,4-bisphenylhydrazone derivatives as potent antioxidant agents and acetylcholinesterase inhibitors.</article-title><source>Molecular Diversity</source><volume>25</volume>(<issue>1</issue>): <fpage>279</fpage>–<lpage>290</lpage>. <ext-link xlink:href="10.1007/s11030-020-10064-8" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1007/s11030-020-10064-8</ext-link></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Ammar</surname><given-names>YA</given-names></name><name name-style="western"><surname>El-Sharief</surname><given-names>AMS</given-names></name><name name-style="western"><surname>Belal</surname><given-names>A</given-names></name><name name-style="western"><surname>Abbas</surname><given-names>SY</given-names></name><name name-style="western"><surname>Mohamed</surname><given-names>YA</given-names></name><name name-style="western"><surname>Mehany</surname><given-names>ABM</given-names></name><name name-style="western"><surname>Ragab</surname><given-names>A</given-names></name></person-group> (<year>2018</year>) <article-title>Design, synthesis, antiproliferative activity, molecular docking and cell cycle analysis of some novel (morpholinosulfonyl) isatins with potential EGFR inhibitory activity.</article-title><source>European Journal of Medicinal Chemistry</source><volume>156</volume>: <fpage>918</fpage>–<lpage>932</lpage>. <ext-link xlink:href="10.1016/j.ejmech.2018.06.061" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2018.06.061</ext-link></mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Anant</surname><given-names>A</given-names></name><name name-style="western"><surname>Kaur</surname><given-names>K</given-names></name><name name-style="western"><surname>Asati</surname><given-names>V</given-names></name></person-group> (<year>2022</year>) Discovery of novel antimalarial drugs based on thiosemicarbazone derivatives: an in silico approach. Current Signal Transduction Therapy 17(1): 59–74(16). <ext-link xlink:href="10.2174/1574362416666211015120514" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2174/1574362416666211015120514</ext-link></mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Aneja</surname><given-names>B</given-names></name><name name-style="western"><surname>Khan</surname><given-names>NS</given-names></name><name name-style="western"><surname>Khan</surname><given-names>P</given-names></name><name name-style="western"><surname>Queen</surname><given-names>A</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>A</given-names></name><name name-style="western"><surname>Rehman</surname><given-names>MT</given-names></name><name name-style="western"><surname>Alajmi</surname><given-names>MF</given-names></name><name name-style="western"><surname>El-Seedi</surname><given-names>HR</given-names></name><name name-style="western"><surname>Ali</surname><given-names>S</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>MI</given-names></name><name name-style="western"><surname>Abid</surname><given-names>M</given-names></name></person-group> (<year>2019</year>) <article-title>Design and development of isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis.</article-title><source>European Journal of Medicinal Chemistry</source><volume>163</volume>: <fpage>840</fpage>–<lpage>852</lpage>. <ext-link xlink:href="10.1016/j.ejmech.2018.12.026" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2018.12.026</ext-link></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Anjum</surname><given-names>R</given-names></name><name name-style="western"><surname>Palanimuthu</surname><given-names>D</given-names></name><name name-style="western"><surname>Kalinowski</surname><given-names>DS</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>W</given-names></name><name name-style="western"><surname>Park</surname><given-names>KC</given-names></name><name name-style="western"><surname>Kovacevic</surname><given-names>Z</given-names></name><name name-style="western"><surname>Khan</surname><given-names>IU</given-names></name><name name-style="western"><surname>Richardson</surname><given-names>DR</given-names></name></person-group> (<year>2019</year>) <article-title>Synthesis, characterization, and <italic>in vitro</italic> anticancer activity of copper and zinc bis(thiosemicarbazone) complexes.</article-title><source>Inorganic Chemistry</source><volume>58</volume>(<issue>20</issue>): <fpage>13709</fpage>–<lpage>13723</lpage>. <ext-link xlink:href="10.1021/acs.inorgchem.9b01281" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1021/acs.inorgchem.9b01281</ext-link></mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Arslan</surname><given-names>AB</given-names></name><name name-style="western"><surname>Kaya</surname><given-names>B</given-names></name><name name-style="western"><surname>Ülküseven</surname><given-names>B</given-names></name></person-group> (<year>2023</year>) Synthesis, SARS‐CoV‐2 3CL main protease inhibitor, anti‐inflammatory, and wound‐healing effects of a zinc (II)‐thiosemicarbazone complex. Applied Organometallic Chemistry 37(4): e7030. <ext-link xlink:href="10.1002/aoc.7030" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1002/aoc.7030</ext-link></mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Asif</surname><given-names>M</given-names></name><name name-style="western"><surname>Husain</surname><given-names>A</given-names></name></person-group> (<year>2013</year>) Analgesic, anti‐inflammatory, and antiplatelet profile of hydrazones containing synthetic molecules. Journal of Applied Chemistry 2013(1): 247203: <ext-link xlink:href="10.1155/2013/247203" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1155/2013/247203</ext-link></mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Azevedo de Brito</surname><given-names>W</given-names></name><name name-style="western"><surname>Gsomes Dantas</surname><given-names>M</given-names></name><name name-style="western"><surname>Andrade Nogueira</surname><given-names>FH</given-names></name><name name-style="western"><surname>Ferreira da Silva-Júnior</surname><given-names>E</given-names></name><name name-style="western"><surname>Xavier de Araújo-Júnior</surname><given-names>J</given-names></name><name name-style="western"><surname>Aquino</surname><given-names>TMD</given-names></name><name name-style="western"><surname>Adélia Nogueira Ribeiro</surname><given-names>Ê</given-names></name><name name-style="western"><surname>Da Silva Solon</surname><given-names>LG</given-names></name><name name-style="western"><surname>Soares Aragão</surname><given-names>CF</given-names></name><name name-style="western"><surname>Barreto Gomes</surname><given-names>AP</given-names></name></person-group> (<year>2017</year>) <article-title>Development and validation of HPLC-DAD and UHPLC-DAD methods for the simultaneous determination of guanylhydrazone derivatives employing a factorial design.</article-title><source>Molecules (Basel, Switzerland)</source><volume>22</volume>(<issue>9</issue>): <fpage>1394</fpage>. <ext-link xlink:href="10.3390/molecules22091394" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/molecules22091394</ext-link></mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Aziz</surname><given-names>T</given-names></name><name name-style="western"><surname>Ullah</surname><given-names>A</given-names></name><name name-style="western"><surname>Ullah</surname><given-names>R</given-names></name><name name-style="western"><surname>Haq</surname><given-names>F</given-names></name><name name-style="western"><surname>Iqbal</surname><given-names>M</given-names></name><name name-style="western"><surname>Khan</surname><given-names>FU</given-names></name><name name-style="western"><surname>Jamil</surname><given-names>MI</given-names></name><name name-style="western"><surname>Raheel</surname><given-names>M</given-names></name><name name-style="western"><surname>Kiran</surname><given-names>M</given-names></name></person-group> (<year>2020</year>) <article-title>Synthesis of isatin and its derivatives and their applications in biological system.</article-title><source>Biomedical Journal of Scientific Technical Research</source><volume>30</volume>(<issue>4</issue>): <fpage>23615</fpage>–<lpage>23621</lpage>. <ext-link xlink:href="10.26717/BJSTR.2020.30.004991" ext-link-type="doi" xlink:type="simple">https://doi.org/10.26717/BJSTR.2020.30.004991</ext-link></mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Bailly</surname><given-names>C</given-names></name></person-group> (<year>2019</year>) <article-title>Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment.</article-title><source>Drug Discovery Today</source><volume>24</volume>(<issue>9</issue>): <fpage>1930</fpage>–<lpage>1936</lpage>. <ext-link xlink:href="10.1016/j.drudis.2019.06.017" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.drudis.2019.06.017</ext-link></mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Banerjee</surname><given-names>I</given-names></name><name name-style="western"><surname>Tripathi</surname><given-names>SK</given-names></name><name name-style="western"><surname>Roy</surname><given-names>AS</given-names></name></person-group> (<year>2014</year>) <article-title>Efficacy of Pralidoxime in organophosphorus poisoning: revisiting the controversy in Indian setting.</article-title><source>Journal of Postgraduate Medicine</source><volume>60</volume>(<issue>1</issue>): <fpage>27</fpage>–<lpage>30</lpage>. <ext-link xlink:href="10.4103/0022-3859.128803" ext-link-type="doi" xlink:type="simple">https://doi.org/10.4103/0022-3859.128803</ext-link></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Banumathi</surname></name><name name-style="western"><surname>Sherapura</surname><given-names>A</given-names></name><name name-style="western"><surname>Malojirao</surname><given-names>VH</given-names></name><name name-style="western"><surname>Zabiulla</surname></name><name name-style="western"><surname>Sharath</surname><given-names>BS</given-names></name><name name-style="western"><surname>Thirusangu</surname><given-names>P</given-names></name><name name-style="western"><surname>Mahmood</surname><given-names>R</given-names></name><name name-style="western"><surname>Kumari</surname><given-names>NS</given-names></name><name name-style="western"><surname>Baliga</surname><given-names>SM</given-names></name><name name-style="western"><surname>Khanum</surname><given-names>SA</given-names></name><name name-style="western"><surname>Prabhakar</surname><given-names>BT</given-names></name></person-group> (<year>2022</year>) <article-title>Antiproliferative pharmacophore azo-hydrazone analogue BT-1F exerts death signalling pathway targeting STAT3 in solid tumour.</article-title><source>Pharmacological Reports</source><volume>74</volume>(<issue>2</issue>): <fpage>353</fpage>–<lpage>365</lpage>. <ext-link xlink:href="10.1007/s43440-021-00345-w" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1007/s43440-021-00345-w</ext-link></mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Basile</surname><given-names>M</given-names></name><name name-style="western"><surname>Gidaro</surname><given-names>S</given-names></name><name name-style="western"><surname>Pacella</surname><given-names>M</given-names></name><name name-style="western"><surname>Biffignandi</surname><given-names>PM</given-names></name><name name-style="western"><surname>Gidaro</surname><given-names>GS</given-names></name></person-group> (<year>2001</year>) <article-title>Parenteral Troxerutin and Carbazochrome combination in the treatment of post-hemorrhoidectomy status: a randomized, double-blind, placebo-controlled, phase IV study.</article-title><source>Current Medical Research and Opinion</source><volume>17</volume>(<issue>4</issue>): <fpage>256</fpage>–<lpage>261</lpage>. <ext-link xlink:href="10.1185/030079901753403144" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1185/030079901753403144</ext-link></mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Bonnett</surname><given-names>SA</given-names></name><name name-style="western"><surname>Dennison</surname><given-names>D</given-names></name><name name-style="western"><surname>Files</surname><given-names>M</given-names></name><name name-style="western"><surname>Bajpai</surname><given-names>A</given-names></name><name name-style="western"><surname>Parish</surname><given-names>T</given-names></name></person-group> (<year>2018</year>) A class of hydrazones are active against non-replicating <tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Mycobacterium</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">tuberculosis</tp:taxon-name-part></tp:taxon-name>. PLoS ONE 13(10): e0198059. <ext-link xlink:href="10.1371/journal.pone.0198059" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1371/journal.pone.0198059</ext-link></mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Bozbey</surname><given-names>İ</given-names></name><name name-style="western"><surname>Özdemir</surname><given-names>Z</given-names></name><name name-style="western"><surname>Uslu</surname><given-names>H</given-names></name><name name-style="western"><surname>Özçelik</surname><given-names>AB</given-names></name><name name-style="western"><surname>Şenol</surname><given-names>FS</given-names></name><name name-style="western"><surname>Orhan</surname><given-names>İE</given-names></name><name name-style="western"><surname>Uysal</surname><given-names>M</given-names></name></person-group> (<year>2020</year>) <article-title>A series of new hydrazone derivatives: synthesis, molecular docking and anticholinesterase activity studies.</article-title><source>Mini Reviews in Medicinal Chemistry</source><volume>20</volume>(<issue>11</issue>): <fpage>1042</fpage>–<lpage>1060</lpage>. <ext-link xlink:href="10.2174/1389557519666191010154444" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2174/1389557519666191010154444</ext-link></mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Chaubey</surname><given-names>AK</given-names></name><name name-style="western"><surname>Pandeya</surname><given-names>SN</given-names></name></person-group> (<year>2012</year>) <article-title>Synthesis and anticonvulsant activity (Chemo Shock) of Schiff and Mannich bases of isatin derivatives with 2-aminopyridine (mechanism of action).</article-title><source>International Journal of PharmTech Research</source><volume>4</volume>(<issue>4</issue>): <fpage>590</fpage>–<lpage>598</lpage>. <ext-link xlink:href="10.11648/j.ajhc.20190502.12" ext-link-type="doi" xlink:type="simple">https://doi.org/10.11648/j.ajhc.20190502.12</ext-link></mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><name name-style="western"><surname>Su</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M</given-names></name><name name-style="western"><surname>He</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>He</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Xue</surname><given-names>W</given-names></name></person-group> (<year>2019</year>) <article-title>Synthesis and antibacterial and antiviral activities of myricetin derivatives containing a 1,2,4-triazole Schiff base.</article-title><source>Royal Society Chemistry Advances</source><volume>9</volume>(<issue>40</issue>): <fpage>23045</fpage>–<lpage>23052</lpage>. <ext-link xlink:href="10.1039/C9ra05139b" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1039/C9ra05139b</ext-link></mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Cheng</surname><given-names>CL</given-names></name><name name-style="western"><surname>Lin</surname><given-names>EG</given-names></name><name name-style="western"><surname>Chou</surname><given-names>CH</given-names></name></person-group> (<year>2003</year>) <article-title>Rapid and sensitive quantitation of the antiproliferative agent Mitoguazone in small volumes of plasma by high-performance liquid chromatography with ultraviolet detection.</article-title><source>Journal of Chromatography B</source><volume>793</volume>(<issue>2</issue>): <fpage>281</fpage>–<lpage>289</lpage>. <ext-link xlink:href="10.1016/S1570-0232(03)00328-3" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/S1570-0232(03)00328-3</ext-link></mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Chohan</surname><given-names>ZH</given-names></name><name name-style="western"><surname>Sumrra</surname><given-names>SH</given-names></name><name name-style="western"><surname>Youssoufi</surname><given-names>MH</given-names></name><name name-style="western"><surname>Hadda</surname><given-names>TB ­­­</given-names></name></person-group> (<year>2010</year>) <article-title>Metal based biologically active compounds: design, synthesis, and antibacterial/antifungal/cytotoxic properties of triazole-derived Schiff bases and their oxovanadium(IV) complexes.</article-title><source>European Journal of Medicinal Chemistry</source><volume>45</volume>(<issue>7</issue>): <fpage>2739</fpage>–<lpage>2747</lpage>. <ext-link xlink:href="10.1016/j.ejmech.2010.02.053" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2010.02.053</ext-link></mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Cinarli</surname><given-names>A</given-names></name><name name-style="western"><surname>Gürbüz</surname><given-names>D</given-names></name><name name-style="western"><surname>Tavman</surname><given-names>A</given-names></name><name name-style="western"><surname>Birteksöz</surname><given-names>AS</given-names></name></person-group> (<year>2012</year>) <article-title>Spectral characterization and antimicrobial activity of some schiff bases derived from 4-chloro-2-aminophenol and various salicylaldehyde derivatives.</article-title><source>Chinese Journal of Chemistry</source><volume>30</volume>(<issue>2</issue>): <fpage>449</fpage>–<lpage>459</lpage>. <ext-link xlink:href="10.1002/cjoc.201180473" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1002/cjoc.201180473</ext-link></mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Corrêa</surname><given-names>JCR</given-names></name><name name-style="western"><surname>Hiene</surname><given-names>MAC</given-names></name><name name-style="western"><surname>Salgado</surname><given-names>HRN</given-names></name></person-group> (<year>2013</year>) <article-title>Physico-chemical characterization and analytical development for sodium Azumolene, a potential drug designed to fight malignant hyperthermia.</article-title><source>Journal of Analytical Bioanalytical Techniques</source><volume>5</volume>(<issue>1</issue>): <fpage>1</fpage>–<lpage>6</lpage>. <ext-link xlink:href="http://hdl.handle.net/11449/133745" ext-link-type="uri" xlink:type="simple">http://hdl.handle.net/11449/133745</ext-link></mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Daoud</surname><given-names>S</given-names></name><name name-style="western"><surname>Thiab</surname><given-names>S</given-names></name><name name-style="western"><surname>Jazzazi</surname><given-names>TMA</given-names></name><name name-style="western"><surname>Al-Shboul</surname><given-names>TMA</given-names></name><name name-style="western"><surname>Ullah</surname><given-names>S</given-names></name></person-group> (<year>2022</year>) <article-title>Evaluation and molecular modelling of bis-Schiff base derivatives as potential leads for management of diabetes mellitus.</article-title><source>Acta Pharmaceutica</source><volume>72</volume>(<issue>3</issue>): <fpage>449</fpage>–<lpage>458</lpage>. <ext-link xlink:href="10.2478/acph-2022-0019" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2478/acph-2022-0019</ext-link></mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Davidson</surname><given-names>K</given-names></name><name name-style="western"><surname>Petit</surname><given-names>T</given-names></name><name name-style="western"><surname>Izbicka</surname><given-names>E</given-names></name><name name-style="western"><surname>Koester</surname><given-names>S</given-names></name><name name-style="western"><surname>Von Hoff</surname><given-names>DD</given-names></name></person-group> (<year>1998</year>) Mitoguazone induces apoptosis via a p53-independent mechanism Anti-Cancer Drugs 9(7): 635–640. <ext-link xlink:href="10.1097/00001813-199808000-00009" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1097/00001813-199808000-00009</ext-link></mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>de Clercq</surname><given-names>E</given-names></name></person-group> (<year>2010</year>) <article-title>Historical Perspectives in the development of antiviral agents against Poxviruses.</article-title><source>Viruses</source><volume>2</volume>(<issue>6</issue>): <fpage>1322</fpage>–<lpage>1339</lpage>. <ext-link xlink:href="10.3390/v2061322" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/v2061322</ext-link></mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>de Morais Cordeiro</surname><given-names>N</given-names></name><name name-style="western"><surname>Freitas</surname><given-names>RHCN</given-names></name><name name-style="western"><surname>Fraga</surname><given-names>CAM</given-names></name><name name-style="western"><surname>Fernandes</surname><given-names>PD</given-names></name></person-group> (<year>2016</year>) Discovery of novel orally active tetrahydro-naphthyl-N-acylhydrazones with <italic>in vivo</italic> anti-TNF-α effect and remarkable anti-inflammatory properties. PLoS ONE 11(5): e0156271. <ext-link xlink:href="10.1371/journal.pone.0156271" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1371/journal.pone.0156271</ext-link></mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>de Morais Cordeiro</surname><given-names>N</given-names></name><name name-style="western"><surname>Freitas</surname><given-names>RHCN</given-names></name><name name-style="western"><surname>Fraga</surname><given-names>CAM</given-names></name><name name-style="western"><surname>Fernandes</surname><given-names>PD</given-names></name></person-group> (<year>2020</year>) New 2-amino-pyridinyl-N-acylhydrazones: synthesis and identification of their mechanism of anti-inflammatory action. Biomedicine Pharmacotherapy 123: 109739. <ext-link xlink:href="https://doi.org10.1016/j.biopha.2019.109739" ext-link-type="uri" xlink:type="simple">https://doi.org10.1016/j.biopha.2019.109739</ext-link></mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Demurtas</surname><given-names>M</given-names></name><name name-style="western"><surname>Baldisserotto</surname><given-names>A</given-names></name><name name-style="western"><surname>Lampronti</surname><given-names>I</given-names></name><name name-style="western"><surname>Moi</surname><given-names>D</given-names></name><name name-style="western"><surname>Balboni</surname><given-names>G</given-names></name><name name-style="western"><surname>Pacifico</surname><given-names>S</given-names></name><name name-style="western"><surname>Vertuani</surname><given-names>S</given-names></name><name name-style="western"><surname>Manfredini</surname><given-names>S</given-names></name><name name-style="western"><surname>Onnis</surname><given-names>V</given-names></name></person-group> (<year>2019</year>) <article-title>Indole derivatives as multifunctional drugs: synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity of indole hydrazones.</article-title><source>Bioorganic Chemistry</source><volume>85</volume>: <fpage>568</fpage>–<lpage>576</lpage>. <ext-link xlink:href="10.1016/j.bioorg.2019.02.007" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.bioorg.2019.02.007</ext-link></mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>de Oliveira Carneiro Brum</surname><given-names>JCB</given-names></name><name name-style="western"><surname>França</surname><given-names>TCC</given-names></name><name name-style="western"><surname>LaPlante</surname><given-names>SR</given-names></name><name name-style="western"><surname>Villar</surname><given-names>JDF</given-names></name></person-group> (<year>2020</year>) <article-title>Synthesis and biological activity of hydrazones and derivatives: a review.</article-title><source>Mini Reviews in Medicinal Chemistry</source><volume>20</volume>(<issue>5</issue>): <fpage>342</fpage>–<lpage>368</lpage>. <ext-link xlink:href="10.2174/1389557519666191014142448" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2174/1389557519666191014142448</ext-link></mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>de Siqueira</surname><given-names>LRP</given-names></name><name name-style="western"><surname>de Moraes Gomes</surname><given-names>PAT</given-names></name><name name-style="western"><surname>de Lima Ferreira</surname><given-names>LP</given-names></name><name name-style="western"><surname>de Melo Rêgo</surname><given-names>MJB</given-names></name><name name-style="western"><surname>Leite</surname><given-names>ACL</given-names></name></person-group> (<year>2019</year>) <article-title>Multi-target compounds acting in cancer progression: focus on thiosemicarbazone, thiazole and thiazolidinone analogues.</article-title><source>European Journal of Medicinal Chemistry</source><volume>170</volume>: <fpage>237</fpage>–<lpage>260</lpage>. <ext-link xlink:href="10.1016/j.ejmech.2019.03.024" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2019.03.024</ext-link></mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation xlink:type="simple">Dhuguru J, Zviagi E, Skouta R<person-group><name name-style="western"><surname>.</surname></name></person-group> (<year>2022</year>) <article-title>FDA-approved oximes and their significance in medicinal chemistry.</article-title><source>Pharmaceuticals (Basel)</source><volume>15</volume>(<issue>1</issue>): <fpage>66</fpage>. <ext-link xlink:href="10.3390/ph15010066" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/ph15010066</ext-link></mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>dos Santos Filho</surname><given-names>JM</given-names></name><name name-style="western"><surname>de Queiroz Silva</surname><given-names>DMA</given-names></name><name name-style="western"><surname>Macedo</surname><given-names>TS</given-names></name><name name-style="western"><surname>Teixeira</surname><given-names>HMP</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>DRM</given-names></name><name name-style="western"><surname>Challal</surname><given-names>S</given-names></name><name name-style="western"><surname>Wolfender</surname><given-names>J-L</given-names></name><name name-style="western"><surname>Queiroz</surname><given-names>EF</given-names></name><name name-style="western"><surname>Soares</surname><given-names>MBP</given-names></name></person-group> (<year>2016</year>) <article-title>Conjugation of N-acylhydrazone and 1,2,4-oxadiazole leads to the identification of active antimalarial agents.</article-title><source>Bioorganic Medicinal Chemistry</source><volume>24</volume>(<issue>22</issue>): <fpage>5693</fpage>–<lpage>5701</lpage>. <ext-link xlink:href="10.1016/j.bmc.2016.09.013" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.bmc.2016.09.013</ext-link></mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Ejidike</surname><given-names>IP</given-names></name><name name-style="western"><surname>Ajibade</surname><given-names>PA</given-names></name></person-group> (<year>2016</year>) <article-title>Synthesis and <italic>in vitro</italic> anticancer, antibacterial, and antioxidant studies of unsymmetrical Schiff base derivatives of 4-[(1E)-N-(2-aminoethyl)ethanimidoyl]benzene-1,3-diol.</article-title><source>Research on Chemical Intermediates</source><volume>42</volume>: <fpage>6543</fpage>–<lpage>6555</lpage>. <ext-link xlink:href="10.1007/s11164-016-2479-x" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1007/s11164-016-2479-x</ext-link></mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>El-Gammal</surname><given-names>OA</given-names></name><name name-style="western"><surname>Mohamed</surname><given-names>FS</given-names></name><name name-style="western"><surname>Rezk</surname><given-names>GN</given-names></name><name name-style="western"><surname>El-Bindary</surname><given-names>AA</given-names></name></person-group> (<year>2021</year>) Synthesis, characterization, catalytic, DNA bnding and antibacterial activities of Co(II), Ni(II) and Cu(II) complexes with new Schiff base ligand. Journal of Molecular Liquids 326: 115223. <ext-link xlink:href="10.1016/j.molliq.2020.115223" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.molliq.2020.115223</ext-link></mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>El-Mekabaty</surname><given-names>A</given-names></name><name name-style="western"><surname>Sofan</surname><given-names>MA</given-names></name><name name-style="western"><surname>Hasel</surname><given-names>AM</given-names></name><name name-style="western"><surname>Said</surname><given-names>SB</given-names></name></person-group> (<year>2021</year>) <article-title>Concise synthesis of some new benzothiazole-based heterocycles as pobable anticancer and antioxidant agents.</article-title><source>Chemistry Select</source><volume>6</volume>(<issue>10</issue>): <fpage>2569</fpage>–<lpage>2575</lpage>. <ext-link xlink:href="10.1002/slct.202100372" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1002/slct.202100372</ext-link></mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Forsyth</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Hernandez</surname><given-names>S</given-names></name><name name-style="western"><surname>Olmedo</surname><given-names>W</given-names></name><name name-style="western"><surname>Abuhamidah</surname><given-names>A</given-names></name><name name-style="western"><surname>Traina</surname><given-names>MI</given-names></name><name name-style="western"><surname>Sanchez</surname><given-names>DR</given-names></name><name name-style="western"><surname>Meymandi</surname><given-names>SK</given-names></name></person-group> (<year>2016</year>) <article-title>Safety profile of Nifurtimox for treatment of Chagas disease in the United States.</article-title><source>Clinical Infectious Diseases</source><volume>63</volume>(<issue>8</issue>): <fpage>1056</fpage>–<lpage>1062</lpage>. <ext-link xlink:href="10.1093/cid/ciw477" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1093/cid/ciw477</ext-link></mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Franca</surname><given-names>PHB</given-names></name><name name-style="western"><surname>Da Silva-Junior</surname><given-names>EF</given-names></name><name name-style="western"><surname>Aquino</surname><given-names>PGV</given-names></name><name name-style="western"><surname>Santana</surname><given-names>AEG</given-names></name><name name-style="western"><surname>Ferro</surname><given-names>JNS</given-names></name><name name-style="western"><surname>De Oliveira Barreto</surname><given-names>E</given-names></name><name name-style="western"><surname>Do Ó Pessoa</surname><given-names>C</given-names></name><name name-style="western"><surname>Meira</surname><given-names>AS</given-names></name><name name-style="western"><surname>De Aquino</surname><given-names>TM</given-names></name><name name-style="western"><surname>Alexandre-Moreira</surname><given-names>MS</given-names></name><name name-style="western"><surname>Schmitt</surname><given-names>M</given-names></name><name name-style="western"><surname>De Araújo-Júnior</surname><given-names>JX</given-names></name></person-group> (<year>2016</year>) <article-title>Preliminary <italic>in vitro</italic> evaluation of the anti-proliferative activity of guanylhydrazone derivatives.</article-title><source>Acta Pharmaceutica</source><volume>66</volume>(<issue>1</issue>): <fpage>129</fpage>–<lpage>137</lpage>. <ext-link xlink:href="10.1515/acph-2016-0015" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1515/acph-2016-0015</ext-link></mixed-citation>
      </ref>
      <ref id="B52">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Francesconi</surname><given-names>V</given-names></name><name name-style="western"><surname>Cichero</surname><given-names>E</given-names></name><name name-style="western"><surname>Schenone</surname><given-names>S</given-names></name><name name-style="western"><surname>Naesens</surname><given-names>L</given-names></name><name name-style="western"><surname>Tonelli</surname><given-names>M</given-names></name></person-group> (<year>2020</year>) <article-title>Synthesis and biological evaluation of novel (thio)semicarbazone-based benzimidazoles as antiviral agents against human respiratory viruses.</article-title><source>Molecules (Basel, Switzerland)</source><volume>25</volume>(<issue>7</issue>): <fpage>1487</fpage>. <ext-link xlink:href="10.3390/molecules2507148" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/molecules2507148</ext-link></mixed-citation>
      </ref>
      <ref id="B53">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Gacitúa</surname><given-names>M</given-names></name><name name-style="western"><surname>Carreño</surname><given-names>A</given-names></name><name name-style="western"><surname>Morales-Guevara</surname><given-names>R</given-names></name><name name-style="western"><surname>Páez-Hernández</surname><given-names>D</given-names></name><name name-style="western"><surname>Martínez-Araya</surname><given-names>JI</given-names></name><name name-style="western"><surname>Araya</surname><given-names>E</given-names></name><name name-style="western"><surname>Preite</surname><given-names>M</given-names></name><name name-style="western"><surname>Otero</surname><given-names>C</given-names></name><name name-style="western"><surname>Rivera-Zaldívar</surname><given-names>MM</given-names></name><name name-style="western"><surname>Silva</surname><given-names>A</given-names></name><name name-style="western"><surname>Fuentes</surname><given-names>JA</given-names></name></person-group> (<year>2022</year>) <article-title>Physicochemical and theoretical characterization of a new small non-metal Schiff base with a differential antimicrobial effect against Gram-positive bacteria.</article-title><source>International Journal of Molecular Sciences</source><volume>23</volume>(<issue>5</issue>): <fpage>2553</fpage>. <ext-link xlink:href="10.3390/ijms23052553" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/ijms23052553</ext-link></mixed-citation>
      </ref>
      <ref id="B54">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Gadad</surname><given-names>AK</given-names></name><name name-style="western"><surname>Mahajanshetti</surname><given-names>CS</given-names></name><name name-style="western"><surname>Nimbalkar</surname><given-names>S</given-names></name><name name-style="western"><surname>Raichurkar</surname><given-names>A</given-names></name></person-group> (<year>2000</year>) <article-title>Synthesis and antibacterial activity of some 5-guanylhydrazone/thiocyanato-6-arylimidazo[2,1-b]-1,3,4-thiadiazole-2-sulfonamide derivatives.</article-title><source>European Journal of Medicinal Chemistry</source><volume>35</volume>(<issue>9</issue>): <fpage>853</fpage>–<lpage>857</lpage>. <ext-link xlink:href="10.1016/s0223-5234(00)00166-5" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/s0223-5234(00)00166-5</ext-link></mixed-citation>
      </ref>
      <ref id="B55">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>González-Barcia</surname><given-names>LM</given-names></name><name name-style="western"><surname>Fernández-Fariña</surname><given-names>S</given-names></name><name name-style="western"><surname>Rodríguez-Silva</surname><given-names>L</given-names></name><name name-style="western"><surname>Bermejo</surname><given-names>MR</given-names></name><name name-style="western"><surname>González-Noya</surname><given-names>AM</given-names></name><name name-style="western"><surname>Pedrido</surname><given-names>R</given-names></name></person-group> (<year>2019</year>) Comparative study of the antitumoral activity of phosphine-thiosemicarbazone gold(I) complexes obtained by different methodologies. Journal of Inorganic Biochemistry 203: 110931. <ext-link xlink:href="10.1016/j.jinorgbio.2019.110931" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.jinorgbio.2019.110931</ext-link></mixed-citation>
      </ref>
      <ref id="B56">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Govindaiah</surname><given-names>P</given-names></name><name name-style="western"><surname>Dumala</surname><given-names>N</given-names></name><name name-style="western"><surname>Mattan</surname><given-names>I</given-names></name><name name-style="western"><surname>Grover</surname><given-names>P</given-names></name><name name-style="western"><surname>Prakash</surname><given-names>JM</given-names></name></person-group> (<year>2019</year>) Design, synthesis, biological and in silico evaluation of Coumarin-hydrazone derivatives as tubulin targeted antiproliferative agents. Bioorganic Chemistry 91: 103143. <ext-link xlink:href="10.1016/j.bioorg.2019.103143" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.bioorg.2019.103143</ext-link></mixed-citation>
      </ref>
      <ref id="B57">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Guilherme</surname><given-names>FD</given-names></name><name name-style="western"><surname>Simonetti</surname><given-names>JÉ</given-names></name><name name-style="western"><surname>Folquitto</surname><given-names>LRS</given-names></name><name name-style="western"><surname>Reis</surname><given-names>ACC</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>JC</given-names></name><name name-style="western"><surname>Dias</surname><given-names>ALT</given-names></name><name name-style="western"><surname>Dias</surname><given-names>DF</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>DT</given-names></name><name name-style="western"><surname>Brandão</surname><given-names>GC</given-names></name><name name-style="western"><surname>de Souza</surname><given-names>TB</given-names></name></person-group> (<year>2019</year>) <article-title>Synthesis, chemical characterization and antimicrobial activity of new acylhydrazones derived from carbohydrates.</article-title><source>Journal of Molecular Structure</source><volume>1184</volume>: <fpage>349</fpage>–<lpage>356</lpage>. <ext-link xlink:href="10.1016/j.molstruc.2019.02.045" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.molstruc.2019.02.045</ext-link></mixed-citation>
      </ref>
      <ref id="B58">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Guo</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X</given-names></name><name name-style="western"><surname>Xu</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Luo</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>B</given-names></name><name name-style="western"><surname>Shi</surname><given-names>D</given-names></name></person-group> (<year>2019</year>) <article-title>discovery of novel bromophenol-thiosemicarbazone hybrids as potent selective inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1) for use in cancer.</article-title><source>Journal of Medicinal Chemistry</source><volume>62</volume>(<issue>6</issue>): <fpage>3051</fpage>–<lpage>3067</lpage>. <ext-link xlink:href="10.1021/acs.jmedchem.8b01946" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1021/acs.jmedchem.8b01946</ext-link></mixed-citation>
      </ref>
      <ref id="B59">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Gürbüz</surname><given-names>D</given-names></name><name name-style="western"><surname>Cinarli</surname><given-names>A</given-names></name><name name-style="western"><surname>Tavman</surname><given-names>A</given-names></name><name name-style="western"><surname>Birteksöz</surname><given-names>AS</given-names></name></person-group> (<year>2012</year>) <article-title>Spectral characterization and antimicrobial activity of some schiff bases derived from 4-methyl-2-aminophenol.</article-title><source>Chinese Journal of Chemistry</source><volume>30</volume>(<issue>4</issue>): <fpage>970</fpage>–<lpage>978</lpage>. <ext-link xlink:href="10.1002/cjoc.201100237" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1002/cjoc.201100237</ext-link></mixed-citation>
      </ref>
      <ref id="B60">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Güzel</surname><given-names>Ö</given-names></name><name name-style="western"><surname>Karalı</surname><given-names>N</given-names></name><name name-style="western"><surname>Salman</surname><given-names>A</given-names></name></person-group> (<year>2008</year>) <article-title>Synthesis and antituberculosis activity of 5-methyl/trifluoromethoxy-1Hindole-2, 3-dione-3-thiosemicarbazone derivatives.</article-title><source>Bioorganic Medicinal Chemistry</source><volume>16</volume>(<issue>19</issue>): <fpage>8976</fpage>–<lpage>8987</lpage>. <ext-link xlink:href="10.1016/j.bmc.2008.08.050" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.bmc.2008.08.050</ext-link></mixed-citation>
      </ref>
      <ref id="B61">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Hasan</surname><given-names>AH</given-names></name><name name-style="western"><surname>Abdulrahman</surname><given-names>FA</given-names></name><name name-style="western"><surname>Obaidullah</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Alotaibi</surname><given-names>HF</given-names></name><name name-style="western"><surname>Alanazi</surname><given-names>MM</given-names></name><name name-style="western"><surname>Noamaan</surname><given-names>MA</given-names></name><name name-style="western"><surname>Murugesan</surname><given-names>S</given-names></name><name name-style="western"><surname>Amran</surname><given-names>SI</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>AR</given-names></name><name name-style="western"><surname>Jamalis</surname><given-names>J</given-names></name></person-group> (<year>2023</year>) <article-title>Discovery of novel Coumarin-Schiff base hybrids as potential acetylcholinesterase inhibitors: design, synthesis, enzyme inhibition, and computational studies.</article-title><source>Pharmaceuticals (Basel)</source><volume>16</volume>(<issue>7</issue>): <fpage>971</fpage>. <ext-link xlink:href="10.3390/ph16070971" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/ph16070971</ext-link></mixed-citation>
      </ref>
      <ref id="B62">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Hashimoto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name><name name-style="western"><surname>Hashimoto</surname><given-names>K</given-names></name></person-group> (<year>2022</year>) <article-title>Old drug Fluvoxamine, new hope for COVID-19.</article-title><source>European Archives of Psychiatry and Clinical Neuroscience</source><volume>272</volume>(<issue>1</issue>): <fpage>161</fpage>–<lpage>163</lpage>. <ext-link xlink:href="10.1007/s00406-021-01326-z" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1007/s00406-021-01326-z</ext-link></mixed-citation>
      </ref>
      <ref id="B63">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Hassan</surname><given-names>AS</given-names></name><name name-style="western"><surname>Askar</surname><given-names>AA</given-names></name><name name-style="western"><surname>Nossier</surname><given-names>ES</given-names></name><name name-style="western"><surname>Naglah</surname><given-names>АМ</given-names></name><name name-style="western"><surname>Moustafa</surname><given-names>GO</given-names></name><name name-style="western"><surname>Al-Omar</surname><given-names>MA</given-names></name></person-group> (<year>2019</year>) <article-title>Antibacterial evaluation, in silico characters and molecular docking of Schiff bases derived from 5-aminopyrazoles.</article-title><source>Molecules (Basel, Switzerland)</source><volume>24</volume>(<issue>17</issue>): <fpage>3130</fpage>. <ext-link xlink:href="10.3390/molecules24173130" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/molecules24173130</ext-link></mixed-citation>
      </ref>
      <ref id="B64">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Hassan</surname><given-names>AS</given-names></name><name name-style="western"><surname>Morsy</surname><given-names>NM</given-names></name><name name-style="western"><surname>Aboulthana</surname><given-names>WM</given-names></name><name name-style="western"><surname>Ragab</surname><given-names>A</given-names></name></person-group> (<year>2023</year>) <article-title>Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis, <italic>in vitro</italic> biological evaluation, and in silico ADMET analysis with molecular modeling simulations.</article-title><source>Royal Society Chemistry Advances</source><volume>13</volume>(<issue>14</issue>): <fpage>9281</fpage>–<lpage>9303</lpage>. <ext-link xlink:href="10.1039/D3RA00297G" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1039/D3RA00297G</ext-link></mixed-citation>
      </ref>
      <ref id="B65">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>He</surname><given-names>Z</given-names></name><name name-style="western"><surname>Qiao</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>W</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>B</given-names></name><name name-style="western"><surname>Ma</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>HM</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>W</given-names></name></person-group> (<year>2019</year>) . Novel thiosemicarbazone derivatives containing indole fragment as potent and selective anticancer agent. European Journal of Medicinal Chemistry 184: 111764. <ext-link xlink:href="10.1016/j.ejmech.2019.111764" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2019.111764</ext-link></mixed-citation>
      </ref>
      <ref id="B66">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Heffeter</surname><given-names>P</given-names></name><name name-style="western"><surname>Pape</surname><given-names>VFS</given-names></name><name name-style="western"><surname>Enyedy</surname><given-names>ÉA</given-names></name><name name-style="western"><surname>Keppler</surname><given-names>BK</given-names></name><name name-style="western"><surname>Szakacs</surname><given-names>G</given-names></name><name name-style="western"><surname>Kowol</surname><given-names>CR</given-names></name></person-group> (<year>2019</year>) <article-title>Anticancer Thiosemicarbazones: chemical properties, interaction with iron metabolism, and resistance development.</article-title><source>Antioxidants Redox Signaling</source><volume>30</volume>(<issue>8</issue>): <fpage>1062</fpage>–<lpage>1082</lpage>. <ext-link xlink:href="10.1089/ars.2017.7487" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1089/ars.2017.7487</ext-link></mixed-citation>
      </ref>
      <ref id="B67">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Howsaui</surname><given-names>HB</given-names></name><name name-style="western"><surname>Basaleh</surname><given-names>AS</given-names></name><name name-style="western"><surname>Abdellattif</surname><given-names>MH</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>WMI</given-names></name><name name-style="western"><surname>Hussien</surname><given-names>MA</given-names></name></person-group> (<year>2021</year>) <article-title>Synthesis, structural investigations, molecular docking, and anticancer activity of some novel Schiff bases and their uranyl complexes.</article-title><source>Biomolecules</source><volume>11</volume>(<issue>8</issue>): <fpage>1138</fpage>. <ext-link xlink:href="10.3390/biom11081138" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/biom11081138</ext-link></mixed-citation>
      </ref>
      <ref id="B68">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Huttner</surname><given-names>A</given-names></name><name name-style="western"><surname>Verhaegh</surname><given-names>EM</given-names></name><name name-style="western"><surname>Harbarth</surname><given-names>S</given-names></name><name name-style="western"><surname>Muller</surname><given-names>AE</given-names></name><name name-style="western"><surname>Theuretzbacher</surname><given-names>U</given-names></name><name name-style="western"><surname>Mouton</surname><given-names>JW</given-names></name></person-group> (<year>2015</year>) <article-title>Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials.</article-title><source>Journal of Antimicrobial Chemotherapy</source><volume>70</volume>(<issue>9</issue>): <fpage>2456</fpage>–<lpage>2464</lpage>. <ext-link xlink:href="10.1093/jac/dkv147" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1093/jac/dkv147</ext-link></mixed-citation>
      </ref>
      <ref id="B69">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Iacopetta</surname><given-names>D</given-names></name><name name-style="western"><surname>Ceramella</surname><given-names>J</given-names></name><name name-style="western"><surname>Catalano</surname><given-names>A</given-names></name><name name-style="western"><surname>Saturnino</surname><given-names>C</given-names></name><name name-style="western"><surname>Bonomo</surname><given-names>MG</given-names></name><name name-style="western"><surname>Franchini</surname><given-names>C</given-names></name><name name-style="western"><surname>Sinicropi</surname><given-names>MS</given-names></name></person-group> (<year>2011</year>) <article-title>Schiff bases: interesting scaffolds with promising antitumoral properties.</article-title><source>Applied Sciences</source><volume>11</volume>(<issue>4</issue>): <fpage>1877</fpage>. <ext-link xlink:href="10.3390/app11041877" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/app11041877</ext-link></mixed-citation>
      </ref>
      <ref id="B70">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Jacomini</surname><given-names>AP</given-names></name><name name-style="western"><surname>Silva</surname><given-names>MJV</given-names></name><name name-style="western"><surname>Silva</surname><given-names>RGM</given-names></name><name name-style="western"><surname>Gonçalves</surname><given-names>DS</given-names></name><name name-style="western"><surname>Volpato</surname><given-names>H</given-names></name><name name-style="western"><surname>Basso</surname><given-names>EA</given-names></name><name name-style="western"><surname>Paula</surname><given-names>FR</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>CV</given-names></name><name name-style="western"><surname>Sarragiotto</surname><given-names>MH</given-names></name><name name-style="western"><surname>Rosa</surname><given-names>FA</given-names></name></person-group> (<year>2016</year>) <article-title>Synthesis and evaluation against <tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Leishmania</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">amazonensis</tp:taxon-name-part></tp:taxon-name> of novel pyrazolo[3,4-d]pyridazinone-N-acylhydrazone-(bi)thiophene hybrids.</article-title><source>European Journal of Medicinal Chemistry</source><volume>124</volume>: <fpage>340</fpage>–<lpage>349</lpage>. <ext-link xlink:href="10.1016/j.ejmech.2016.08.048" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2016.08.048</ext-link></mixed-citation>
      </ref>
      <ref id="B71">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Jarrahpour</surname><given-names>A</given-names></name><name name-style="western"><surname>Khalili</surname><given-names>D</given-names></name><name name-style="western"><surname>De Clercq</surname><given-names>E</given-names></name><name name-style="western"><surname>Salmi</surname><given-names>C</given-names></name><name name-style="western"><surname>Brunel</surname><given-names>JM</given-names></name></person-group> (<year>2007</year>) <article-title>Synthesis, antibacterial, antifungal and antiviral activity evaluation of some new bis-Schiff bases of isatin and their derivatives.</article-title><source>Molecules (Basel, Switzerland)</source><volume>12</volume>(<issue>8</issue>): <fpage>1720</fpage>–<lpage>1730</lpage>. <ext-link xlink:href="10.3390/12081720" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/12081720</ext-link></mixed-citation>
      </ref>
      <ref id="B72">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Jarrahpour</surname><given-names>A</given-names></name><name name-style="western"><surname>Shirvani</surname><given-names>P</given-names></name><name name-style="western"><surname>Sharghi</surname><given-names>H</given-names></name><name name-style="western"><surname>Aberi</surname><given-names>M</given-names></name><name name-style="western"><surname>Sinou</surname><given-names>V</given-names></name><name name-style="western"><surname>Latour</surname><given-names>C</given-names></name><name name-style="western"><surname>Brunel</surname><given-names>JM</given-names></name></person-group> (<year>2015</year>) <article-title>Synthesis of novel mono- and bis-Schiff bases of morpholine derivatives and the investigation of their antimalarial and antiproliferative activities.</article-title><source>Medicinal Chemistry Research</source><volume>24</volume>(<issue>12</issue>): <fpage>4105</fpage>–<lpage>4112</lpage>. <ext-link xlink:href="10.1007/s00044-015-1455-0" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1007/s00044-015-1455-0</ext-link></mixed-citation>
      </ref>
      <ref id="B73">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Jelić</surname><given-names>S</given-names></name><name name-style="western"><surname>Kovčin</surname><given-names>V</given-names></name><name name-style="western"><surname>Milanović</surname><given-names>N</given-names></name><name name-style="western"><surname>Kreačić</surname><given-names>M</given-names></name><name name-style="western"><surname>Pendjer</surname><given-names>I</given-names></name><name name-style="western"><surname>Jovanović</surname><given-names>V</given-names></name><name name-style="western"><surname>Ristović</surname><given-names>Z</given-names></name><name name-style="western"><surname>Oprić</surname><given-names>M</given-names></name><name name-style="western"><surname>Mitrović</surname><given-names>L</given-names></name></person-group> (<year>1997</year>) <article-title>Randomized study of Zorubicin versus Zorubicin-Cisplatin in undifferentiated carcinoma of the nasopharynx (UCNT).</article-title><source>Annals of Oncology</source><volume>8</volume>(<issue>8</issue>): <fpage>739</fpage>–<lpage>744</lpage>. <ext-link xlink:href="10.1023/A:1008210527637" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1023/A:1008210527637</ext-link></mixed-citation>
      </ref>
      <ref id="B74">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Jin</surname><given-names>X</given-names></name><name name-style="western"><surname>McGrath</surname><given-names>MS</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name></person-group> (<year>2015</year>) <article-title>Inhibition of HIV expression and integration in macrophages by methylglyoxal-bis-guanylhydrazone.</article-title><source>Journal of Virology</source><volume>89</volume>(<issue>22</issue>): <fpage>11176</fpage>–<lpage>11189</lpage>. <ext-link xlink:href="10.1128/JVI.01692-15" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1128/JVI.01692-15</ext-link></mixed-citation>
      </ref>
      <ref id="B75">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Jorge</surname><given-names>J</given-names></name><name name-style="western"><surname>Del Pino Santos</surname><given-names>KF</given-names></name><name name-style="western"><surname>Timóteo</surname><given-names>F</given-names></name><name name-style="western"><surname>Piva Vasconcelos</surname><given-names>RR</given-names></name><name name-style="western"><surname>Cáceres</surname><given-names>OIA</given-names></name><name name-style="western"><surname>Granja</surname><given-names>IJA</given-names></name><name name-style="western"><surname>de Souza</surname><given-names>MD</given-names></name><name name-style="western"><surname>Frizon</surname><given-names>EAT</given-names></name><name name-style="western"><surname>Di Vaccari-Botteselle</surname><given-names>G</given-names></name><name name-style="western"><surname>Braga</surname><given-names>LA</given-names></name><name name-style="western"><surname>Saba</surname><given-names>S</given-names></name><name name-style="western"><surname>Ur Rashid</surname><given-names>H</given-names></name><name name-style="western"><surname>Rafique</surname><given-names>J</given-names></name></person-group> (<year>2024</year>) <article-title>Recent advances on the antimicrobial activities of Schiff bases and their metal complexes: an updated overview.</article-title><source>Current Medicinal Chemistry</source><volume>31</volume>(<issue>17</issue>): <fpage>2330</fpage>–<lpage>2344</lpage>. <ext-link xlink:href="10.2174/0929867330666230224092830" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2174/0929867330666230224092830</ext-link></mixed-citation>
      </ref>
      <ref id="B76">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Kallus</surname><given-names>S</given-names></name><name name-style="western"><surname>Uhlik</surname><given-names>L</given-names></name><name name-style="western"><surname>van Schoonhoven</surname><given-names>S</given-names></name><name name-style="western"><surname>Pelivan</surname><given-names>K</given-names></name><name name-style="western"><surname>Berger</surname><given-names>W</given-names></name><name name-style="western"><surname>Enyedy</surname><given-names>ÉA</given-names></name><name name-style="western"><surname>Hofmann</surname><given-names>T</given-names></name><name name-style="western"><surname>Heffeter</surname><given-names>P</given-names></name><name name-style="western"><surname>Kowol</surname><given-names>CR</given-names></name><name name-style="western"><surname>Keppler</surname><given-names>BK</given-names></name></person-group> (<year>2019</year>) <article-title>Synthesis and biological evaluation of biotin-conjugated anticancer thiosemicarbazones and their iron(III) and copper(II) complexes.</article-title><source>Journal of Inorganic Biochemistry</source><volume>190</volume>: <fpage>85</fpage>–<lpage>97</lpage>. <ext-link xlink:href="10.1016/j.jinorgbio.2018.10.006" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.jinorgbio.2018.10.006</ext-link></mixed-citation>
      </ref>
      <ref id="B77">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Kandile</surname><given-names>NG</given-names></name><name name-style="western"><surname>Mohamed</surname><given-names>MI</given-names></name><name name-style="western"><surname>Ismaeel</surname><given-names>HM</given-names></name></person-group> (<year>2017</year>) <article-title>Synthesis of new Schiff bases bearing 1,2,4-triazole, thiazolidine and chloroazetidine moieties and their pharmacological evaluation.</article-title><source>Journal of Enzyme Inhibition and Medicinal Chemistry</source><volume>32</volume>(<issue>1</issue>): <fpage>119</fpage>–<lpage>129</lpage>. <ext-link xlink:href="10.1080/14756366.2016.1238365" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1080/14756366.2016.1238365</ext-link></mixed-citation>
      </ref>
      <ref id="B78">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Kassab</surname><given-names>AE</given-names></name></person-group> (<year>2023</year>) <article-title>Anticancer agents incorporating the N‐acylhydrazone scaffold: Progress from 2017 to present.</article-title><source>Archiv der Pharmazie (Weinheim)</source><volume>356</volume>(<issue>5</issue>): <fpage>2200548</fpage>. <ext-link xlink:href="10.1002/ardp.202200548" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1002/ardp.202200548</ext-link></mixed-citation>
      </ref>
      <ref id="B79">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Katherashala</surname><given-names>S</given-names></name><name name-style="western"><surname>Bollam</surname><given-names>B</given-names></name><name name-style="western"><surname>Garrepalli</surname><given-names>S</given-names></name><name name-style="western"><surname>Bethi</surname><given-names>S</given-names></name></person-group> (<year>2014</year>) <article-title>Synthesis and evaluation of novel isatin derivatives for antimicrobial activity.</article-title><source>Asian Journal of Pharmaceutical and Clinical Research</source><volume>7</volume>(<issue>2</issue>): <fpage>182</fpage>–<lpage>184</lpage>.</mixed-citation>
      </ref>
      <ref id="B80">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Kaushik</surname><given-names>S</given-names></name><name name-style="western"><surname>Paliwal</surname><given-names>SK</given-names></name><name name-style="western"><surname>Iyer</surname><given-names>MR</given-names></name><name name-style="western"><surname>Patil</surname><given-names>VM</given-names></name></person-group> (<year>2023</year>) <article-title>Promising Schiff bases in antiviral drug design and discovery.</article-title><source>Medicinal Chemistry Research</source><volume>32</volume>(<issue>6</issue>): <fpage>1063</fpage>–<lpage>1076</lpage>. <ext-link xlink:href="10.1007/s00044-023-03068-0" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1007/s00044-023-03068-0</ext-link></mixed-citation>
      </ref>
      <ref id="B81">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Knight</surname><given-names>WAT</given-names></name><name name-style="western"><surname>Fabian</surname><given-names>C</given-names></name><name name-style="western"><surname>Costanzi</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Jones</surname><given-names>SE</given-names></name><name name-style="western"><surname>Coltman</surname><given-names>CA</given-names></name></person-group> (<year>1983</year>) <article-title>Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in lymphoma and Hodgkin’s disease. A Phase II trial of the Southwest Oncology Group.</article-title><source>Investigational New Drugs</source><volume>1</volume>(<issue>3</issue>): <fpage>235</fpage>–<lpage>237</lpage>. <ext-link xlink:href="10.1007/BF00208895" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1007/BF00208895</ext-link></mixed-citation>
      </ref>
      <ref id="B82">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Kulkarni</surname><given-names>AA</given-names></name><name name-style="western"><surname>Wankhede</surname><given-names>SB</given-names></name><name name-style="western"><surname>Dhawale</surname><given-names>ND</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>PB</given-names></name><name name-style="western"><surname>Deore</surname><given-names>VV</given-names></name><name name-style="western"><surname>Gonjari</surname><given-names>ID</given-names></name></person-group> (<year>2017</year>) Synthesis, characterization and biological behavior of some Schiff’s and Mannich base derivatives of Lamotrigine. Arabian Journal of Chemistry 10(1): S184–S189. <ext-link xlink:href="10.1016/j.arabjc.2012.07.020" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.arabjc.2012.07.020</ext-link></mixed-citation>
      </ref>
      <ref id="B83">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Kumar</surname><given-names>BD</given-names></name><name name-style="western"><surname>Rawat</surname><given-names>DS</given-names></name></person-group> (<year>2013</year>) <article-title>Synthesis and antioxidant activity of thymol and carvacrol based Schiff bases.</article-title><source>Bioorganic Medicinal Chemistry Letters</source><volume>23</volume>(<issue>3</issue>): <fpage>641</fpage>–<lpage>645</lpage>. <ext-link xlink:href="10.1016/j.bmcl.2012.12.001" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.bmcl.2012.12.001</ext-link></mixed-citation>
      </ref>
      <ref id="B84">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yan</surname><given-names>W</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hu</surname><given-names>M</given-names></name><name name-style="western"><surname>Bai</surname><given-names>P</given-names></name><name name-style="western"><surname>Tang</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name></person-group> (<year>2018</year>) <article-title>Discovery of novel α-carboline/acylhydrazone hybrids as potent antitumor agents and overcome drug resistance.</article-title><source>European Journal of Medicinal Chemistry</source><volume>152</volume>: <fpage>516</fpage>–<lpage>526</lpage>. <ext-link xlink:href="10.1016/j.ejmech.2018.05.003" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2018.05.003</ext-link></mixed-citation>
      </ref>
      <ref id="B85">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Liang</surname><given-names>C</given-names></name><name name-style="western"><surname>Xia</surname><given-names>J</given-names></name><name name-style="western"><surname>Lei</surname><given-names>D</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Gao</surname><given-names>J</given-names></name></person-group> (<year>2014</year>) <article-title>Synthesis <italic>in vitro</italic> and <italic>in vivo</italic> antitumor activity of symmetrical bis-Schiff base derivatives of isatin.</article-title><source>European Journal of Medicinal Chemistry</source><volume>74</volume>: <fpage>742</fpage>–<lpage>750</lpage>. <ext-link xlink:href="10.1016/j.ejmech.2013.04.040" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2013.04.040</ext-link></mixed-citation>
      </ref>
      <ref id="B86">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Lingala</surname><given-names>S</given-names></name><name name-style="western"><surname>Kotagiri</surname><given-names>N</given-names></name><name name-style="western"><surname>Nerella</surname><given-names>R</given-names></name></person-group> (<year>2013</year>) <article-title>Synthesis and evaluation of Schiff bases of 5-sulfamoyl isatin for their antimicrobial and anti-inflammatory activity.</article-title><source>World Journal Pharmacy and Pharmaceutical Science</source><volume>2</volume>(<issue>6</issue>): <fpage>5511</fpage>–<lpage>5520</lpage>.</mixed-citation>
      </ref>
      <ref id="B87">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Machado</surname><given-names>RS</given-names></name><name name-style="western"><surname>Silva</surname><given-names>MR</given-names></name><name name-style="western"><surname>Viriato</surname><given-names>A</given-names></name></person-group> (<year>2008</year>) <article-title>Furazolidone, Tetracycline and Omeprazole: a low-cost alternative for Helicobacter pylori eradication in children.</article-title><source>Jornal de Pediatria</source><volume>84</volume>(<issue>2</issue>): <fpage>160</fpage>–<lpage>165</lpage>. <ext-link xlink:href="10.2223/JPED.1772" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2223/JPED.1772</ext-link></mixed-citation>
      </ref>
      <ref id="B88">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Magalhães</surname><given-names>TFF</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>CM</given-names></name><name name-style="western"><surname>Dos Santos</surname><given-names>LBF</given-names></name><name name-style="western"><surname>Santos</surname><given-names>DA</given-names></name><name name-style="western"><surname>Silva</surname><given-names>LM</given-names></name><name name-style="western"><surname>Fuchs</surname><given-names>BB</given-names></name><name name-style="western"><surname>Mylonakis</surname><given-names>E</given-names></name><name name-style="western"><surname>Martin</surname><given-names>CVB</given-names></name><name name-style="western"><surname>de Resende-Stoianoff</surname><given-names>MA</given-names></name><name name-style="western"><surname>de Fátima</surname><given-names>Â</given-names></name></person-group> (<year>2020</year>) <article-title>Cinnamyl Schiff bases: synthesis, cytotoxic effects and antifungal activity of clinical interest.</article-title><source>Letters in Applied Microbiology</source><volume>71</volume>(<issue>5</issue>): <fpage>490</fpage>–<lpage>497</lpage>. <ext-link xlink:href="10.1111/lam.13356" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1111/lam.13356</ext-link></mixed-citation>
      </ref>
      <ref id="B89">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Magd-El-Din</surname><given-names>AA</given-names></name><name name-style="western"><surname>Mousa</surname><given-names>HA</given-names></name><name name-style="western"><surname>Labib</surname><given-names>AA</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>AS</given-names></name><name name-style="western"><surname>Abd El-All</surname><given-names>AS</given-names></name><name name-style="western"><surname>Ali</surname><given-names>MM</given-names></name><name name-style="western"><surname>El-Rashedy</surname><given-names>AA</given-names></name><name name-style="western"><surname>El-Desoky</surname><given-names>AH</given-names></name></person-group> (<year>2018</year>) <article-title>Benzimidazole-Schiff bases and their complexes: synthesis, anticancer activity and molecular modeling as Aurora kinase inhibitor.</article-title><source>Zeitschrift für Naturforschung C</source><volume>73</volume>(<issue>11–12</issue>): <fpage>465</fpage>–<lpage>478</lpage>. <ext-link xlink:href="10.1515/znc-2018-0010" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1515/znc-2018-0010</ext-link></mixed-citation>
      </ref>
      <ref id="B90">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Mali</surname><given-names>SN</given-names></name><name name-style="western"><surname>Thorat</surname><given-names>BR</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>DR</given-names></name><name name-style="western"><surname>Pandey</surname><given-names>A</given-names></name></person-group> (<year>2021</year>) <article-title>Mini-review of the importance of hydrazides and their derivative - synthesis and biological activity.</article-title><source>Engineering Proceedings</source><volume>11</volume>(<issue>1</issue>): <fpage>21</fpage>. <ext-link xlink:href="10.3390/ASEC2021-11157" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/ASEC2021-11157</ext-link></mixed-citation>
      </ref>
      <ref id="B91">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Mandewale</surname><given-names>MC</given-names></name><name name-style="western"><surname>Kokate</surname><given-names>S</given-names></name><name name-style="western"><surname>Thorat</surname><given-names>B</given-names></name><name name-style="western"><surname>Sawant</surname><given-names>S</given-names></name><name name-style="western"><surname>Yamgar</surname><given-names>R</given-names></name></person-group> (<year>2019</year>) <article-title>Zinc complexes of hydrazone derivatives bearing 3,4-dihydroquinolin-2(1H)-one nucleus as new anti-tubercularagents.</article-title><source>Arabian Journal of Chemistry</source><volume>12</volume>(<issue>8</issue>): <fpage>4479</fpage>–<lpage>4489</lpage>. <ext-link xlink:href="10.1016/j.arabjc.2016.07.016" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.arabjc.2016.07.016</ext-link></mixed-citation>
      </ref>
      <ref id="B92">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Mathew</surname><given-names>B</given-names></name><name name-style="western"><surname>Vakketh</surname><given-names>SS</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name></person-group> (<year>2010</year>) <article-title>Synthesis, molecular properties and anthelmintic activity of some Schiff bases of 1,3,4-thiadiazole derivatives.</article-title><source>Der Pharma Chemica</source><volume>2</volume>(<issue>5</issue>): <fpage>337</fpage>–<lpage>343</lpage>. <ext-link xlink:href="http://derpharmachemica.com/vol2-iss5/DPC-2010-2-5-337-343.pdf" ext-link-type="uri" xlink:type="simple">http://derpharmachemica.com/vol2-iss5/DPC-2010-2-5-337-343.pdf</ext-link></mixed-citation>
      </ref>
      <ref id="B93">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Marchev</surname><given-names>S</given-names></name><name name-style="western"><surname>Andreeva-Gateva</surname><given-names>P</given-names></name><name name-style="western"><surname>Tzoneva</surname><given-names>R</given-names></name><name name-style="western"><surname>Surcheva</surname><given-names>S</given-names></name><name name-style="western"><surname>Tzonev</surname><given-names>A</given-names></name><name name-style="western"><surname>Kamenova</surname><given-names>K</given-names></name><name name-style="western"><surname>Angelova</surname><given-names>VT</given-names></name><name name-style="western"><surname>Tchekalarova</surname><given-names>J</given-names></name><name name-style="western"><surname>Vlaskovska</surname><given-names>M</given-names></name></person-group> (<year>2019</year>) <article-title>Analgesic activity of some aroylhydrazone-based molecular hybrids with antiseizure activity: <italic>in vivo</italic> and in silico evaluations.</article-title><source>Biotechnology Biotechnological Equipment</source><volume>33</volume>(<issue>1</issue>): <fpage>98</fpage>–<lpage>107</lpage>. <ext-link xlink:href="10.1080/13102818.2018.1555009" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1080/13102818.2018.1555009</ext-link></mixed-citation>
      </ref>
      <ref id="B94">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Matar</surname><given-names>SA</given-names></name><name name-style="western"><surname>Talib</surname><given-names>WH</given-names></name><name name-style="western"><surname>Mustafa</surname><given-names>MS</given-names></name><name name-style="western"><surname>Mubarak</surname><given-names>MS</given-names></name><name name-style="western"><surname>Al Damen</surname><given-names>MA</given-names></name></person-group> (<year>2015</year>) <article-title>Synthesis, characterization, and antimicrobial activity of Schiff bases derived from benzaldehydes and 3,3’-diaminodipropylamine.</article-title><source>Arabian Journal of Chemistry</source><volume>8</volume>(<issue>6</issue>): <fpage>850</fpage>–<lpage>857</lpage>. <ext-link xlink:href="10.1016/j.arabjc.2012.12.039" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.arabjc.2012.12.039</ext-link></mixed-citation>
      </ref>
      <ref id="B95">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Matesanz</surname><given-names>AI</given-names></name><name name-style="western"><surname>Herrero</surname><given-names>JM</given-names></name><name name-style="western"><surname>Quiroga</surname><given-names>AG</given-names></name></person-group> (<year>2021</year>) <article-title>Chemical and biological evaluation of thiosemicarbazone-nearing heterocyclic metal complexes.</article-title><source>Current Topics in Medicinal Chemistry</source><volume>21</volume>(<issue>1</issue>): <fpage>59</fpage>–<lpage>72</lpage>. <ext-link xlink:href="10.2174/1568026620666201022144004" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2174/1568026620666201022144004</ext-link></mixed-citation>
      </ref>
      <ref id="B96">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Matsa</surname><given-names>R</given-names></name><name name-style="western"><surname>Makam</surname><given-names>P</given-names></name><name name-style="western"><surname>Kaushik</surname><given-names>M</given-names></name><name name-style="western"><surname>Hoti</surname><given-names>SL</given-names></name><name name-style="western"><surname>Kannan</surname><given-names>T</given-names></name></person-group> (<year>2019</year>) Thiosemicarbazone derivatives: design, synthesis and <italic>in vitro</italic> antimalarial activity studies. Journal of Pharmaceutical Sciences 137: 104986. <ext-link xlink:href="10.1016/j.ejps.2019.104986" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejps.2019.104986</ext-link></mixed-citation>
      </ref>
      <ref id="B97">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Mavroidi</surname><given-names>B</given-names></name><name name-style="western"><surname>Kaminari</surname><given-names>A</given-names></name><name name-style="western"><surname>Matiadis</surname><given-names>D</given-names></name><name name-style="western"><surname>Hadjipavlou-Litina</surname><given-names>D</given-names></name><name name-style="western"><surname>Pelecanou</surname><given-names>M</given-names></name><name name-style="western"><surname>Tzinia</surname><given-names>A</given-names></name><name name-style="western"><surname>Sagnou</surname><given-names>M</given-names></name></person-group> (<year>2022</year>) <article-title>The prophylactic and multimodal activity of two isatin thiosemicarbazones against Alzheimer’s disease <italic>in vitro</italic>.</article-title><source>Brain Sciences</source><volume>12</volume>(<issue>6</issue>): <fpage>806</fpage>. <ext-link xlink:href="10.3390/brainsci12060806" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/brainsci12060806</ext-link></mixed-citation>
      </ref>
      <ref id="B98">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>McCreary</surname><given-names>EK</given-names></name><name name-style="western"><surname>Heil</surname><given-names>EL</given-names></name><name name-style="western"><surname>Tamma</surname><given-names>PD</given-names></name></person-group> (<year>2021</year>) New perspectives on antimicrobial agents: Cefiderocol. Antimicrobial Agents and Chemotherapy 65(8): e02171–20. <ext-link xlink:href="10.1128/AAC.02171-20" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1128/AAC.02171-20</ext-link></mixed-citation>
      </ref>
      <ref id="B99">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Meenakshi</surname><given-names>K</given-names></name><name name-style="western"><surname>Chandra</surname><given-names>N</given-names></name><name name-style="western"><surname>Sarangapani</surname><given-names>M</given-names></name><name name-style="western"><surname>Raghunandan</surname><given-names>N</given-names></name><name name-style="western"><surname>Gopal</surname><given-names>N</given-names></name></person-group> (<year>2015</year>) <article-title>Synthesis, characterization and anticancer activity of new sulphamoyl isatin derivatives.</article-title><source>Der Pharmacia Lettre</source><volume>7</volume>(<issue>7</issue>): <fpage>198</fpage>–<lpage>203</lpage>. <ext-link xlink:href="http://scholarsresearchlibrary.com/archive.html" ext-link-type="uri" xlink:type="simple">http://scholarsresearchlibrary.com/archive.html</ext-link></mixed-citation>
      </ref>
      <ref id="B100">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Meira</surname><given-names>CS</given-names></name><name name-style="western"><surname>dos Santos Filho</surname><given-names>JM</given-names></name><name name-style="western"><surname>Sousa</surname><given-names>CC</given-names></name><name name-style="western"><surname>Anjos</surname><given-names>PS</given-names></name><name name-style="western"><surname>Cerqueira</surname><given-names>JV</given-names></name><name name-style="western"><surname>Dias Neto</surname><given-names>HA</given-names></name><name name-style="western"><surname>da Silveira</surname><given-names>RG</given-names></name><name name-style="western"><surname>Russo</surname><given-names>HM</given-names></name><name name-style="western"><surname>Wolfender</surname><given-names>J-L</given-names></name><name name-style="western"><surname>Queiroz</surname><given-names>EF</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>DRM</given-names></name><name name-style="western"><surname>Soares</surname><given-names>MBP</given-names></name></person-group> (<year>2018</year>) <article-title>Structural design, synthesis and substituent effect of hydrazone-N-acylhydrazones reveal potent immunomodulatory agents.</article-title><source>Bioorganic Medicinal Chemistry</source><volume>26</volume>(<issue>8</issue>): <fpage>1971</fpage>–<lpage>1985</lpage>. <ext-link xlink:href="10.1016/j.bmc.2018.02.047" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.bmc.2018.02.047</ext-link></mixed-citation>
      </ref>
      <ref id="B101">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Meleddu</surname><given-names>R</given-names></name><name name-style="western"><surname>Distinto</surname><given-names>S</given-names></name><name name-style="western"><surname>Corona</surname><given-names>A</given-names></name><name name-style="western"><surname>Tramontano</surname><given-names>E</given-names></name><name name-style="western"><surname>Bianco</surname><given-names>G</given-names></name><name name-style="western"><surname>Melis</surname><given-names>C</given-names></name><name name-style="western"><surname>Cottiglia</surname><given-names>F</given-names></name><name name-style="western"><surname>Maccioni</surname><given-names>E</given-names></name></person-group> (<year>2017</year>) <article-title>Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase.</article-title><source>Journal of Enzyme Inhibition and Medicinal Chemistry</source><volume>32</volume>(<issue>1</issue>): <fpage>130</fpage>–<lpage>136</lpage>. <ext-link xlink:href="10.1080/14756366.2016.1238366" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1080/14756366.2016.1238366</ext-link></mixed-citation>
      </ref>
      <ref id="B102">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Mesripour</surname><given-names>A</given-names></name><name name-style="western"><surname>Jafari</surname><given-names>E</given-names></name><name name-style="western"><surname>Hajibeiki</surname><given-names>MR</given-names></name><name name-style="western"><surname>Hassanzadeh</surname><given-names>F</given-names></name></person-group> (<year>2023</year>) <article-title>Design, synthesis, docking, and antidepressant activity evaluation of isatin derivatives bearing Schiff bases.</article-title><source>Iranian Journal of Basic Medical Sciences</source><volume>26</volume>(<issue>4</issue>): <fpage>438</fpage>–<lpage>444</lpage>. <ext-link xlink:href="10.22038/IJBMS.2023.68363.14916" ext-link-type="doi" xlink:type="simple">https://doi.org/10.22038/IJBMS.2023.68363.14916</ext-link></mixed-citation>
      </ref>
      <ref id="B103">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Moghadam</surname><given-names>ME</given-names></name><name name-style="western"><surname>Esfahani</surname><given-names>MH</given-names></name><name name-style="western"><surname>Behzad</surname><given-names>M</given-names></name><name name-style="western"><surname>Zolghadri</surname><given-names>S</given-names></name><name name-style="western"><surname>Ramezani</surname><given-names>N</given-names></name><name name-style="western"><surname>Azadi</surname><given-names>Y</given-names></name></person-group> (<year>2023</year>) <article-title>New platinum(II) complexes based on schiff bases: synthesis, specification, X-ray structure, ADMET, DFT, molecular docking, and anticancer activity against breast cancer.</article-title><source>Journal of Biological Inorganic Chemistry</source><volume>28</volume>(<issue>5</issue>): <fpage>519</fpage>–<lpage>529</lpage>. <ext-link xlink:href="10.1007/s00775-023-02005-1" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1007/s00775-023-02005-1</ext-link></mixed-citation>
      </ref>
      <ref id="B104">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Moharana</surname><given-names>AK</given-names></name><name name-style="western"><surname>Dash</surname><given-names>RN</given-names></name><name name-style="western"><surname>Subudhi</surname><given-names>BB</given-names></name></person-group> (<year>2020</year>) <article-title>Thiosemicarbazides: updates on antivirals strategy.</article-title><source>Mini Reviews in Medicinal Chemistry</source><volume>20</volume>(<issue>20</issue>): <fpage>2135</fpage>–<lpage>2152</lpage>. <ext-link xlink:href="10.2174/1389557520666200818212408" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2174/1389557520666200818212408</ext-link></mixed-citation>
      </ref>
      <ref id="B105">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Mrozek-Wilczkiewicz</surname><given-names>A</given-names></name><name name-style="western"><surname>Malarz</surname><given-names>K</given-names></name><name name-style="western"><surname>Rejmund</surname><given-names>M</given-names></name><name name-style="western"><surname>Polanski</surname><given-names>J</given-names></name><name name-style="western"><surname>Musiol</surname><given-names>R</given-names></name></person-group> (<year>2019</year>) <article-title>Anticancer activity of the thiosemicarbazones that are based on di-2-pyridine ketone and quinoline moiety.</article-title><source>European Journal of Medicinal Chemistry</source><volume>171</volume>: <fpage>180</fpage>–<lpage>194</lpage>. <ext-link xlink:href="10.1016/j.ejmech.2019.03.027" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2019.03.027</ext-link></mixed-citation>
      </ref>
      <ref id="B106">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Mukhtar</surname><given-names>SS</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>AS</given-names></name><name name-style="western"><surname>Morsy</surname><given-names>NM</given-names></name><name name-style="western"><surname>Hafez</surname><given-names>TS</given-names></name><name name-style="western"><surname>Hassaneen</surname><given-names>HM</given-names></name><name name-style="western"><surname>Saleh</surname><given-names>FM</given-names></name></person-group> (<year>2021</year>) <article-title>Overview on synthesis, reactions, applications, and biological activities of Schiff bases.</article-title><source>Egyptian Journal of Chemistry</source><volume>64</volume>(<issue>11</issue>): <fpage>6541</fpage>–<lpage>6554</lpage>. <ext-link xlink:href="10.21608/EJCHEM.2021.79736.3920" ext-link-type="doi" xlink:type="simple">https://doi.org/10.21608/EJCHEM.2021.79736.3920</ext-link></mixed-citation>
      </ref>
      <ref id="B107">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Nesterkina</surname><given-names>M</given-names></name><name name-style="western"><surname>Barbalat</surname><given-names>D</given-names></name><name name-style="western"><surname>Kravchenko</surname><given-names>I</given-names></name></person-group> (<year>2020</year>) Design, synthesis and pharmacological profile of (−)Verbenone hydrazones. Open Chemistry 18(1): <ext-link xlink:href="10.1515/chem-2020-0103" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1515/chem-2020-0103</ext-link></mixed-citation>
      </ref>
      <ref id="B108">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Nirmal</surname><given-names>R</given-names></name><name name-style="western"><surname>Prakash</surname><given-names>C</given-names></name><name name-style="western"><surname>Meenakshi</surname><given-names>K</given-names></name><name name-style="western"><surname>Shanmugapandiyan</surname><given-names>P</given-names></name></person-group> (<year>2010</year>) <article-title>Synthesis and antimicrobial evaluation of novel Schiff bases analogue of 3-(4-(amino)phenylimino) 5-fluoroindolin-2-one.</article-title><source>Journal of Young Pharmacists</source><volume>2</volume>(<issue>2</issue>): <fpage>162</fpage>–<lpage>168</lpage>. <ext-link xlink:href="10.4103/0975-1483.63162" ext-link-type="doi" xlink:type="simple">https://doi.org/10.4103/0975-1483.63162</ext-link></mixed-citation>
      </ref>
      <ref id="B109">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Noureen</surname><given-names>A</given-names></name><name name-style="western"><surname>Saleem</surname><given-names>S</given-names></name><name name-style="western"><surname>Farima</surname><given-names>T</given-names></name><name name-style="western"><surname>Siddiqi</surname><given-names>HM</given-names></name><name name-style="western"><surname>Mirza</surname><given-names>B</given-names></name></person-group> (<year>2013</year>) <article-title>Synthesis, characterization, biological evaluation and QSAR of some Schiff base esters: promising new antitumor, antioxidant and anti-inflammatory agents.</article-title><source>Pakistan Journal of Pharmaceutical Sciences</source><volume>26</volume>(<issue>1</issue>): <fpage>113</fpage>–<lpage>123</lpage>. [PMID: <ext-link xlink:type="simple" ext-link-type="pmid" xlink:href="23261736">23261736</ext-link>]</mixed-citation>
      </ref>
      <ref id="B110">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Nyawade</surname><given-names>EA</given-names></name><name name-style="western"><surname>Sibuyi</surname><given-names>NR</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>M</given-names></name><name name-style="western"><surname>Lalancette</surname><given-names>R</given-names></name><name name-style="western"><surname>Onani</surname><given-names>MO</given-names></name></person-group> (<year>2021</year>) Synthesis, characterization and anticancer activity of new 2-acetyl-5-methyl thiophene and cinnamaldehyde thiosemicarbazones and their palladium(II) complexes. Inorganica Chimica Acta 515: 120036. <ext-link xlink:href="10.1016/j.ica.2020.120036" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ica.2020.120036</ext-link></mixed-citation>
      </ref>
      <ref id="B111">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Oladipo</surname><given-names>SD</given-names></name><name name-style="western"><surname>Luckay</surname><given-names>RC</given-names></name><name name-style="western"><surname>Olofinsan</surname><given-names>KA</given-names></name><name name-style="western"><surname>Obakachi</surname><given-names>VA</given-names></name><name name-style="western"><surname>Zamisa</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Adeleke</surname><given-names>AA</given-names></name><name name-style="western"><surname>Badeji</surname><given-names>AA</given-names></name><name name-style="western"><surname>Ogundare</surname><given-names>SA</given-names></name><name name-style="western"><surname>George</surname><given-names>BP</given-names></name></person-group> (<year>2023</year>) Antidiabetes and antioxidant potential of Schiff bases derived from 2-naphthaldehyde and substituted aromatic amines: synthesis, crystal structure, hirshfeld surface analysis, computational, and <italic>in vitro</italic> studies. Heliyon 10(1): e23174. <ext-link xlink:href="10.1016/j.heliyon.2023.e23174" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.heliyon.2023.e23174</ext-link></mixed-citation>
      </ref>
      <ref id="B112">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Padmanabhan</surname><given-names>P</given-names></name><name name-style="western"><surname>Khaleefathullah</surname><given-names>S</given-names></name><name name-style="western"><surname>Kaveri</surname><given-names>K</given-names></name><name name-style="western"><surname>Palani</surname><given-names>G</given-names></name><name name-style="western"><surname>Ramanathan</surname><given-names>G</given-names></name><name name-style="western"><surname>Thennarasu</surname><given-names>S</given-names></name><name name-style="western"><surname>Sivagnanam</surname><given-names>UT</given-names></name></person-group> (<year>2017</year>) <article-title>Antiviral activity of thiosemicarbazones derived from α-amino acids against Dengue virus.</article-title><source>Journal of Medical Virology</source><volume>89</volume>(<issue>3</issue>): <fpage>546</fpage>–<lpage>552</lpage>. <ext-link xlink:href="10.1002/jmv.2465" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1002/jmv.2465</ext-link></mixed-citation>
      </ref>
      <ref id="B113">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Palanimuthu</surname><given-names>D</given-names></name><name name-style="western"><surname>Poon</surname><given-names>R</given-names></name><name name-style="western"><surname>Sahni</surname><given-names>S</given-names></name><name name-style="western"><surname>Anjum</surname><given-names>R</given-names></name><name name-style="western"><surname>Hibbs</surname><given-names>D</given-names></name><name name-style="western"><surname>Lin</surname><given-names>HY</given-names></name><name name-style="western"><surname>Bernhardt</surname><given-names>PV</given-names></name><name name-style="western"><surname>Danuta</surname><given-names>S</given-names></name><name name-style="western"><surname>Kalinowski</surname><given-names>DS</given-names></name><name name-style="western"><surname>Richardson</surname><given-names>DR</given-names></name></person-group> (<year>2017</year>) <article-title>A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer’s disease.</article-title><source>European Journal of Medicinal Chemistry</source><volume>139</volume>: <fpage>612</fpage>–<lpage>632</lpage>. <ext-link xlink:href="10.1016/j.ejmech.2017.08.021" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2017.08.021</ext-link></mixed-citation>
      </ref>
      <ref id="B114">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Palma</surname><given-names>E</given-names></name><name name-style="western"><surname>Botelho</surname><given-names>HM</given-names></name><name name-style="western"><surname>Morais</surname><given-names>GR</given-names></name><name name-style="western"><surname>Rodrigues</surname><given-names>I</given-names></name><name name-style="western"><surname>Santos</surname><given-names>IC</given-names></name><name name-style="western"><surname>Campello</surname><given-names>MPC</given-names></name><name name-style="western"><surname>Raposinho</surname><given-names>P</given-names></name><name name-style="western"><surname>Belchior</surname><given-names>A</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>SS</given-names></name><name name-style="western"><surname>Araújo</surname><given-names>MF</given-names></name><name name-style="western"><surname>Correia</surname><given-names>I</given-names></name><name name-style="western"><surname>Ribeiro</surname><given-names>N</given-names></name><name name-style="western"><surname>Gama</surname><given-names>S</given-names></name><name name-style="western"><surname>Mendes</surname><given-names>F</given-names></name><name name-style="western"><surname>Paulo</surname><given-names>A</given-names></name></person-group> (<year>2019</year>) <article-title>Unravelling the antitumoral potential of novel bis(thiosemicarbazonato) Zn(II) complexes: structural and cellular studies.</article-title><source>Journal of Biological Inorganic Chemistry</source><volume>24</volume>(<issue>1</issue>): <fpage>71</fpage>–<lpage>89</lpage>. <ext-link xlink:href="10.1007/s00775-018-1629-6" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1007/s00775-018-1629-6</ext-link></mixed-citation>
      </ref>
      <ref id="B115">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Pandey</surname><given-names>A</given-names></name><name name-style="western"><surname>Rajavel</surname><given-names>R</given-names></name><name name-style="western"><surname>Chandraker</surname><given-names>S</given-names></name><name name-style="western"><surname>Dash</surname><given-names>D</given-names></name></person-group> (<year>2012</year>) <article-title>Synthesis of Schiff bases of 2-amino-5-aryl-1, 3,4-thiadiazole and its analgesic, anti-inflammatory and anti-bacterial activity.</article-title><source>Journal of Chemistry</source><volume>9</volume>(<issue>4</issue>): <fpage>2524</fpage>–<lpage>2531</lpage>. <ext-link xlink:href="10.1155/2012/145028" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1155/2012/145028</ext-link></mixed-citation>
      </ref>
      <ref id="B116">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Panneerselvam</surname><given-names>P</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>RS</given-names></name><name name-style="western"><surname>Murali</surname><given-names>K</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>NR</given-names></name></person-group> (<year>2010</year>) <article-title>Synthesis, analgesic, anti-inflammatory and antimicrobial activities of some novel Schiff’s bases of 5-subsituted isatin.</article-title><source>Der Pharma Chemica</source><volume>2</volume>(<issue>1</issue>): <fpage>28</fpage>–<lpage>37</lpage>. <ext-link xlink:href="http://derpharmachemica.com/archive.html" ext-link-type="uri" xlink:type="simple">http://derpharmachemica.com/archive.html</ext-link></mixed-citation>
      </ref>
      <ref id="B117">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Patil</surname><given-names>SA</given-names></name><name name-style="western"><surname>Manjunatha</surname><given-names>M</given-names></name><name name-style="western"><surname>Kamble</surname><given-names>UV</given-names></name><name name-style="western"><surname>Badami</surname><given-names>PS</given-names></name></person-group> (<year>2011</year>) <article-title>Synthesis, spectral characterization and biological evaluation Co(II), Ni(II), Cu(II) and Mn(II) metal complexes of novel isatin Schiff base ligand.</article-title><source>Der Pharma Chemica</source><volume>3</volume>(<issue>3</issue>): <fpage>97</fpage>–<lpage>108</lpage>. <ext-link xlink:href="http://derpharmachemica.com/vol3-iss3/DPC-2011-3-3-97-108.pdf" ext-link-type="uri" xlink:type="simple">http://derpharmachemica.com/vol3-iss3/DPC-2011-3-3-97-108.pdf</ext-link></mixed-citation>
      </ref>
      <ref id="B118">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Pelivan</surname><given-names>K</given-names></name><name name-style="western"><surname>Miklos</surname><given-names>W</given-names></name><name name-style="western"><surname>van Schoonhoven</surname><given-names>S</given-names></name><name name-style="western"><surname>Koellensperger</surname><given-names>G</given-names></name><name name-style="western"><surname>Gille</surname><given-names>L</given-names></name><name name-style="western"><surname>Berger</surname><given-names>W</given-names></name><name name-style="western"><surname>Keppler</surname><given-names>BK</given-names></name></person-group> (<year>2015</year>) <article-title>Differences in protein binding and excretion of Triapine and its Fe(III) complex.</article-title><source>Journal of Inorganic Biochemistry</source><volume>160</volume>: <fpage>61</fpage>–<lpage>69</lpage>.<ext-link xlink:href="10.1016/j.jinorgbio.2015.10.006" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.jinorgbio.2015.10.006</ext-link></mixed-citation>
      </ref>
      <ref id="B119">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Pervaiz</surname><given-names>M</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>I</given-names></name><name name-style="western"><surname>Yousaf</surname><given-names>M</given-names></name><name name-style="western"><surname>Kirn</surname><given-names>S</given-names></name><name name-style="western"><surname>Munawar</surname><given-names>A</given-names></name><name name-style="western"><surname>Saeed</surname><given-names>Z</given-names></name><name name-style="western"><surname>Adnan</surname><given-names>A</given-names></name><name name-style="western"><surname>Gulzar</surname><given-names>T</given-names></name><name name-style="western"><surname>Kamal</surname><given-names>T</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>A</given-names></name><name name-style="western"><surname>Rashid</surname><given-names>A</given-names></name></person-group> (<year>2019</year>) <article-title>Synthesis, spectral and antimicrobial studies of amino acid derivative Schiff base metal (Co, Mn, Cu, and Cd) complexes.</article-title><source>Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy</source><volume>206</volume>: <fpage>642</fpage>–<lpage>649</lpage>. <ext-link xlink:href="10.1016/j.saa.2018.05.057" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.saa.2018.05.057</ext-link></mixed-citation>
      </ref>
      <ref id="B120">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Pervez</surname><given-names>H</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M</given-names></name><name name-style="western"><surname>Zaib</surname><given-names>S</given-names></name><name name-style="western"><surname>Yaqub</surname><given-names>M</given-names></name><name name-style="western"><surname>Naseer</surname><given-names>MM</given-names></name><name name-style="western"><surname>Iqbal</surname><given-names>J</given-names></name></person-group> (<year>2016</year>) <article-title>Synthesis, cytotoxic and urease inhibitory activities of some novel isatin-derived bis-Schiff bases and their copper(II) complexes.</article-title><source>Medicinal Chemistry Communications</source><volume>7</volume>(<issue>5</issue>): <fpage>914</fpage>–<lpage>923</lpage>. <ext-link xlink:href="10.1039/C5MD00529A" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1039/C5MD00529A</ext-link></mixed-citation>
      </ref>
      <ref id="B121">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Pham</surname><given-names>VH</given-names></name><name name-style="western"><surname>Phan</surname><given-names>TPD</given-names></name><name name-style="western"><surname>Phan</surname><given-names>DC</given-names></name><name name-style="western"><surname>Vu</surname><given-names>BD</given-names></name></person-group> (<year>2020</year>) <article-title>Synthesis and bioactivity of thiosemicarbazones containing adamantane skeletons.</article-title><source>Molecules (Basel, Switzerland)</source><volume>25</volume>(<issue>2</issue>): <fpage>324</fpage>. <ext-link xlink:href="https://doi.org.10.3390/molecules25020324" ext-link-type="uri" xlink:type="simple">https://doi.org.10.3390/molecules25020324</ext-link></mixed-citation>
      </ref>
      <ref id="B122">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Prakash</surname><given-names>CR</given-names></name><name name-style="western"><surname>Raja</surname><given-names>S</given-names></name></person-group> (<year>2013</year>) <article-title>Synthesis, characterization and <italic>in vitro</italic> antimicrobial activity of some novel 5-substituted Schiff and Mannich base of isatin derivatives.</article-title><source>Journal of Saudi Chemical Society</source><volume>17</volume>(<issue>3</issue>): <fpage>337</fpage>–<lpage>344</lpage>. <ext-link xlink:href="10.1016/j.jscs.2011.10.022" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.jscs.2011.10.022</ext-link></mixed-citation>
      </ref>
      <ref id="B123">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Qi</surname><given-names>J</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Qian</surname><given-names>K</given-names></name><name name-style="western"><surname>Tian</surname><given-names>L</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yang</surname><given-names>D</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name></person-group> (<year>2018</year>) <article-title>Synthesis, antiproliferative activity and mechanism of gallium(III)-thiosemicarbazone complexes as potential anti-breast cancer agents.</article-title><source>European Journal of Medicinal Chemistry</source><volume>154</volume>: <fpage>91</fpage>–<lpage>100</lpage>. <ext-link xlink:href="10.1016/j.ejmech.2018.05.016" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2018.05.016</ext-link></mixed-citation>
      </ref>
      <ref id="B124">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Raczuk</surname><given-names>E</given-names></name><name name-style="western"><surname>Dmochowska</surname><given-names>B</given-names></name><name name-style="western"><surname>Samaszko-Fiertek</surname><given-names>J</given-names></name><name name-style="western"><surname>Madaj</surname><given-names>J</given-names></name></person-group> (<year>2022</year>) <article-title>Different Schiff bases-structure, importance, and classification.</article-title><source>Molecules (Basel, Switzerland)</source><volume>27</volume>(<issue>3</issue>): <fpage>787</fpage>. <ext-link xlink:href="10.3390/molecules27030787" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/molecules27030787</ext-link></mixed-citation>
      </ref>
      <ref id="B125">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Raju</surname><given-names>SK</given-names></name><name name-style="western"><surname>Settu</surname><given-names>A</given-names></name><name name-style="western"><surname>Thiyagarajan</surname><given-names>A</given-names></name><name name-style="western"><surname>Rama</surname><given-names>D</given-names></name><name name-style="western"><surname>Sekar</surname><given-names>P</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name></person-group> (<year>2022</year>) <article-title>Biological applications of Schiff bases: an overview.</article-title><source>GSC Biological and Pharmaceutical Sciences</source><volume>21</volume>(<issue>3</issue>): <fpage>203</fpage>–<lpage>215</lpage>. <ext-link xlink:href="10.30574/gscbps.2022.21.3.0484" ext-link-type="doi" xlink:type="simple">https://doi.org/10.30574/gscbps.2022.21.3.0484</ext-link></mixed-citation>
      </ref>
      <ref id="B126">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Rangaraju</surname><given-names>A</given-names></name><name name-style="western"><surname>Pannerselvam</surname><given-names>P</given-names></name><name name-style="western"><surname>Murali</surname><given-names>K</given-names></name></person-group> (<year>2013</year>) <article-title>Synthesis of novel 1H-indole-2,3-dione derivatives as potent antimycobacterial agents.</article-title><source>International Journal of Advances in Pharmacy, Biology and Chemistry</source><volume>2</volume>(<issue>4</issue>): <fpage>616</fpage>–<lpage>622</lpage>. <ext-link xlink:type="simple" ext-link-type="uri" xlink:href="http://www.ijapbs.com">www.ijapbs.com</ext-link></mixed-citation>
      </ref>
      <ref id="B127">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Rezki</surname><given-names>N</given-names></name><name name-style="western"><surname>Al-Sodies</surname><given-names>SA</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>HEA</given-names></name><name name-style="western"><surname>Ihmaid</surname><given-names>S</given-names></name><name name-style="western"><surname>Messali</surname><given-names>M</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>S</given-names></name><name name-style="western"><surname>Aouad</surname><given-names>MR</given-names></name></person-group> (<year>2019</year>) <article-title>A novel dicationic ionic liquids encompassing pyridinium hydrazone-phenoxy conjugates as antimicrobial agents targeting diverse high resistant microbial strains.</article-title><source>Journal of Molecular Liquids</source><volume>284</volume>: <fpage>431</fpage>–<lpage>444</lpage>. <ext-link xlink:href="10.1016/j.molliq.2019.04.010" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.molliq.2019.04.010</ext-link></mixed-citation>
      </ref>
      <ref id="B128">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Reznichenko</surname><given-names>O</given-names></name><name name-style="western"><surname>Quillévéré</surname><given-names>A</given-names></name><name name-style="western"><surname>Martins</surname><given-names>RP</given-names></name><name name-style="western"><surname>Loaëc</surname><given-names>N</given-names></name><name name-style="western"><surname>Kang</surname><given-names>H</given-names></name><name name-style="western"><surname>Lista</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Beauvineau</surname><given-names>C</given-names></name><name name-style="western"><surname>González-García</surname><given-names>J</given-names></name><name name-style="western"><surname>Guillot</surname><given-names>R</given-names></name><name name-style="western"><surname>Voisset</surname><given-names>C</given-names></name><name name-style="western"><surname>Daskalogianni</surname><given-names>C</given-names></name><name name-style="western"><surname>Fåhraeus</surname><given-names>R</given-names></name><name name-style="western"><surname>Teulade-Fichou</surname><given-names>M-P</given-names></name><name name-style="western"><surname>Blondel</surname><given-names>M</given-names></name><name name-style="western"><surname>Granzhan</surname><given-names>A</given-names></name></person-group> (<year>2019</year>) <article-title>Novel cationic bis(acylhydrazones) as modulators of Epstein–Barr virus immune evasion acting through disruption of interaction between nucleolin and G-quadruplexes of EBNA1 mRNA.</article-title><source>European Journal of Medicinal Chemistry</source><volume>178</volume>: <fpage>13</fpage>–<lpage>29</lpage>. <ext-link xlink:href="10.1016/j.ejmech.2019.05.042" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2019.05.042</ext-link></mixed-citation>
      </ref>
      <ref id="B129">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Rohane</surname><given-names>SH</given-names></name><name name-style="western"><surname>Chauhan</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Fuloria</surname><given-names>NK</given-names></name><name name-style="western"><surname>Fuloria</surname><given-names>S</given-names></name></person-group> (<year>2020</year>) <article-title>Synthesis and in vitro antimycobacterial potential of novel hydrazones of eugenol.</article-title><source>Arabian Journal of Chemistry</source><volume>13</volume>(<issue>2</issue>): <fpage>4495</fpage>–<lpage>4504</lpage>. <ext-link xlink:href="10.1016/j.arabjc.2019.09.004" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.arabjc.2019.09.004</ext-link></mixed-citation>
      </ref>
      <ref id="B130">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Rogolino</surname><given-names>D</given-names></name><name name-style="western"><surname>Bacchi</surname><given-names>A</given-names></name><name name-style="western"><surname>De Luca</surname><given-names>L</given-names></name><name name-style="western"><surname>Rispoli</surname><given-names>G</given-names></name><name name-style="western"><surname>Sechi</surname><given-names>M</given-names></name><name name-style="western"><surname>Stevaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Naesens</surname><given-names>L</given-names></name><name name-style="western"><surname>Carcelli</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>) <article-title>Investigation of the salicylaldehyde thiosemicarbazone scaffold for inhibition of influenza virus PA endonuclease.</article-title><source>Journal of Biological Inorganic Chemistry</source><volume>20</volume>(<issue>7</issue>): <fpage>1109</fpage>–<lpage>1121</lpage>. <ext-link xlink:href="10.1007/s00775-015-1292-0" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1007/s00775-015-1292-0</ext-link></mixed-citation>
      </ref>
      <ref id="B131">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Roque-Marques</surname><given-names>KM</given-names></name><name name-style="western"><surname>do Desterro</surname><given-names>MR</given-names></name><name name-style="western"><surname>de Arruda</surname><given-names>SM</given-names></name><name name-style="western"><surname>de Araújo Neto</surname><given-names>LN</given-names></name><name name-style="western"><surname>do Carmo Alves de Lima</surname><given-names>M</given-names></name><name name-style="western"><surname>de Almeida</surname><given-names>SMV</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>ECD</given-names></name><name name-style="western"><surname>de Aquino</surname><given-names>TM</given-names></name><name name-style="western"><surname>da Silva-Júnior</surname><given-names>EF</given-names></name><name name-style="western"><surname>de Araújo-Júnior</surname><given-names>JX</given-names></name><name name-style="western"><surname>de Silva</surname><given-names>M</given-names></name><name name-style="western"><surname>de Dantas</surname><given-names>MD</given-names></name><name name-style="western"><surname>Santos</surname><given-names>JCC</given-names></name><name name-style="western"><surname>Figueiredo</surname><given-names>IM</given-names></name><name name-style="western"><surname>Bazin</surname><given-names>MA</given-names></name><name name-style="western"><surname>Marchand</surname><given-names>P</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>TG</given-names></name><name name-style="western"><surname>Mendonça Junior</surname><given-names>FJB</given-names></name></person-group> (<year>2019</year>) <article-title>5-Nitro-thiophene-thiosemicarbazone derivatives present antitumor activity mediated by aApoptosis and DNA intercalation.</article-title><source>Current Topics in Medicinal Chemistry</source><volume>19</volume>(<issue>13</issue>): <fpage>1075</fpage>–<lpage>1091</lpage>. <ext-link xlink:href="10.2174/1568026619666190621120304" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2174/1568026619666190621120304</ext-link></mixed-citation>
      </ref>
      <ref id="B132">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Sandhu</surname><given-names>QUA</given-names></name><name name-style="western"><surname>Pervaiz</surname><given-names>M</given-names></name><name name-style="western"><surname>Majid</surname><given-names>A</given-names></name><name name-style="western"><surname>Younas</surname><given-names>U</given-names></name><name name-style="western"><surname>Saeed</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ashraf</surname><given-names>A</given-names></name><name name-style="western"><surname>Khan</surname><given-names>RRM</given-names></name><name name-style="western"><surname>Ullah</surname><given-names>S</given-names></name><name name-style="western"><surname>Ali</surname><given-names>F</given-names></name><name name-style="western"><surname>Jelani</surname><given-names>S</given-names></name></person-group> (<year>2023</year>) <article-title>Schiff base metal complexes as anti-inflammatory agents.</article-title><source>Journal of Coordination Chemistry</source><volume>76</volume>(<issue>9–10</issue>): <fpage>1094</fpage>–<lpage>1118</lpage>. <ext-link xlink:href="10.1080/00958972.2023.2226794" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1080/00958972.2023.2226794</ext-link></mixed-citation>
      </ref>
      <ref id="B133">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Saranya</surname><given-names>S</given-names></name><name name-style="western"><surname>Haribabu</surname><given-names>J</given-names></name><name name-style="western"><surname>Palakkeezhillam</surname><given-names>VNV</given-names></name><name name-style="western"><surname>Jerome</surname><given-names>P</given-names></name><name name-style="western"><surname>Gomathi</surname><given-names>K</given-names></name><name name-style="western"><surname>Rao</surname><given-names>KK</given-names></name><name name-style="western"><surname>Babu</surname><given-names>VHHS</given-names></name><name name-style="western"><surname>Karvembu</surname><given-names>R</given-names></name><name name-style="western"><surname>Gayathri</surname><given-names>D</given-names></name></person-group> (<year>2019</year>) . Molecular structures, hirshfeld analysis and biological investigations of isatin based thiosemicarbazones. Journal of Molecular Structure 1198. <ext-link xlink:href="10.1016/j.molstruc.2019.126904" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.molstruc.2019.126904</ext-link></mixed-citation>
      </ref>
      <ref id="B134">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Sarvi</surname><given-names>S</given-names></name><name name-style="western"><surname>Crispin</surname><given-names>R</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>L</given-names></name><name name-style="western"><surname>Hurley</surname><given-names>TD</given-names></name><name name-style="western"><surname>Houston</surname><given-names>DR</given-names></name><name name-style="western"><surname>Kriegsheim</surname><given-names>A</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CH</given-names></name><name name-style="western"><surname>Mochly-Rosen</surname><given-names>D</given-names></name><name name-style="western"><surname>Ranzani</surname><given-names>M</given-names></name><name name-style="western"><surname>Mathers</surname><given-names>ME</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Adams</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Carragher</surname><given-names>NO</given-names></name><name name-style="western"><surname>Fujita</surname><given-names>M</given-names></name><name name-style="western"><surname>Schuchter</surname><given-names>L</given-names></name><name name-style="western"><surname>Unciti-Broceta</surname><given-names>A</given-names></name><name name-style="western"><surname>Brunton</surname><given-names>VG</given-names></name><name name-style="western"><surname>Patton</surname><given-names>EE</given-names></name></person-group> (<year>2018</year>) <article-title>ALDH1 bio-activates Nifuroxazide to eradicate ALDH high melanoma-initiating cells.</article-title><source>Cell Chemical Biology</source><volume>25</volume>(<issue>12</issue>): <fpage>1456</fpage>–<lpage>1469</lpage>. <ext-link xlink:href="10.1016/j.chembiol.2018.09.005" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.chembiol.2018.09.005</ext-link></mixed-citation>
      </ref>
      <ref id="B135">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Scheeren</surname><given-names>TW</given-names></name></person-group> (<year>2015</year>) <article-title>Ceftobiprole medocaril in the treatment of hospital-acquired pneumonia.</article-title><source>Future Microbiology</source><volume>10</volume>(<issue>12</issue>): <fpage>1913</fpage>–<lpage>1928</lpage>. <ext-link xlink:href="10.2217/fmb.15.115" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2217/fmb.15.115</ext-link></mixed-citation>
      </ref>
      <ref id="B136">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Şen</surname><given-names>B</given-names></name><name name-style="western"><surname>Kalhan</surname><given-names>HK</given-names></name><name name-style="western"><surname>Demir</surname><given-names>V</given-names></name><name name-style="western"><surname>Güler</surname><given-names>EE</given-names></name><name name-style="western"><surname>Kayalı</surname><given-names>HA</given-names></name><name name-style="western"><surname>Subaşı</surname><given-names>E</given-names></name></person-group> (<year>2019</year>) <article-title>Crystal structures, spectroscopic properties of new cobalt(II), nickel(II), zinc(II) and palladium(II) complexes derived from 2-acetyl-5-chloro thiophene thiosemicarbazone: anticancer evaluation.</article-title><source>Materials Science and Engineering C</source><volume>98</volume>: <fpage>550</fpage>–<lpage>559</lpage>. <ext-link xlink:href="10.1016/j.msec.2018.12.080" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.msec.2018.12.080</ext-link></mixed-citation>
      </ref>
      <ref id="B137">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Serafim</surname><given-names>MRA</given-names></name><name name-style="western"><surname>Gonçalves</surname><given-names>JE</given-names></name><name name-style="western"><surname>de Souza</surname><given-names>FP</given-names></name><name name-style="western"><surname>de Melo Loureiro</surname><given-names>AP</given-names></name><name name-style="western"><surname>Storpirtis</surname><given-names>S</given-names></name><name name-style="western"><surname>Krogh</surname><given-names>R</given-names></name><name name-style="western"><surname>Andricopulo</surname><given-names>AD</given-names></name><name name-style="western"><surname>Dias</surname><given-names>LC</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>EI</given-names></name></person-group> (<year>2014</year>) <article-title>Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-<tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Trypanosoma</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">cruzi</tp:taxon-name-part></tp:taxon-name> activity.</article-title><source>European Journal of Medicinal Chemistry</source><volume>82</volume>: <fpage>418</fpage>–<lpage>425</lpage>. <ext-link xlink:href="10.1016/j.ejmech.2014.05.077" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2014.05.077</ext-link></mixed-citation>
      </ref>
      <ref id="B138">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Sevinçli</surname><given-names>ZŞ</given-names></name><name name-style="western"><surname>Duran</surname><given-names>GN</given-names></name><name name-style="western"><surname>Özbil</surname><given-names>M</given-names></name><name name-style="western"><surname>Karalı</surname><given-names>N</given-names></name></person-group> (<year>2020</year>) Synthesis, molecular modeling and antiviral activity of novel 5-fluoro-1H-indole-2,3-dione 3-thiosemicarbazones. Bioorganic Chemistry 104: 104202. <ext-link xlink:href="10.1016/j.bioorg.2020.104202" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.bioorg.2020.104202</ext-link></mixed-citation>
      </ref>
      <ref id="B139">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Shah</surname><given-names>MA</given-names></name><name name-style="western"><surname>Uddin</surname><given-names>A</given-names></name><name name-style="western"><surname>Shah</surname><given-names>MR</given-names></name><name name-style="western"><surname>Ali</surname><given-names>I</given-names></name><name name-style="western"><surname>Ullah</surname><given-names>R</given-names></name><name name-style="western"><surname>Hannan</surname><given-names>PA</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>H</given-names></name></person-group> (<year>2022</year>) <article-title>Synthesis and characterization of novel hydrazone derivatives of Isonicotinic hydrazide and their evaluation for antibacterial and cytotoxic potential.</article-title><source>Molecules</source><volume>27</volume>(<issue>19</issue>): <fpage>6770</fpage>. <ext-link xlink:href="10.3390/molecules27196770" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/molecules27196770</ext-link></mixed-citation>
      </ref>
      <ref id="B140">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Shakya</surname><given-names>B</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>PN</given-names></name></person-group> (<year>2020</year>) <article-title>Thiosemicarbazones as potent anticancer agents and their modes of action.</article-title><source>Mini Reviews in Medicinal Chemistry</source><volume>20</volume>(<issue>8</issue>): <fpage>638</fpage>–<lpage>661</lpage>. <ext-link xlink:href="10.2174/1389557519666191029130310" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2174/1389557519666191029130310</ext-link></mixed-citation>
      </ref>
      <ref id="B141">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Sharma</surname><given-names>V</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>R</given-names></name><name name-style="western"><surname>Bua</surname><given-names>S</given-names></name><name name-style="western"><surname>Supuran</surname><given-names>CT</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>PK</given-names></name></person-group> (<year>2019</year>) <article-title>Synthesis of novel benzenesulfonamide bearing 1,2,3-triazole linked hydroxy-trifluoromethylpyrazolines and hydrazones as selective carbonic anhydrase isoforms IX and XII inhibitors.</article-title><source>Bioorganic Chemistry</source><volume>85</volume>: <fpage>198</fpage>–<lpage>208</lpage>. <ext-link xlink:href="10.1016/j.bioorg.2019.01.002" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.bioorg.2019.01.002</ext-link></mixed-citation>
      </ref>
      <ref id="B142">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Shehzad</surname><given-names>MT</given-names></name><name name-style="western"><surname>Hameed</surname><given-names>A</given-names></name><name name-style="western"><surname>Al-Rashida</surname><given-names>M</given-names></name><name name-style="western"><surname>Imran</surname><given-names>A</given-names></name><name name-style="western"><surname>Uroos</surname><given-names>M</given-names></name><name name-style="western"><surname>Asari</surname><given-names>A</given-names></name><name name-style="western"><surname>Mohamad</surname><given-names>H</given-names></name><name name-style="western"><surname>Islam</surname><given-names>M</given-names></name><name name-style="western"><surname>Iftikhar</surname><given-names>S</given-names></name><name name-style="western"><surname>Shafiq</surname><given-names>Z</given-names></name><name name-style="western"><surname>Iqbal</surname><given-names>J</given-names></name></person-group> (<year>2019</year>) Exploring antidiabetic potential of adamantyl-thiosemicarbazones via aldose reductase (ALR2) inhibition. Bioorganic Chemistry 92: 103244. <ext-link xlink:href="10.1016/j.bioorg.2019.103244" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.bioorg.2019.103244</ext-link></mixed-citation>
      </ref>
      <ref id="B143">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Shirin</surname><given-names>M</given-names></name><name name-style="western"><surname>Islam</surname><given-names>MS</given-names></name></person-group> (<year>2020</year>) <article-title>Ceftriaxone, an empirical goldmine: a systematic review of randomized controlled trials.</article-title><source>Mathews Journal of Pharmaceutical Science</source><volume>4</volume>(<issue>1</issue>): <fpage>1</fpage>–<lpage>5</lpage>. <ext-link xlink:href="10.30654/MJPS.10001" ext-link-type="doi" xlink:type="simple">https://doi.org/10.30654/MJPS.10001</ext-link></mixed-citation>
      </ref>
      <ref id="B144">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Shukla</surname><given-names>SN</given-names></name><name name-style="western"><surname>Gaur</surname><given-names>P</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>JP</given-names></name><name name-style="western"><surname>Mathews</surname><given-names>S</given-names></name><name name-style="western"><surname>Rai</surname><given-names>N</given-names></name></person-group> (<year>2015</year>) <article-title>Synthesis, characterization and antibacterial activity of complexes of palladium with Schiff bases derived from 1,3-diaminopropane.</article-title><source>International Journal of Basic and Applied Chemical Science</source><volume>5</volume>(<issue>1</issue>): <fpage>18</fpage>–<lpage>28</lpage>. <ext-link xlink:href="http://www.cibtech.org/jcs.htm" ext-link-type="uri" xlink:type="simple">http://www.cibtech.org/jcs.htm</ext-link></mixed-citation>
      </ref>
      <ref id="B145">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Silva</surname><given-names>BNM</given-names></name><name name-style="western"><surname>Sales Junior</surname><given-names>PA</given-names></name><name name-style="western"><surname>Romanha</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Murta</surname><given-names>SMF</given-names></name><name name-style="western"><surname>Lima</surname><given-names>CHS</given-names></name><name name-style="western"><surname>Albuquerque</surname><given-names>MG</given-names></name><name name-style="western"><surname>D’Elia</surname><given-names>E</given-names></name><name name-style="western"><surname>Rodrigues</surname><given-names>JGA</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>VF</given-names></name><name name-style="western"><surname>Silva</surname><given-names>FC</given-names></name><name name-style="western"><surname>Angelo</surname><given-names>C Pinto</given-names></name><name name-style="western"><surname>Silva</surname><given-names>BV</given-names></name></person-group> (<year>2019</year>) <article-title>Synthesis of new thiosemicarbazones and semicarbazones containing the 1,2,3-1H-triazole-isatin scaffold: trypanocidal, cytotoxicity, electrochemical assays, and molecular docking.</article-title><source>Medicinal Chemistry</source><volume>15</volume>(<issue>3</issue>): <fpage>240</fpage>–<lpage>256</lpage>. <ext-link xlink:href="10.2174/1573406414666180912120502" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2174/1573406414666180912120502</ext-link></mixed-citation>
      </ref>
      <ref id="B146">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Singh</surname><given-names>P</given-names></name><name name-style="western"><surname>Rawat</surname><given-names>S</given-names></name><name name-style="western"><surname>Agrahari</surname><given-names>AK</given-names></name><name name-style="western"><surname>Singh</surname><given-names>M</given-names></name><name name-style="western"><surname>Chugh</surname><given-names>S</given-names></name><name name-style="western"><surname>Gurcha</surname><given-names>S</given-names></name><name name-style="western"><surname>Singh</surname><given-names>A</given-names></name><name name-style="western"><surname>Abrahams</surname><given-names>K</given-names></name><name name-style="western"><surname>Besra</surname><given-names>GS</given-names></name><name name-style="western"><surname>Asthana</surname><given-names>S</given-names></name><name name-style="western"><surname>Rawat</surname><given-names>DS</given-names></name><name name-style="western"><surname>Singh</surname><given-names>R</given-names></name></person-group> (<year>2022</year>) NSC19723, a thiacetazone-like benzaldehyde thiosemicarbazone improves the efficacy of TB drugs <italic>in vitro</italic> and <italic>in vivo</italic>. Microbiology Spectrum 10(6): e0259222. <ext-link xlink:href="10.1128/spectrum.02592-22" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1128/spectrum.02592-22</ext-link></mixed-citation>
      </ref>
      <ref id="B147">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Socea</surname><given-names>L-I</given-names></name><name name-style="western"><surname>Barbuceanu</surname><given-names>S-F</given-names></name><name name-style="western"><surname>Pahontu</surname><given-names>EM</given-names></name><name name-style="western"><surname>Dumitru</surname><given-names>A-C</given-names></name><name name-style="western"><surname>Nitulescu</surname><given-names>GM</given-names></name><name name-style="western"><surname>Sfetea</surname><given-names>RC</given-names></name><name name-style="western"><surname>Apostol</surname><given-names>T-V</given-names></name></person-group> (<year>2022</year>) Acylhydrazones and their biological activity: a review. Molecules (Basel, Switzerland) 27: 8719. <ext-link xlink:href="10.3390/molecules27248719" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/molecules27248719</ext-link></mixed-citation>
      </ref>
      <ref id="B148">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Sólimo</surname><given-names>A</given-names></name><name name-style="western"><surname>Santacruz</surname><given-names>MCS</given-names></name><name name-style="western"><surname>Perez</surname><given-names>AIL</given-names></name><name name-style="western"><surname>de Kier Joffé</surname><given-names>EB</given-names></name><name name-style="western"><surname>Finkielsztein</surname><given-names>LM</given-names></name><name name-style="western"><surname>Callero</surname><given-names>MA</given-names></name></person-group> (<year>2018</year>) <article-title>N<sup>4</sup>-aryl substituted thiosemicarbazones derived from 1-indanones as potential anti-tumor agents for breast cancer treatment.</article-title><source>Journal of Cellular Physiology</source><volume>233</volume>(<issue>6</issue>): <fpage>4677</fpage>–<lpage>4687</lpage>. <ext-link xlink:href="10.1002/jcp.26240" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1002/jcp.26240</ext-link></mixed-citation>
      </ref>
      <ref id="B149">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Stetsiouk</surname><given-names>OU</given-names></name><name name-style="western"><surname>Kovalenko</surname><given-names>TN</given-names></name><name name-style="western"><surname>Andreeva</surname><given-names>IV</given-names></name><name name-style="western"><surname>Belkova</surname><given-names>YuA</given-names></name></person-group> (<year>2023</year>) <article-title>The known-unknown: third-and fourth-generation cephalosporins combined with sulbactam.</article-title><source>Clinical Microbiology and Antimicrobial Chemotherapy</source><volume>25</volume>(<issue>1</issue>): <fpage>41</fpage>–<lpage>55</lpage>. <ext-link xlink:href="10.36488/cmac.2023.1.41-55" ext-link-type="doi" xlink:type="simple">https://doi.org/10.36488/cmac.2023.1.41-55</ext-link></mixed-citation>
      </ref>
      <ref id="B150">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Subasi</surname><given-names>NT</given-names></name></person-group> (<year>2022</year>) Schiff Base in Organic, Inorganic and Physical Chemistry. Edited by Takashiro Akitsu. <ext-link xlink:href="10.5772/intechopen.108178" ext-link-type="doi" xlink:type="simple">https://doi.org/10.5772/intechopen.108178</ext-link> [ISBN978-1-80355-679-6; PRINT ISBN: 978-1-80355-678-9; EBOOK ISBN: 978-1-80355-680-2]</mixed-citation>
      </ref>
      <ref id="B151">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Sumalatha</surname><given-names>V</given-names></name><name name-style="western"><surname>Daravath</surname><given-names>S</given-names></name><name name-style="western"><surname>Rambabu</surname><given-names>A</given-names></name><name name-style="western"><surname>Ramesh</surname><given-names>G</given-names></name><name name-style="western"><surname>Shivaraj</surname></name></person-group> (<year>2021</year>) <article-title>Antioxidant, antimicrobial, DNA binding and cleavage studies of novel Co(II), Ni(II) and Cu(II) complexes of N, O donor Schiff bases: synthesis and spectral characterization.</article-title><source>Journal of Molecular Structure</source><volume>1229</volume>: <fpage>129606</fpage>–<lpage>129614</lpage>. <ext-link xlink:href="10.1016/j.molstruc.2020.129606" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.molstruc.2020.129606</ext-link></mixed-citation>
      </ref>
      <ref id="B152">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Sumrra</surname><given-names>SH</given-names></name><name name-style="western"><surname>Kausar</surname><given-names>S</given-names></name><name name-style="western"><surname>Raza</surname><given-names>MA</given-names></name><name name-style="western"><surname>Zubai</surname><given-names>M</given-names></name><name name-style="western"><surname>Zafar</surname><given-names>MN</given-names></name><name name-style="western"><surname>Nadeem</surname><given-names>MA</given-names></name><name name-style="western"><surname>Mughal</surname><given-names>EU</given-names></name><name name-style="western"><surname>Chohan</surname><given-names>ZH</given-names></name><name name-style="western"><surname>Mushtaq</surname><given-names>F</given-names></name><name name-style="western"><surname>Rashid</surname><given-names>U</given-names></name></person-group> (<year>2018</year>) <article-title>Metal based triazole compounds: their synthesis, computational, antioxidant, enzyme inhibition and antimicrobial properties.</article-title><source>Journal of Molecular Structure</source><volume>1168</volume>: <fpage>202</fpage>–<lpage>211</lpage>. <ext-link xlink:href="10.1016/j.molstruc.2018.05.036" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.molstruc.2018.05.036</ext-link></mixed-citation>
      </ref>
      <ref id="B153">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Tadele</surname><given-names>KT</given-names></name><name name-style="western"><surname>Tsega</surname><given-names>TW</given-names></name></person-group> (<year>2019</year>) <article-title>Schiff bases and their metal complexes as potential anticancer candidates: a review of recent works.</article-title><source>Anti-Cancer Agents in Medicinal Chemistry</source><volume>19</volume>(<issue>15</issue>): <fpage>1786</fpage>–<lpage>1795</lpage>. <ext-link xlink:href="10.2174/1871520619666190227171716" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2174/1871520619666190227171716</ext-link></mixed-citation>
      </ref>
      <ref id="B154">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Tariq</surname><given-names>Q-N</given-names></name><name name-style="western"><surname>Malik</surname><given-names>S</given-names></name><name name-style="western"><surname>Khan</surname><given-names>A</given-names></name><name name-style="western"><surname>Naseer</surname><given-names>MM</given-names></name><name name-style="western"><surname>Khan</surname><given-names>SU</given-names></name><name name-style="western"><surname>Ashraf</surname><given-names>A</given-names></name><name name-style="western"><surname>Ashraf</surname><given-names>M</given-names></name><name name-style="western"><surname>Rafiq</surname><given-names>M</given-names></name><name name-style="western"><surname>Mahmood</surname><given-names>K</given-names></name><name name-style="western"><surname>Tahir</surname><given-names>MN</given-names></name><name name-style="western"><surname>Shafiq</surname><given-names>Z</given-names></name></person-group> (<year>2019</year>) <article-title>Xanthenone-based hydrazones as potent α-glucosidase inhibitors: Synthesis, solid state self-assembly and in silico studies.</article-title><source>Bioorganic Chemistry</source><volume>84</volume>: <fpage>372</fpage>–<lpage>383</lpage>. <ext-link xlink:href="10.1016/j.bioorg.2018.11.053" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.bioorg.2018.11.053</ext-link></mixed-citation>
      </ref>
      <ref id="B155">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Thota</surname><given-names>S</given-names></name><name name-style="western"><surname>Rodrigues</surname><given-names>DA</given-names></name><name name-style="western"><surname>de Sena</surname><given-names>PMP</given-names></name><name name-style="western"><surname>Lima</surname><given-names>LM</given-names></name><name name-style="western"><surname>Fraga</surname><given-names>CAM</given-names></name><name name-style="western"><surname>Barreiro</surname><given-names>EJ</given-names></name></person-group> (<year>2018</year>) <article-title>N-Acylhydrazones as drugs.</article-title><source>Bioorganic Medicinal Chemistry Letters</source><volume>28</volume>(<issue>17</issue>): <fpage>2797</fpage>–<lpage>2806</lpage>. <ext-link xlink:href="10.1016/j.bmcl.2018.07.015" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.bmcl.2018.07.015</ext-link></mixed-citation>
      </ref>
      <ref id="B156">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Tyagi</surname><given-names>P</given-names></name><name name-style="western"><surname>Chandra</surname><given-names>S</given-names></name><name name-style="western"><surname>Saraswat</surname><given-names>BS</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>D</given-names></name></person-group> (<year>2015</year>) Design, spectral characterization, thermal, DFT studies and anticancer cell line activities of Co(II), Ni(II) and Cu(II) complexes of Schiff bases derived from 4-amino-5-(pyridin-4-Yl)-4H-1,2,4-triazole-3-thiol. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 145:155–164. <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1016/j.saa.2015.03.034">10.1016/j.saa.2015.03.034</ext-link></mixed-citation>
      </ref>
      <ref id="B157">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>VerNooy</surname><given-names>RA</given-names></name><name name-style="western"><surname>Mangrum</surname><given-names>JM</given-names></name></person-group> (<year>2005</year>) <article-title>Azimilide, a novel oral class III antiarrhythmic for both supraventricular and ventricular arrhythmias.</article-title><source>Current Drug Targets-Cardiovascular Hematological Disorders</source><volume>5</volume>(<issue>1</issue>): <fpage>75</fpage>–<lpage>84</lpage>. <ext-link xlink:href="10.2174/1568006053004985" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2174/1568006053004985</ext-link></mixed-citation>
      </ref>
      <ref id="B158">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Vhanale</surname><given-names>B</given-names></name><name name-style="western"><surname>Kadam</surname><given-names>D</given-names></name><name name-style="western"><surname>Shind</surname><given-names>A</given-names></name></person-group> (<year>2022</year>) Synthesis, spectral studies, antioxidant and antibacterial evaluation of aromatic nitro and halogenated tetradentate Schiff bases. Heliyon 8(6): e09650. <ext-link xlink:href="10.1016/j.heliyon.2022.e09650" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.heliyon.2022.e09650</ext-link></mixed-citation>
      </ref>
      <ref id="B159">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Vilková</surname><given-names>M</given-names></name><name name-style="western"><surname>Hudácová</surname><given-names>M</given-names></name><name name-style="western"><surname>Palušeková</surname><given-names>N</given-names></name><name name-style="western"><surname>Jendželovský</surname><given-names>R</given-names></name><name name-style="western"><surname>Almáši</surname><given-names>M</given-names></name><name name-style="western"><surname>Béres</surname><given-names>T</given-names></name><name name-style="western"><surname>Fedorocko</surname><given-names>P</given-names></name><name name-style="western"><surname>Kožurková</surname><given-names>M</given-names></name></person-group> (<year>2022</year>) <article-title>Acridine based N-acylhydrazone derivatives as potential anticancer agents: synthesis, characterization and ctDNA/HSA spectroscopic binding properties.</article-title><source>Molecules (Basel, Switzerland)</source><volume>27</volume>(<issue>9</issue>): <fpage>2883</fpage>. <ext-link xlink:href="10.3390/molecules27092883" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/molecules27092883</ext-link></mixed-citation>
      </ref>
      <ref id="B160">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Visbal</surname><given-names>G</given-names></name><name name-style="western"><surname>Justo</surname><given-names>RMS</given-names></name><name name-style="western"><surname>dos Santos da Silva</surname><given-names>MG</given-names></name><name name-style="western"><surname>de Macedo Silva</surname><given-names>ST</given-names></name><name name-style="western"><surname>de Souza</surname><given-names>W</given-names></name><name name-style="western"><surname>Rodrigues</surname><given-names>JCF</given-names></name><name name-style="western"><surname>Navarro</surname><given-names>M</given-names></name></person-group> (<year>2023</year>) <article-title>Zinc(II)-sterol hydrazone complex as a potent anti-<tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Leishmania</tp:taxon-name-part></tp:taxon-name> agent: synthesis, characterization, and insight into its mechanism of antiparasitic action.</article-title><source>Pharmaceutics (Basel)</source><volume>15</volume>(<issue>4</issue>): <fpage>1113</fpage>. <ext-link xlink:href="10.3390/pharmaceutics15041113" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/pharmaceutics15041113</ext-link></mixed-citation>
      </ref>
      <ref id="B161">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Waddai</surname><given-names>FY</given-names></name><name name-style="western"><surname>Kareem</surname><given-names>EK</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>SA</given-names></name></person-group> (<year>2018</year>) <article-title>Synthesis, spectral characterization and antimicrobial activity of some transition metal complexes with new Schiff base ligand (BDABI).</article-title><source>Oriental Journal of Chemistry</source><volume>34</volume>(<issue>1</issue>): <fpage>434</fpage>–<lpage>443</lpage>. <ext-link xlink:href="10.13005/ojc/340147" ext-link-type="doi" xlink:type="simple">https://doi.org/10.13005/ojc/340147</ext-link></mixed-citation>
      </ref>
      <ref id="B162">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Welte</surname><given-names>T</given-names></name><name name-style="western"><surname>Kantecki</surname><given-names>M</given-names></name><name name-style="western"><surname>Stone</surname><given-names>GG</given-names></name><name name-style="western"><surname>Hammond</surname><given-names>J</given-names></name></person-group> (<year>2019</year>) <article-title>Ceftaroline fosamil as a potential treatment option for <tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Staphylococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">aureus</tp:taxon-name-part></tp:taxon-name> community-acquired pneumonia in adults.</article-title><source>International Journal of Antimicrobial Agents</source><volume>54</volume>(<issue>4</issue>): <fpage>410</fpage>–<lpage>422</lpage>. <ext-link xlink:href="10.1016/j.ijantimicag.2019.08.012" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ijantimicag.2019.08.012</ext-link></mixed-citation>
      </ref>
      <ref id="B163">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Yahav</surname><given-names>D</given-names></name><name name-style="western"><surname>Paul</surname><given-names>M</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>A</given-names></name><name name-style="western"><surname>Sarid</surname><given-names>N</given-names></name><name name-style="western"><surname>Leibovici</surname><given-names>L</given-names></name></person-group> (<year>2007</year>) <article-title>Efficacy and safety of Cefepime: a systematic review and meta-analysis.</article-title><source>The Lancet Infectious Diseases</source><volume>7</volume>(<issue>5</issue>): <fpage>338</fpage>–<lpage>348</lpage>. <ext-link xlink:href="10.1016/S1473-3099(07)70109-3" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/S1473-3099(07)70109-3</ext-link></mixed-citation>
      </ref>
      <ref id="B164">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Yang</surname><given-names>HS</given-names></name><name name-style="western"><surname>Choi</surname><given-names>JM</given-names></name><name name-style="western"><surname>In</surname><given-names>J</given-names></name><name name-style="western"><surname>Sung</surname><given-names>TY</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YB</given-names></name><name name-style="western"><surname>Sultana</surname><given-names>S</given-names></name></person-group> (<year>2023</year>) <article-title>Current clinical application of Dantrolene sodium.</article-title><source>Anesthesia and Pain Medicine (Seoul)</source><volume>18</volume>(<issue>3</issue>): <fpage>220</fpage>–<lpage>232</lpage>. <ext-link xlink:href="10.17085/apm.22260" ext-link-type="doi" xlink:type="simple">https://doi.org/10.17085/apm.22260</ext-link></mixed-citation>
      </ref>
      <ref id="B165">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Xia</surname><given-names>D</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name></person-group> (<year>2020</year>) <article-title>Antioxidant properties of camphene-based thiosemicarbazones: experimental and theoretical evaluation.</article-title><source>Molecules (Basel, Switzerland)</source><volume>25</volume>(<issue>5</issue>): <fpage>1192</fpage>. <ext-link xlink:href="10.3390/molecules25051192" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/molecules25051192</ext-link></mixed-citation>
      </ref>
      <ref id="B166">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Yao</surname><given-names>X</given-names></name><name name-style="western"><surname>Hu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>W</given-names></name><name name-style="western"><surname>Song</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Q</given-names></name></person-group> (<year>2021</year>) <article-title>Synthesis, antimicrobial activity, and Molecular docking studies of aminoguanidine derivatives containing an acylhydrazone moiety.</article-title><source>Iranian Journal of Pharmaceutical Research</source><volume>20</volume>(<issue>2</issue>): <fpage>536</fpage>–<lpage>545</lpage>. <ext-link xlink:href="10.22037/ijpr.2020.113711.14446" ext-link-type="doi" xlink:type="simple">https://doi.org/10.22037/ijpr.2020.113711.14446</ext-link></mixed-citation>
      </ref>
      <ref id="B167">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Yoneda</surname><given-names>JD</given-names></name><name name-style="western"><surname>Albuquerque</surname><given-names>MG</given-names></name><name name-style="western"><surname>Leal</surname><given-names>KZ</given-names></name><name name-style="western"><surname>da Costa Santos Santos</surname><given-names>F</given-names></name><name name-style="western"><surname>Batalha</surname><given-names>PN</given-names></name><name name-style="western"><surname>Brozeguini</surname><given-names>L</given-names></name><name name-style="western"><surname>Seidl</surname><given-names>PR</given-names></name><name name-style="western"><surname>de Alencastro</surname><given-names>RB</given-names></name><name name-style="western"><surname>Cunha</surname><given-names>AC</given-names></name><name name-style="western"><surname>de Souza</surname><given-names>MCBV</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>VF</given-names></name><name name-style="western"><surname>Giongo</surname><given-names>VA</given-names></name><name name-style="western"><surname>Cirne-Santos</surname><given-names>C</given-names></name><name name-style="western"><surname>Paixão</surname><given-names>ICP</given-names></name></person-group> (<year>2014</year>) <article-title>Docking of anti-HIV-1 oxoquinoline-acylhydrazone derivatives as potential HSV-1 DNA polymerase inhibitors.</article-title><source>Journal of Molecular Structure</source><volume>1074</volume>: <fpage>263</fpage>–<lpage>270</lpage>. <ext-link xlink:href="10.1016/j.molstruc.2014.05.081" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.molstruc.2014.05.081</ext-link></mixed-citation>
      </ref>
      <ref id="B168">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Zarei</surname><given-names>M</given-names></name><name name-style="western"><surname>Naeimi</surname><given-names>H</given-names></name><name name-style="western"><surname>Zarei</surname><given-names>M.</given-names></name></person-group> (<year>2024</year>) <article-title>Design, preparation and characterization of magnetic ne and their use as a reusable nanocatalystanoparticles functionalized with chitosan/Schiff bas for the green synthesis of 1H-isochromenes under mild conditions.</article-title><source>Royal Society Chemistry Advances</source><volume>14</volume>(<issue>2</issue>): <fpage>1407</fpage>–<lpage>1416</lpage>. <ext-link xlink:href="10.1039/D3RA06416F" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1039/D3RA06416F</ext-link></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
